TWI568796B - A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device - Google Patents

A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device Download PDF

Info

Publication number
TWI568796B
TWI568796B TW102106205A TW102106205A TWI568796B TW I568796 B TWI568796 B TW I568796B TW 102106205 A TW102106205 A TW 102106205A TW 102106205 A TW102106205 A TW 102106205A TW I568796 B TWI568796 B TW I568796B
Authority
TW
Taiwan
Prior art keywords
liquid crystal
crystal alignment
group
treatment agent
carbon atoms
Prior art date
Application number
TW102106205A
Other languages
Chinese (zh)
Other versions
TW201343788A (en
Inventor
Noritoshi Miki
Masaaki Katayama
Koji Sonoyama
Kazuyoshi Hosaka
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW201343788A publication Critical patent/TW201343788A/en
Application granted granted Critical
Publication of TWI568796B publication Critical patent/TWI568796B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D179/00Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen, with or without oxygen, or carbon only, not provided for in groups C09D161/00 - C09D177/00
    • C09D179/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C09D179/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1042Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • C08G73/1078Partially aromatic polyimides wholly aromatic in the diamino moiety
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/13378Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation
    • G02F1/133788Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation by light irradiation, e.g. linearly polarised light photo-polymerisation

Description

組成物、液晶配向處理劑、液晶配向膜及液晶顯示元件 Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element

本發明係有關形成聚醯亞胺膜所使用之組成物,製造液晶顯示元件所使用之液晶配向處理劑,由該液晶配向處理劑所得之液晶配向膜及使用該液晶配向膜之液晶顯示元件。 The present invention relates to a composition for forming a polyimide film, a liquid crystal alignment treatment agent used for producing a liquid crystal display element, a liquid crystal alignment film obtained from the liquid crystal alignment treatment agent, and a liquid crystal display element using the liquid crystal alignment film.

聚醯亞胺系之有機膜因易形成及絕緣性能等而受入注目,被廣泛使用於電子裝置領域中,作為層間絕緣膜、保護膜、液晶顯示元件中之液晶配向膜等用。 Polyimide-based organic films have been attracting attention due to their ease of formation and insulating properties, and are widely used in the field of electronic devices, and are used as interlayer insulating films, protective films, liquid crystal alignment films in liquid crystal display devices, and the like.

近年來伴隨著液晶顯示元件之大畫面化、高精細化,而增加所使用之基板及基板段差的凹凸程度。該狀況下,既使相對於大型基板,及具有較大凹凸段差,仍要求均勻之液晶配向膜。 In recent years, with the increase in the size and definition of liquid crystal display elements, the degree of unevenness of the substrate and substrate used is increased. In this case, a uniform liquid crystal alignment film is required even for a large substrate and a large unevenness step.

製作液晶配向膜之過程中,將含有聚醯胺酸或溶劑可溶性聚醯亞胺(也稱為樹脂)之液晶配向處理劑塗佈於基板時,工業上一般係以柔版印刷法或噴墨塗佈法等進行。 In the process of producing a liquid crystal alignment film, when a liquid crystal alignment treatment agent containing polylysine or a solvent-soluble polyimine (also referred to as a resin) is applied to a substrate, industrially, a flexographic printing method or an inkjet method is generally used. The coating method or the like is carried out.

此時液晶配向處理劑之塗膜性不良時,會發生迸開或 針孔,結果作為液晶顯示元件用時該部分會造成顯示缺陷。因此液晶配向處理劑之溶劑中,除了具有優良之樹脂溶解性的溶劑(也稱為良溶劑)N-甲基-2-吡咯烷酮或γ-丁內酯等,另混合提高液晶配向膜之塗膜性用的樹脂溶解性較低之溶劑(也稱為弱溶劑)乙二醇單丁基醚等(例如參考專利文獻1)。 At this time, when the coating property of the liquid crystal alignment agent is poor, cracking may occur or Pinholes, as a result, can cause display defects when used as a liquid crystal display element. Therefore, in the solvent of the liquid crystal alignment treatment agent, in addition to a solvent having a good resin solubility (also referred to as a good solvent), N-methyl-2-pyrrolidone or γ-butyrolactone, and the like, the film of the liquid crystal alignment film is further mixed. A solvent (also referred to as a weak solvent), ethylene glycol monobutyl ether or the like having a low solubility in a resin (for example, refer to Patent Document 1).

先前技術文獻 Prior technical literature 專利文獻 Patent literature

專利文獻1:日本特開平2-37324號公報 Patent Document 1: Japanese Patent Laid-Open No. 2-37324

但弱溶劑溶解聚醯胺酸或溶劑可溶性聚醯亞胺之能力較差,因此需大量混合,結果會有析出樹脂之問題。 However, weak solvents have poor ability to dissolve polyaminic acid or solvent-soluble polyimine, so that a large amount of mixing is required, and as a result, there is a problem of precipitation of the resin.

另外近年來所使用之智慧型手機或行動電話等行動用途之液晶顯示元件中,為了確保大量顯示面,接合液晶顯示元件之基板間所使用的密封劑係靠近液晶配向膜端部之位置而存在。因此會降低液晶配向膜端部之塗膜性,即,液晶配向膜端部非直線時,或該端部為隆起狀態時,會降低液晶配向膜與密封劑之接合效果,而降低液晶顯示元件之顯示特性及信賴性。 In addition, in a liquid crystal display device for mobile use such as a smart phone or a mobile phone used in recent years, in order to secure a large number of display surfaces, the sealant used between the substrates for bonding the liquid crystal display elements is close to the end of the liquid crystal alignment film. . Therefore, the coating property of the end portion of the liquid crystal alignment film is lowered, that is, when the end portion of the liquid crystal alignment film is not linear, or when the end portion is in a raised state, the bonding effect between the liquid crystal alignment film and the sealant is lowered, and the liquid crystal display element is lowered. Display characteristics and reliability.

有鑑於上述事情,本發明之目的為,提供形成聚醯亞 胺膜用之具有優良塗膜性的組成物。又,藉由本發明之組成物作為液晶配向處理劑用,所得的提高塗佈溶液相對於基板之濕擴性而得均勻之塗膜性,既使端部也具有優良塗膜性之液晶配向膜。特別是既使使用使用具有支鏈之二胺化合物所得的聚醯胺酸或溶劑可溶性聚醯亞胺之液晶配向處理劑,也可具有優良該等特性之液晶配向膜,另外係提供具有上述液晶配向膜之液晶顯示元件。 In view of the above, it is an object of the present invention to provide for the formation of poly A composition having an excellent coating property for an amine film. Moreover, the composition of the present invention is used as a liquid crystal alignment treatment agent, and the obtained coating film is improved in wettability with respect to the substrate to obtain uniform coating property, and the liquid crystal alignment film having excellent coating properties at the end portion. . In particular, even if a liquid crystal alignment treatment agent using a polyaminic acid or a solvent-soluble polyimine obtained by using a branched diamine compound is used, a liquid crystal alignment film having such characteristics can be provided, and the liquid crystal having the above-mentioned liquid crystal is provided. A liquid crystal display element of an alignment film.

經本發明者專心研究後發現,含有具有特定構造之溶劑,與由聚醯亞胺先驅物及聚醯亞胺先驅物經聚醯亞胺化所得之聚醯亞胺所成群中選出的至少一種之聚合物的組成物,對達成上述目的極為有效,而完成本發明。 As a result of intensive research by the present inventors, it has been found that at least one selected from the group consisting of a solvent having a specific structure and a polyimine obtained by polyimine imidization of a polyimide precursor and a polyimide precursor. The composition of the polymer is extremely effective for achieving the above object, and the present invention has been completed.

即,本發明具有下述要旨。 That is, the present invention has the following gist.

(1)一種組成物,其為含有下述成分(A)及成分(B),成分(A):下述式〔1〕所表示之溶劑, (1) A composition comprising the following component (A) and component (B), and component (A): a solvent represented by the following formula [1],

(式〔1〕中,X1表示碳數1至3之烷基)。 (In the formula [1], X 1 represents an alkyl group having 1 to 3 carbon atoms).

成分(B):由聚醯亞胺先驅物及聚醯亞胺先驅物經醯亞胺化所得之聚醯亞胺所成群中選出的至少一種之聚合物。 Component (B): at least one polymer selected from the group consisting of polyimine precursors and polyimine precursors obtained by hydrazine imidization.

(2)如上述(1)所記載之組成物,其中前 述成分(B)為,由以具有下述式〔2〕所表示之支鏈的二胺化合物為原料之一部分用的聚醯亞胺先驅物及聚醯亞胺先驅物經醯亞胺化所得之聚醯亞胺所成群中選出的至少一種之聚合物, (2) The component (B) is a polyimine which is partially used as a raw material of a diamine compound having a branch represented by the following formula [2]. a polymer of at least one selected from the group consisting of a precursor and a polyimine precursor obtained by quinone imidization of a polyimine.

(式〔2〕中,Y1為單鏈、-(CH2)a-(a為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-;Y2為單鍵或-(CH2)b-(b為1至15之整數);Y3為單鍵、-(CH2)c-(c為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-;Y4為由苯環、環己烷環及雜環所成群中選出的二價之環狀基,或具有巢類骨架之碳數12至25的二價之有機基,前述環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代;Y5為由苯環、環己烷環及雜環所成群中所選出的二價之環狀基,該等環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代;n為0至4之整數;Y6為碳數1至18之烷基、碳數1至18的含氟之烷基、碳數1至18之烷氧基或碳數1至18的含氟之烷氧基)。 (In the formula [2], Y 1 is a single chain, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-; Y 2 Is a single bond or -(CH 2 ) b - (b is an integer from 1 to 15); Y 3 is a single bond, -(CH 2 ) c - (c is an integer from 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-; Y 4 is a divalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, or a carbon number 12 to 25 having a nest skeleton The divalent organic group, any hydrogen atom on the above cyclic group may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, or carbon a fluorine-containing alkoxy group or a fluorine atom substituted by 1 to 3; Y 5 is a divalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring, and a heterocyclic ring, and the cyclic groups are Any of the hydrogen atoms may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or Substituted with a fluorine atom; n is an integer of 0 to 4; Y 6 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a carbon number of 1 to 18 fluorine-containing alkoxy group).

(3)如上述(2)所記載之組成物,其中具有前述式〔2〕所表示之支鏈的二胺化合物為,下述式〔2a〕所表示之二胺化合物, (3) The composition according to the above (2), wherein the diamine compound having a branch represented by the formula [2] is a diamine compound represented by the following formula [2a],

(式〔2a〕中,Y1為單鍵、-(CH2)a-(a為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-;Y2為單鍵或-(CH2)b-(b為1至15之整數);Y3為單鍵、-(CH2)c-(c為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-;Y4為由苯環、環己烷環及雜環所成群中選出的二價之環狀基,或具有巢類骨架之碳數12至25的二價之有機基,前述環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3之含氟之烷基、碳數1至3之含氟之烷氧基或氟原子取代;Y5為由苯環、環己烷環及雜環所成群中選出的二價之環狀基,該等環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代;n為0至4之整數;Y6為碳數1至18之烷基、碳數1至18的含氟之烷基、碳數1至18之烷氧基或碳數1至18的含氟之烷氧基;m為1至4之整數)。 (In the formula [2a], Y 1 is a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-; Y 2 Is a single bond or -(CH 2 ) b - (b is an integer from 1 to 15); Y 3 is a single bond, -(CH 2 ) c - (c is an integer from 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-; Y 4 is a divalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, or a carbon number 12 to 25 having a nest skeleton The divalent organic group, any hydrogen atom on the above cyclic group may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, carbon a fluorine-containing alkoxy group or a fluorine atom substituted by 1 to 3; Y 5 is a divalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, and the cyclic groups are Any hydrogen atom may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or fluorine. Atom substituted; n is an integer from 0 to 4; Y 6 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a carbon number of 1 to 18 Fluorinated alkoxy; m is an integer from 1 to 4.

(4)如上述(2)或(3)所記載之組成物,其中具有前述式〔2〕所表示之支鏈的二胺化合物或式〔2a〕所表示之二胺化合物為,二胺成分中之5至80莫耳%。 (4) The composition according to the above (2) or (3), wherein the diamine compound represented by the above formula [2] or the diamine compound represented by the formula [2a] is a diamine component. 5 to 80% of the total.

(5)如上述(1)至(4)中任何一項所記載之組成 物,其中前述成分(B)為,使用含有下述式〔3〕所表示之四羧酸二酐的四羧酸二酐成分之聚合物, (5) The composition according to any one of the above-mentioned (1), wherein the component (B) is a tetracarboxylic acid containing a tetracarboxylic dianhydride represented by the following formula [3]. a polymer of a dianhydride component,

(式〔3〕中,Z1為由下述式〔3a〕至式〔3j〕所成群中選出的至少一種之構造)。 (In the formula [3], Z 1 is a structure of at least one selected from the group consisting of the following formulas [3a] to [3j]).

(式〔3a〕中,Z2至Z5為氫原子、甲基、氯原子或苯環,可各自相同或相異,式〔3g〕中,Z6及Z7為氫原子或甲基,可各自相同或相異)。 (In the formula [3a], Z 2 to Z 5 are a hydrogen atom, a methyl group, a chlorine atom or a benzene ring, and may be the same or different. In the formula [3g], Z 6 and Z 7 are a hydrogen atom or a methyl group. Can be the same or different).

(6)如上述(1)至(5)中任何一項所記載之組成物,其中含有成分(C)用,由N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮及γ-丁內酯所成群中選出的至少一種之溶劑。 (6) The composition according to any one of the above (1) to (5) which contains the component (C), which is composed of N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone and γ - at least one solvent selected from the group consisting of butyrolactone.

(7)如上述(1)至(6)中任何一項所記載之組成物,其中含有成分(D)用,由1-己醇、環己醇、1,2-乙 二醇、1,2-丙二醇、乙二醇單甲基醚、乙二醇單乙基醚、乙二醇單丁基醚、二乙二醇單甲基醚、二乙二醇單乙基醚、二乙二醇單丁基醚、丙二醇單甲基醚、丙二醇單乙基醚及丙二醇單丁基醚所成群中選出的至少一種之溶劑。 (7) The composition according to any one of the above (1) to (6) which contains the component (D), which is composed of 1-hexanol, cyclohexanol, 1,2-B. Glycol, 1,2-propanediol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether At least one solvent selected from the group consisting of diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, and propylene glycol monobutyl ether.

(8)如上述(1)至(7)中任何一項所記載之組成物,其中前述(A)成分為組成物所含的溶劑全體之5至60質量%。 The composition according to any one of the above-mentioned items (1), wherein the component (A) is 5 to 60% by mass based on the total amount of the solvent contained in the composition.

(9)如上述(6)至(8)中任何一項所記載之組成物,其中前述(C)成分為組成物所含的溶劑全體之40至80質量%。 (9) The composition according to any one of the above (6), wherein the component (C) is 40 to 80% by mass based on the total amount of the solvent contained in the composition.

(10)如上述(7)至(9)中任何一項所記載之組成物,其中前述(D)成分為組成物所含的溶劑全體之1至50質量%。 (10) The composition according to any one of the above (7), wherein the component (D) is from 1 to 50% by mass based on the total amount of the solvent contained in the composition.

(11)如上述(1)至(10)中任何一項所記載之組成物,其中組成物中之前述(B)成分為0.1至30質量%。 (11) The composition according to any one of the above (1), wherein the component (B) in the composition is from 0.1 to 30% by mass.

(12)一種聚醯亞胺膜,其為使用如上述(1)至(11)中任何一項所記載之組成物所得。 (12) A polyimine film obtained by using the composition according to any one of the above (1) to (11).

(13)一種液晶配向處理劑,其為使用如上述(1)至(11)中任何一項所記載之組成物所得。 (13) A liquid crystal alignment treatment agent obtained by using the composition according to any one of the above (1) to (11).

(14)一種液晶配向膜,其為使用如上述(13)所記載之液晶配向處理劑所得。 (14) A liquid crystal alignment film obtained by using the liquid crystal alignment treatment agent according to (13) above.

(15)一種液晶配向膜,其為使用如上述(13)所記載之液晶配向處理劑,由噴墨印刷法所得。 (15) A liquid crystal alignment film obtained by an inkjet printing method using the liquid crystal alignment treatment agent according to the above (13).

(16)一種液晶顯示元件,其為具有如上述(14)或(15)所記載之液晶配向膜。 (16) A liquid crystal display element comprising the liquid crystal alignment film according to (14) or (15) above.

(17)如上述(14)或(15)所記載之液晶配向膜,其為使用於一對備有電極之基板之間具有液晶層,且前述一對基板之間配置含有藉由活性能量線及熱中至少一方而聚合之聚合性化合物的液晶組成物,經由將電壓施加於前述電極間且使前述聚合物聚合之步驟所製造的液晶顯示元件上。 (17) The liquid crystal alignment film according to the above (14) or (15), wherein a liquid crystal layer is provided between a pair of substrates having electrodes, and an active energy ray is disposed between the pair of substrates The liquid crystal composition of the polymerizable compound polymerized by at least one of the heat is applied to the liquid crystal display element produced by the step of applying a voltage between the electrodes and polymerizing the polymer.

(18)一種液晶顯示元件,其為具有如上述(17)所記載之液晶配向膜。 (18) A liquid crystal display element comprising the liquid crystal alignment film according to (17) above.

(19)如上述(14)或(15)所記載之液晶配向膜,其為使用於一對備有電極之基板之間具有液晶層且前述一對基板之間配置含有藉由活性的能量線及熱中至少一方而聚合之聚合性化合物的液晶配向膜,經由將電壓施加於前述電極間且使前述聚合性基聚合之步驟所製造的液晶顯示元件上。 (19) The liquid crystal alignment film according to the above (14) or (15), wherein a liquid crystal layer is provided between a pair of substrates having electrodes, and an active energy ray is disposed between the pair of substrates. A liquid crystal alignment film of a polymerizable compound polymerized by at least one of the heat is applied to a liquid crystal display element produced by a step of applying a voltage between the electrodes and polymerizing the polymerizable group.

(20)一種液晶顯示元件,其為具有如上述(19)所記載之液晶配向膜。 (20) A liquid crystal display element comprising the liquid crystal alignment film according to (19) above.

本發明之含有具有特定構造之溶劑,與由聚醯亞胺先驅物及聚醯亞胺所成群中選出的至少一種之聚合物的組成物可提供形成具有優良塗膜性之聚醯亞胺膜用的組成物。又,以本發明之組成物作為液晶配向處理劑用時 可提供,提高塗佈溶液相對於基板之濕擴性而得均勻之塗膜性,且既使液晶配向膜之端部也具有優良塗膜性的液晶配向膜。特別是既使為使用使用具有支鏈之二胺化合物所得的聚醯胺酸或溶劑可溶性聚醯亞胺之液晶配向處理劑,也可提供具有優良之該等特性的液晶配向膜。另外可提供具有上述液晶配向膜之液晶顯示元件、及可提供上述液晶配向膜之液晶配向處理劑。 The composition of the present invention containing a solvent having a specific structure, and at least one polymer selected from the group consisting of a polyimide and a polyimide, can provide a polyimide having excellent coating properties. A composition for a film. Moreover, when the composition of the present invention is used as a liquid crystal alignment treatment agent It is possible to provide a liquid crystal alignment film which has a coating property which is uniform in the wettability of the coating solution with respect to the substrate, and which has excellent coating properties even at the end portion of the liquid crystal alignment film. In particular, a liquid crystal alignment film having excellent properties can be provided even in the case of using a liquid crystal alignment treatment agent using a polyaminic acid or a solvent-soluble polyimine obtained by using a branched diamine compound. Further, a liquid crystal display element having the above liquid crystal alignment film and a liquid crystal alignment treatment agent capable of providing the above liquid crystal alignment film can be provided.

圖1為,以倍率25倍之光學顯微鏡觀察到的鉻蒸鍍基板上聚醯亞胺膜影像之擴大模式圖。 Fig. 1 is an enlarged schematic view showing an image of a polyimide film on a chromium vapor-deposited substrate observed by an optical microscope at a magnification of 25 times.

圖2為,以倍率25倍之光學顯微鏡觀察到的鉻蒸鍍基板上聚醯亞胺膜影像之擴大模式圖。 Fig. 2 is an enlarged schematic view showing an image of a polyimide film on a chromium vapor-deposited substrate observed by an optical microscope at a magnification of 25 times.

下面將詳細說明本發明。 The invention will be described in detail below.

本發明為,含有下述成分(A)及成分(B)之組成物、液晶配向處理劑,使用該液晶配向處理劑所得之液晶配向膜,及具有該液晶配向膜之液晶顯示元件。 The present invention contains a composition of the following components (A) and (B), a liquid crystal alignment treatment agent, a liquid crystal alignment film obtained by using the liquid crystal alignment treatment agent, and a liquid crystal display element having the liquid crystal alignment film.

成分(A):下述式〔1〕所表示之溶劑(也稱為特定溶劑)。 Component (A): a solvent (also referred to as a specific solvent) represented by the following formula [1].

(式〔1〕中,X1表示碳數1至3之烷基)。 (In the formula [1], X 1 represents an alkyl group having 1 to 3 carbon atoms).

成分(B):由聚醯亞胺先驅物及聚醯亞胺先驅物經醯亞胺化所得之聚醯亞胺所成群中選出的至少一種之聚合物。 Component (B): at least one polymer selected from the group consisting of polyimine precursors and polyimine precursors obtained by hydrazine imidization.

本發明之特定溶劑可作為提高聚醯亞胺膜或液晶配向膜之塗膜性所使用的弱溶劑用。本發明之特定溶劑一般為,比較弱溶劑所使用之乙二醇單丁基醚(也稱為丁基溶纖劑或BCS),具有較低之溶劑用的表面張力。因此使用特定溶劑之塗佈溶劑,比較未使用其之塗佈溶液,可提高塗佈溶液相對於基板之濕擴性,既使未使用大量之樹脂溶解性較低的弱溶劑,也可得塗膜性優良之聚醯亞胺膜或液晶配向膜。又,提高塗佈溶液之濕擴性下形成聚醯亞胺膜或液晶配向膜時,可提高聚醯亞胺膜之端部的直線性。 The specific solvent of the present invention can be used as a weak solvent for improving the coating property of a polyimide film or a liquid crystal alignment film. The particular solvent of the present invention is generally a relatively low solvent surface tension for ethylene glycol monobutyl ether (also known as butyl cellosolve or BCS) used in relatively weak solvents. Therefore, by using a coating solvent of a specific solvent and comparing the coating solution which is not used, the wettability of the coating solution with respect to the substrate can be improved, and even if a weak solvent having a low solubility of a large amount of resin is not used, it can be coated. A polyimide film or a liquid crystal alignment film excellent in film properties. Further, when the polyimine film or the liquid crystal alignment film is formed under the wet expandability of the coating solution, the linearity of the end portion of the polyimide film can be improved.

另外本發明之特定溶劑為,比較一般作為弱溶劑用之乙二醇單丁基醚,具有較高之沸點。因此使用特定溶劑之塗佈溶液為,形成聚醯亞胺膜或液晶配向膜時,可抑制聚醯亞胺膜之端部隆起。 Further, the specific solvent of the present invention is a polyethylene glycol monobutyl ether which is generally used as a weak solvent and has a relatively high boiling point. Therefore, when a coating solution using a specific solvent is used to form a polyimide film or a liquid crystal alignment film, edge bulging of the polyimide film can be suppressed.

本發明之成分(B)為,由聚醯亞胺先驅物及聚醯亞胺先驅物經醯亞胺化所得之聚醯亞胺所成群中選出的至少一種之聚合物。其中又以本發明之組成物作為液晶 配向劑用使用於液晶配向膜時,使用由具有下述式〔2〕所表示之支鏈(也稱為特定支鏈構造)的聚醯亞胺先驅物及聚醯亞胺先驅物經醯亞胺化所得之聚醯亞胺所成群中選出的至少一種之聚合物(也稱為特定聚合物)為佳。 The component (B) of the present invention is at least one polymer selected from the group consisting of polyimine imines and polyimine precursors obtained by hydrazine imidization. Wherein the composition of the present invention is used as a liquid crystal When the alignment agent is used for a liquid crystal alignment film, a polyimine precursor and a polyimine precursor which are branched (also referred to as a specific branched structure) represented by the following formula [2] are used. It is preferred that at least one polymer (also referred to as a specific polymer) selected from the group consisting of polyamidimides obtained by amination.

(式〔2〕中,Y1為單鍵、-(CH2)a-(a為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-。Y2為單鍵或-(CH2)b-(b為1至15之整數);Y3為單鍵、-(CH2)c-(c為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-;Y4為由苯環、環己烷環及雜環所成群中選出的二價之環狀基,或具有巢類骨架之碳數12至25的二價之有機基,前述環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代;Y5表示由苯環、環己烷環及雜環所成群中所選出的二價之環狀基,該等環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代。n為0至4之整數。Y6為碳數1至18之烷基、碳數1至18的含氟之烷基、碳數1至18之烷氧基或碳數1至18的含氟之烷氧基)。 (In the formula [2], Y 1 is a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-. Y 2 Is a single bond or -(CH 2 ) b - (b is an integer from 1 to 15); Y 3 is a single bond, -(CH 2 ) c - (c is an integer from 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-; Y 4 is a divalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, or a carbon number 12 to 25 having a nest skeleton The divalent organic group, any hydrogen atom on the above cyclic group may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, or carbon a fluorine-containing alkoxy group or a fluorine atom substituted by 1 to 3; Y 5 represents a divalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a hetero ring, on which the cyclic group is Any of the hydrogen atoms may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or Substituted by a fluorine atom. n is an integer of 0 to 4. Y 6 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a carbon number of 1 to 18 fluorine-containing alkoxy group).

本發明之特定支鏈構造為,支鏈部分具有苯環、環己基環或雜環,或具有巢類骨架之碳數12至25的 二價之有機基。該等苯環、環己基環或雜環,或具有巢類骨架之碳數12至25的二價之有機基為,比較先前技術之長鏈烷基,具有剛直之構造。因此可提升支鏈部位相對於熱及紫外線之安定性,得既使相對於熱及光也可具有安定預傾角之液晶配向膜。 The specific branching structure of the present invention is such that the branched portion has a benzene ring, a cyclohexyl ring or a heterocyclic ring, or has a nest-like skeleton having a carbon number of 12 to 25 The organic base of divalent. The benzene ring, the cyclohexyl ring or the hetero ring, or the divalent organic group having a nest-like skeleton having 12 to 25 carbon atoms is a straight-chain structure compared to the long-chain alkyl group of the prior art. Therefore, the stability of the branch portion with respect to heat and ultraviolet rays can be improved, and a liquid crystal alignment film having a stable pretilt angle with respect to heat and light can be obtained.

由上述得知,含有本發明之特定溶劑與由聚醯亞胺先驅物及聚醯亞胺先驅物經醯亞胺化所得之聚醯亞胺所成群中選出的至少一種之聚合物的組成物,可實現形成塗膜性優良之聚醯亞胺膜或液晶配向膜用的組成物或液晶配向處理劑。 From the above, the composition of at least one polymer selected from the group consisting of the specific solvent of the present invention and the polyimine imine obtained by the ruthenium imidization of the polyimide precursor and the polyimide precursor A composition for forming a polyimide film or a liquid crystal alignment film excellent in coating property or a liquid crystal alignment treatment agent can be realized.

又,由含有本發明之特定溶劑與由具有前述式〔2〕所表示之特定支鏈構造的聚醯亞胺先驅物及聚醯亞胺先驅物經醯亞胺化所得之聚醯亞胺所成群中選出的至少一種之聚合物的組成物所得之液晶配向處理劑為,可形成既使長時間曝露於高溫及光照射下,也不會改變預傾角之液晶配向膜。又,使用該液晶配向膜可提供,具有優良顯示特性之高信賴性的液晶顯示元件。 Further, the polyimine obtained by the imidization of a specific solvent of the present invention and a polyimide precursor and a polyimine precursor having a specific branched structure represented by the above formula [2] The liquid crystal alignment treatment agent obtained by the composition of at least one of the polymers selected in the group is such that a liquid crystal alignment film which does not change the pretilt angle even when exposed to high temperature and light for a long period of time can be formed. Further, by using the liquid crystal alignment film, a liquid crystal display element having high display performance and excellent display characteristics can be provided.

<特定溶劑> <specific solvent>

本發明之特定溶劑為,下述式〔1〕所表示。 The specific solvent of the present invention is represented by the following formula [1].

式〔1〕中,X1表示碳數1至3之烷基。 In the formula [1], X 1 represents an alkyl group having 1 to 3 carbon atoms.

具體為,下述式〔1a〕至式〔1c〕中任何一式所表示之構造。 Specifically, it is a structure represented by any one of the following formulas [1a] to [1c].

本發明之特定溶劑為了提高上述塗佈溶液相對於基板之濕擴性的提升效果,較佳為液晶配向處理劑所含的溶劑全體之5至70質量%。其中又以5至65質量%為佳。更佳為5至60質量%,特佳為10至55質量%。 The specific solvent of the present invention is preferably from 5 to 70% by mass based on the total amount of the solvent contained in the liquid crystal alignment treatment agent in order to enhance the effect of improving the wettability of the coating solution with respect to the substrate. Among them, 5 to 65 mass% is preferred. More preferably, it is 5 to 60% by mass, and particularly preferably 10 to 55% by mass.

組成物中之溶劑全體中本發明的特定溶劑含量較多時,可得具有本發明之效果,即,提高塗佈溶液相對基板之濕擴性,具有優良塗膜性之聚醯亞胺膜或液晶配向膜。 When the specific solvent content of the present invention is large in the solvent in the composition, the effect of the present invention, that is, the polyimide film having excellent coating property can be obtained by improving the wet expandability of the coating solution with respect to the substrate. Liquid crystal alignment film.

<特定支鏈構造> <specific branch structure>

本發明之聚合物為了具有提高作為聚醯亞胺膜用時之聚醯亞胺膜的排水性之效果,及提高作為液晶配向膜用時之預傾角的安定性之效果,較佳為使用具有下述式〔2〕所表示之特定支鏈構造的特定聚合物。 The polymer of the present invention preferably has an effect of improving the drainage property of the polyimide film as a polyimide film and improving the stability of the pretilt angle when used as a liquid crystal alignment film. A specific polymer having a specific branched structure represented by the following formula [2].

式〔2〕中,Y1為單鍵、-(CH2)a-(a為1至15之 整數)、-O-、-CH2O-、-COO-或-OCO-。其中又以單鍵、-(CH2)a-(a為1至15之整數)、-O-、-CH2O-或-COO-易合成支鏈構造而為佳。更佳為單鍵、-(CH2)a-(a為1至10之整數)、-O-、-CH2O-或-COO-。 In the formula [2], Y 1 is a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-. Among them, a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O- or -COO- is preferably synthesized. More preferably a single bond, - (CH 2) a - (a is an integer of 1 to 10), - O -, - CH 2 O- or -COO-.

式〔2〕中,Y2為單鍵或-(CH2)b-(b為1至15之整數)。其中較佳為單鍵或-(CH2)b-(b為1至10之整數)。 In the formula [2], Y 2 is a single bond or -(CH 2 ) b - (b is an integer of 1 to 15). Among them, a single bond or -(CH 2 ) b - (b is an integer of 1 to 10) is preferable.

式〔2〕中,Y3為單鍵、-(CH2)c-(c為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-。其中又以單鍵、-(CH2)c-(c為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-易合成而為佳。更佳為單鍵、-(CH2)c-(c為1至10之整數)、-O-、-CH2O-、-COO-或-OCO-。 In the formula [2], Y 3 is a single bond, -(CH 2 ) c - (c is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-. Further, it is preferably a single bond, -(CH 2 ) c - (c is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-. More preferably, it is a single bond, -(CH 2 ) c - (c is an integer of 1 to 10), -O-, -CH 2 O-, -COO- or -OCO-.

式〔2〕中,Y4為由苯環、環己烷環及雜環所成群中選出的環狀基,該等環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代。又,Y4為由具有巢類骨架之碳數12至25之有機基所成群中選出的2價之有機基。其中較佳為苯環、環己烷環,或具有巢類骨架之碳數12至25之有機基。 In the formula [2], Y 4 is a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, and any hydrogen atom on the cyclic group may be an alkyl group having 1 to 3 carbon atoms. And an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom. Further, Y 4 is a divalent organic group selected from the group consisting of organic groups having 12 to 25 carbon atoms of the nest skeleton. Among them, a benzene ring, a cyclohexane ring, or an organic group having a shell-like skeleton having 12 to 25 carbon atoms is preferred.

式〔2〕中,Y5為由苯環、環己烷環及雜環所成群中選出的環狀基,該等環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代。 In the formula [2], Y 5 is a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, and any hydrogen atom on the cyclic group may be an alkyl group having 1 to 3 carbon atoms. And an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom.

式〔2〕中,n為0至4之整數,較佳為0至2之整數。 In the formula [2], n is an integer of 0 to 4, preferably an integer of 0 to 2.

式〔2〕中,Y6為碳數1至18之烷基、碳數1至18之含氟之烷基、碳數1至18之烷氧基或碳數1至18的含氟之烷氧基。其中較佳為碳數1至18之烷基、碳數1至10的含氟之烷基、碳數1至18之烷氧基或碳數1至10的含氟之烷氧基。又以碳數1至12之烷基或碳數1至12之烷氧基為佳。更佳為碳數1至9之烷基或碳數1至9之烷氧基。 In the formula [2], Y 6 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkane having 1 to 18 carbon atoms. Oxygen. Among them, preferred are an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 10 carbon atoms. Further, it is preferably an alkyl group having 1 to 12 carbon atoms or an alkoxy group having 1 to 12 carbon atoms. More preferably, it is an alkyl group having 1 to 9 carbon atoms or an alkoxy group having 1 to 9 carbon atoms.

式〔2〕中,Y1、Y2、Y3、Y4、Y5、Y6及n之較佳組合如,與國際公開會報WO2011/132751(2011.10.27公開)之13項至34項的表6至表47所揭示(2-1)至(2-629)相同之組合。又,國際公開公報之各表中,本發明之Y1至Y6係以Y1至Y6表示,Y1至Y6為Y1至Y6另一種讀法。 In the formula [2], preferred combinations of Y 1 , Y 2 , Y 3 , Y 4 , Y 5 , Y 6 and n are, for example, 13 to 34 of the International Public Commentary WO2011/132751 (2011.10.27 publication). The same combinations of (2-1) to (2-629) are disclosed in Tables 6 to 47. Further, in the tables of the International Publications, Y 1 to Y 6 of the present invention are represented by Y1 to Y6, and Y1 to Y6 are another reading of Y 1 to Y 6 .

<特定支鏈型二胺化合物> <Specific branched diamine compound>

本發明之特定聚合物,即,由聚醯亞胺先驅物及聚醯亞胺先驅物經醯亞胺化所得之聚醯亞胺所成群中選出的至少一種導入式〔2〕所表示之特定支鏈構造的方法較佳為,以具有特定支鏈構造之二胺化合物作為原料之一部分用。特佳為使用下述式〔2a〕所表示之二胺化合物(也稱為特定支鏈型二胺化合物)。 The specific polymer of the present invention, that is, at least one selected from the group [2] selected from the group consisting of polyimine precursors and polyimine precursors obtained by quinone imidization. The method of the specific branched structure is preferably carried out by using a diamine compound having a specific branched structure as a raw material. It is particularly preferred to use a diamine compound (also referred to as a specific branched diamine compound) represented by the following formula [2a].

式〔2a〕中,Y1為單鍵、-(CH2)a-(a為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-。其中又以單鍵、-(CH2)a-(a為1至15之整數)、-O-、-CH2O-或-COO-易合成支鏈構造而為佳。更佳為單鍵、-(CH2)a-(a為1至10之整數)、-O-、-CH2O-或-COO-。 In the formula [2a], Y 1 is a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-. Among them, a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O- or -COO- is preferably synthesized. More preferably a single bond, - (CH 2) a - (a is an integer of 1 to 10), - O -, - CH 2 O- or -COO-.

式〔2a〕中,Y2為單鍵或-(CH2)b-(b為1至15之整數)。其中較佳為單鍵或-(CH2)b-(b為1至10之整數)。 In the formula [2a], Y 2 is a single bond or -(CH 2 ) b - (b is an integer of 1 to 15). Among them, a single bond or -(CH 2 ) b - (b is an integer of 1 to 10) is preferable.

式〔2a〕中,Y3為單鍵-(CH2)c-(c為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-。其中又以單鍵、-(CH2)c-(c為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-易合成而為佳。更佳為單鍵、-(CH2)c-(c為1至10之整數)、-O-、-CH2O-、-COO-或-OCO-。 In the formula [2a], Y 3 is a single bond -(CH 2 ) c - (c is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-. Further, it is preferably a single bond, -(CH 2 ) c - (c is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-. More preferably, it is a single bond, -(CH 2 ) c - (c is an integer of 1 to 10), -O-, -CH 2 O-, -COO- or -OCO-.

式〔2a〕中,Y4為由苯環、環己烷環及雜環所成群中選出之環狀基,該等環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代。又,Y4為由具有巢類骨架之碳數12至25之有機基中選出的二價之有機基。其中較佳為苯環、環己烷環或具有巢類骨架之碳數12至25之有機基。 In the formula [2a], Y 4 is a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, and any hydrogen atom on the cyclic group may be an alkyl group having 1 to 3 carbon atoms. And an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom. Further, Y 4 is a divalent organic group selected from an organic group having a carbon number of 12 to 25 of a nest skeleton. Among them, a benzene ring, a cyclohexane ring or an organic group having a shell-like skeleton having 12 to 25 carbon atoms is preferred.

式〔2a〕中,Y5為由苯環、環己烷環及雜環所成群中選出的環狀基,該等環狀基上之任意氫原子可被碳數1至 3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代。 In the formula [2a], Y 5 is a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, and any hydrogen atom on the cyclic group may be an alkyl group having 1 to 3 carbon atoms. And an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom.

式〔2a〕中,n為0至4之整數。較佳為0至2之整數。 In the formula [2a], n is an integer of 0 to 4. It is preferably an integer of 0 to 2.

式〔2a〕中,Y6為碳數1至18之烷基、碳數1至18的含氟之烷基、碳數1至18之烷氧基或碳數1至18的含氟之烷氧基。其中較佳為碳數1至18之烷基、碳數1至10的含氟之烷基、碳數1至18之烷氧基或碳數1至10的含氟之烷氧基。又以碳數1至12之烷基或碳數1至12之烷氧基為佳。更佳為碳數1至9之烷基或碳數1至9之烷氧基。 In the formula [2a], Y 6 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkane having 1 to 18 carbon atoms. Oxygen. Among them, preferred are an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 10 carbon atoms. Further, it is preferably an alkyl group having 1 to 12 carbon atoms or an alkoxy group having 1 to 12 carbon atoms. More preferably, it is an alkyl group having 1 to 9 carbon atoms or an alkoxy group having 1 to 9 carbon atoms.

式〔2a〕中Y1、Y2、Y3、Y4、Y5、Y6及n之較佳組合與式〔2〕相同。 A preferred combination of Y 1 , Y 2 , Y 3 , Y 4 , Y 5 , Y 6 and n in the formula [2a] is the same as the formula [2].

Y1、Y2、Y3、Y4、Y5、Y6及n之組合中,更佳之組合為2-25至2-96、2-145至2-168、2-217至2-240、2-268至2-315、2-364至2-387、2-436至2-483或2-603至2-615等,特佳之組合為1-49至1-96、1-145至1-168、1-217至1-240或2-603至2-606等。 Among the combinations of Y 1 , Y 2 , Y 3 , Y 4 , Y 5 , Y 6 and n, a more preferable combination is 2-25 to 2-96, 2-145 to 2-168, 2-217 to 2-240 , 2-268 to 2-315, 2-364 to 2-387, 2-436 to 2-383 or 2-603 to 2-615, etc., particularly preferred combinations are 1-49 to 1-96, 1-145 to 1-168, 1-217 to 1-240 or 2-603 to 2-606, and the like.

式〔2a〕中,m為1至4之整數。較佳為1。 In the formula [2a], m is an integer of 1 to 4. It is preferably 1.

具體例如,下述式〔2-1〕至式〔2-31〕所表示之構造的化合物。 Specifically, for example, a compound having the structure represented by the following formula [2-1] to formula [2-31].

(式〔2-1〕至式〔2-3〕中,R1表示-O-、-OCH2-、-CH2O-、-COOCH2-或-CH2OCO-。R2為碳數1至22之直鏈狀或支鏈狀烷基、碳數1至22之直鏈狀或支鏈狀烷氧基、碳數1至22的直鏈狀或支鏈狀含氟之烷基,或碳數1至22的含氟之烷氧基)。 (In the formula [2-1] to the formula [2-3], R 1 represents -O-, -OCH 2 -, -CH 2 O-, -COOCH 2 - or -CH 2 OCO-. R 2 is a carbon number a linear or branched alkyl group of 1 to 22, a linear or branched alkoxy group having 1 to 22 carbon atoms, or a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms, Or a fluorine-containing alkoxy group having a carbon number of 1 to 22.

(式〔2-4〕至式〔2-6〕中,R3表示-COO-、-OCO-、-CONH-、-NHCO-、-COOCH2-、-CH2OCO-、-CH2O-、-OCH2-或-CH2-。R4為碳數1至22之直鏈狀或支鏈狀烷基、碳數1至22之直鏈狀或支鏈狀烷氧基、碳數1至22的直鏈狀或支鏈狀含氟之烷基,或碳數1至22的含氟之烷氧基)。 (In the formula [2-4] to the formula [2-6], R 3 represents -COO-, -OCO-, -CONH-, -NHCO-, -COOCH 2 -, -CH 2 OCO-, -CH 2 O -, -OCH 2 - or -CH 2 -. R 4 is a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched alkoxy group having 1 to 22 carbon atoms, and a carbon number. A linear or branched fluorine-containing alkyl group of 1 to 22, or a fluorine-containing alkoxy group having 1 to 22 carbon atoms).

(式〔2-7〕及式〔2-8〕中,R5表示-COO-、-OCO-、-CONH-、-NHCO-、-COOCH2-、-CH2OCO-、-CH2O-、-OCH2-、-CH2-、-O-或-NH-。R6為氟基、氰基、三氟甲烷基、硝基、偶氮基、甲醯基、乙醯基、乙醯氧基或羥基)。 (In the formula [2-7] and the formula [2-8], R 5 represents -COO-, -OCO-, -CONH-, -NHCO-, -COOCH 2 -, -CH 2 OCO-, -CH 2 O -, -OCH 2 -, -CH 2 -, -O- or -NH-. R 6 is a fluoro group, a cyano group, a trifluoromethyl group, a nitro group, an azo group, a methyl group, an ethyl group, a Alkoxy or hydroxy).

(式〔2-9〕及式〔2-10〕中,R7為碳數3至12之直鏈狀或支鏈狀烷基,1,4-環己烯之順-反異構各自為反異構體)。 (In the formula [2-9] and the formula [2-10], R 7 is a linear or branched alkyl group having 3 to 12 carbon atoms, and each of the cis-trans isomers of 1,4-cyclohexene is Anti-isomer).

(式〔2-11〕及式〔2-12〕中,R8為碳數3至12之直鏈狀或支鏈狀烷基,1,4-環己烯之順-反異構各自為反異構體)。 (In the formula [2-11] and the formula [2-12], R 8 is a linear or branched alkyl group having 3 to 12 carbon atoms, and each of the cis-trans isomers of 1,4-cyclohexene is Anti-isomer).

(式〔2-13〕中,A4為可被氟原子取代之碳數3至20之直鏈狀或支鏈狀烷基。A3為1,4-環伸己基或1,4-伸苯基。A2為氧原子或COO-*(但附「*」之鍵結手係與A3鍵結)。A1為氧原子或COO-*(但附「*」之鍵結手係與(CH2)a2)鍵結)。又,a1為0或1之整數,a2為2至10之整數,a3為0或1之整數)。 (In the formula [2-13], A 4 is a linear or branched alkyl group having 3 to 20 carbon atoms which may be substituted by a fluorine atom. A 3 is a 1,4-cyclohexyl group or a 1,4-stretch. Phenyl. A 2 is an oxygen atom or COO-* (but a "*" bond is bonded to A 3 ). A 1 is an oxygen atom or COO-* (but with a "*" bond hand system) Bonded with (CH 2 )a 2 )). Further, a 1 is an integer of 0 or 1, a 2 is an integer of 2 to 10, and a 3 is an integer of 0 or 1.

上述式〔2-1〕至〔2-31〕中,特佳構造之二胺化合物為,式〔2-1〕至式〔2-6〕、式〔2-9〕至式〔2-13〕或式〔2-22〕至式〔2-31〕等。 In the above formulas [2-1] to [2-31], the diamine compound of a particularly preferable structure is a formula [2-1] to a formula [2-6], a formula [2-9] to a formula [2-13]. Or equation [2-22] to formula [2-31] and the like.

上述之特定支鏈型二胺化合物等因應作為本發明之聚合物用時相對於溶劑之溶解性,使用於聚醯亞胺膜時之聚醯亞胺膜的排水性,及作為液晶配向膜用時之液晶配向性、電壓保持率、蓄積電荷等之特性,使用一種或混合二種以上。 The above-mentioned specific branched type diamine compound or the like is used as a liquid crystal alignment film for the solubility of the polymer of the present invention with respect to a solvent, the polyimine film used for the polyimide film, and the liquid crystal alignment film. In the case of the characteristics of the liquid crystal alignment, the voltage holding ratio, and the accumulated electric charge, one type or a mixture of two or more types may be used.

<其他二胺化合物> <Other diamine compounds>

本發明中無損本發明之效果下,可以特定支鏈型二胺化合物以外之其他二胺化合物(也稱為其他二胺化合物)作為原料之二胺成分用。其具體例如下所述。 In the present invention, the diamine component other than the branched diamine compound (also referred to as another diamine compound) may be used as a raw material diamine component without impairing the effects of the present invention. This is specifically described below.

p-伸苯基二胺、2,3,5,6-四甲基-p-伸苯基二胺、2,5-二甲基-p-伸苯基二胺、m-伸苯基二胺、2,4-二甲基-m-伸苯 基二胺、2,5-二胺基甲基、2,6-二胺基甲苯、2,5-二胺基酚、2,4-二胺基酚、3,5-二胺基酚、3,5-二胺基苄基醇、2,4-二胺基苄基醇、4,6-二胺基間苯二酚、4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、3,3’-二羥基-4,4’-二胺基聯苯、3,3’-二羧基-4,4’-二胺基聯苯、3,3’-二氟-4,4’-聯苯、3,3’-三氟甲基-4,4’-二胺基聯苯、3,4’-二胺基聯苯、3,3’-二胺基聯苯、2,2’-二胺基聯苯、2,3’-二胺基聯苯、4,4’-二胺基二苯基甲烷、3,3’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、2,2’-二胺基二苯基甲烷、2,3’-二胺基二苯基甲烷、4,4’-二胺基二苯基醚、3,3’-二胺基二苯基醚、3,4’-二胺基二苯基醚、2,2’-二胺基二苯基醚、2,3’-二胺基二苯基醚、4,4’-磺醯二苯胺、3,3’-磺醯二苯胺、雙(4-胺基苯基)矽烷、雙(3-胺基苯基)矽烷、二甲基-雙(4-胺基苯基)矽烷、二甲基-雙(3-胺基苯基)矽烷、4,4’-硫二苯胺、3,3’-硫二苯胺、4,4’-二胺基二苯基胺、3,3’-二胺基二苯基胺、3,4’-二胺基二苯基胺、2,2’-二胺基二苯基胺、2,3’-二胺基二苯基胺、N-甲基(4,4’-二胺基二苯基)胺、N-甲基(3,3’-二胺基二苯基)胺、N-甲基(3,4’-二胺基二苯基)胺、N-甲基(2,2’-二胺基二苯基)胺、N-甲基(2,3’-二胺基二苯基)胺、4,4’-二胺基二苯甲酮、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、1,4-二胺基萘、2,2’-二胺基二苯甲酮、2,3’-二胺基二苯甲酮、1,5-二胺基萘、1,6-二胺基萘、1,7-二胺基萘、1,8-二胺基萘、2,5-二胺基萘、2,6-二 胺基萘、2,7-二胺基萘、2,8-二胺基萘、1,2-雙(4-胺基苯基)乙烷、1,2-雙(3-胺基苯基)乙烷、1,3-雙(4-胺基苯基)丙烷、1,3-雙(3-胺基苯基)丙烷、1,4-雙(4-胺基苯基)丁烷、1,4-雙(3-胺基苯基)丁烷、雙(3,5-二乙基-4-胺基苯基)甲烷、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯基)苯、1,3-雙(4-胺基苯基)苯、1,4-雙(4-胺基苄基)苯、1,3-雙(4-胺基苯氧基)苯、4,4’-〔1,4-伸苯基雙(伸甲基)〕二苯胺、4,4’-〔1,3-伸苯基雙(伸甲基)〕二苯胺、3,4’-〔1,4-伸苯基雙(伸甲基)〕二苯胺、3,4’-〔1,3-伸苯基雙(伸甲基)〕二苯胺、3,3’-〔1,4-伸苯基雙(伸甲基)〕二苯胺、3,3’-〔1,3-伸苯基雙(伸甲基)〕二苯胺、1,4-伸苯基雙〔(4-胺基苯基)甲酮〕、1,4-伸苯基雙〔(3-胺基苯基)甲酮〕、1,3-伸苯基雙〔(4-胺基苯基)甲酮〕、1,3-伸苯基雙〔(3-胺基苯基)甲酮〕、1,4-伸苯基雙(4-胺基苯甲酸酯)、1,4-伸苯基雙(3-胺基苯甲酸酯)、1,3-伸苯基雙(4-胺基苯甲酸酯)、1,3-伸苯基雙(3-胺基苯甲酸酯)、雙(4-胺基苯基)對苯二甲酸酯、雙(3-胺基苯基)對苯二甲酸酯、雙(4-胺基苯基)間苯二甲酸酯、雙(3-胺基苯基)間苯二甲酸酯、N,N’-(1,4-伸苯基)雙(4-胺基苯醯胺)、N,N’-(1,3-伸苯基)雙(4-胺基苯醯胺)、N,N’-(1,4-伸苯基)雙(3-胺基苯醯胺)、N,N’-(1,3-伸苯基)雙(3-胺基苯醯胺)、N,N’-雙(4-胺基苯基)對苯二醯胺、N,N’-雙(3- 胺基苯基)對苯二醯胺、N,N’-雙(4-胺基苯基)間苯二醯胺、N,N’-雙(3-胺基苯基)間苯二醯胺、9,10-雙(4-胺基苯基)蒽、4,4’-雙(4-胺基苯氧基)二苯基碸、2,2’-雙〔4-(4-胺基苯氧基)苯基〕丙烷、2,2’-雙〔4-(4-胺基苯氧基)苯基〕六氟丙烷、2,2’-雙(4-胺基苯基)六氟丙烷、2,2’-雙(3-胺基苯基)六氟丙烷、2,2’-雙(3-胺基-4-甲基苯基)六氟丙烷、2,2’-雙(4-胺基苯基)丙烷、2,2’-雙(3-胺基苯基)丙烷、2,2’-雙(3-胺基-4-甲基苯基)丙烷、3,5-二胺基苯甲酸、2,5-二胺基苯甲酸、1,3-雙(4-胺基苯氧基)丙烷、1,3-雙(3-胺基苯氧基)丙烷、1,4-雙(4-胺基苯氧基)丁烷、1,4-雙(3-胺基苯氧基)丁烷、1,5-雙(4-胺基苯氧基)戊烷、1,5-雙(3-胺基苯氧基)戊烷、1,6-雙(4-胺基苯氧基)己烷、1,6-雙(3-胺基苯氧基)己烷、1,7-雙(4-胺基苯氧基)庚烷、1,7-(3-胺基苯氧基)庚烷、1,8-雙(4-胺基苯氧基)辛烷、1,8-雙(3-胺基苯氧基)辛烷、1,9-雙(4-胺基苯氧基)壬烷、1,9-雙(3-胺基苯氧基)壬烷、1,10-(4-胺基苯氧基)癸烷、1,10-(3-胺基苯氧基)癸烷、1,11-(4-胺基苯氧基)十一烷、1,11-(3-胺基苯氧基)十一烷、1,12-(4-胺基苯氧基)十二烷、1,12-(3-胺基苯氧基)十二烷等之芳香族二胺化合物、雙(4-胺基環己基)甲烷、雙(4-胺基-3-甲基環己基)甲烷等之脂環式二胺化合物、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、 1,10-二胺基癸烷、1,11-二胺基十一烷、1,12-二胺基十二烷等之脂肪族二胺化合物。 P-phenylenediamine, 2,3,5,6-tetramethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, m-phenylene Amine, 2,4-dimethyl-m-benzene Diamine, 2,5-diaminomethyl, 2,6-diaminotoluene, 2,5-diaminophenol, 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoresorcinol, 4,4'-diaminobiphenyl, 3,3'- Dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 3,3'-dihydroxy-4,4'-di Aminobiphenyl, 3,3'-dicarboxy-4,4'-diaminobiphenyl, 3,3'-difluoro-4,4'-biphenyl, 3,3'-trifluoromethyl- 4,4'-diaminobiphenyl, 3,4'-diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2'-diaminobiphenyl, 2,3'-di Aminobiphenyl, 4,4'-diaminodiphenylmethane, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 2,2'-di Aminodiphenylmethane, 2,3'-diaminodiphenylmethane, 4,4'-diaminodiphenyl ether, 3,3'-diaminodiphenyl ether, 3,4' -diaminodiphenyl ether, 2,2'-diaminodiphenyl ether, 2,3'-diaminodiphenyl ether, 4,4'-sulfonyldiphenylamine, 3,3'- Sulfonodiphenylamine, bis(4-aminophenyl)decane, bis(3-aminophenyl)decane, dimethyl - bis(4-aminophenyl)decane, dimethyl-bis(3-aminophenyl)decane, 4,4'-thiodiphenylamine, 3,3'-thiodiphenylamine, 4,4'- Diaminodiphenylamine, 3,3'-diaminodiphenylamine, 3,4'-diaminodiphenylamine, 2,2'-diaminodiphenylamine, 2,3 '-Diaminodiphenylamine, N-methyl(4,4'-diaminodiphenyl)amine, N-methyl(3,3'-diaminodiphenyl)amine, N- Methyl (3,4'-diaminodiphenyl)amine, N-methyl(2,2'-diaminodiphenyl)amine, N-methyl (2,3'-diaminodiyl) Phenyl)amine, 4,4'-diaminobenzophenone, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 1,4-diamine Naphthalene, 2,2'-diaminobenzophenone, 2,3'-diaminobenzophenone, 1,5-diaminonaphthalene, 1,6-diaminonaphthalene, 1,7 -diaminonaphthalene, 1,8-diaminonaphthalene, 2,5-diaminonaphthalene, 2,6-di Amino naphthalene, 2,7-diaminonaphthalene, 2,8-diaminonaphthalene, 1,2-bis(4-aminophenyl)ethane, 1,2-bis(3-aminophenyl) Ethane, 1,3-bis(4-aminophenyl)propane, 1,3-bis(3-aminophenyl)propane, 1,4-bis(4-aminophenyl)butane, 1,4-bis(3-aminophenyl)butane, bis(3,5-diethyl-4-aminophenyl)methane, 1,4-bis(4-aminophenoxy)benzene , 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1,4 - bis(4-aminobenzyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 4,4'-[1,4-phenylenebis(methyl)diphenylamine , 4,4'-[1,3-phenylenebis(methyl)diphenylamine, 3,4'-[1,4-phenylenebis(methyl)diphenylamine, 3,4 '-[1,3-Exophenyl bis(methyl))diphenylamine, 3,3'-[1,4-phenylenebis(methyl)diphenylamine, 3,3'-[1 , 3-phenylphenyl bis(methyl)diphenylamine, 1,4-phenylene bis[(4-aminophenyl)methanone], 1,4-phenylene bis[(3-amine) Phenyl phenyl) ketone], 1,3-phenylene bis[(4-aminophenyl)methanone], 1,3-phenylene bis[(3-aminophenyl)methanone], 1,4-phenylene bis(4-aminobenzoic acid) Ester), 1,4-phenylene bis(3-aminobenzoate), 1,3-phenylene bis(4-aminobenzoate), 1,3-phenylene bis ( 3-amino benzoate), bis(4-aminophenyl)terephthalate, bis(3-aminophenyl)terephthalate, bis(4-aminophenyl) ) isophthalate, bis(3-aminophenyl)isophthalate, N,N'-(1,4-phenylene)bis(4-aminophenylguanamine), N , N'-(1,3-phenylene) bis(4-aminophenylguanamine), N,N'-(1,4-phenylene)bis(3-aminophenylguanamine), N , N'-(1,3-phenylene) bis(3-aminophenylguanamine), N,N'-bis(4-aminophenyl)terephthalamide, N,N'-double (3- Aminophenyl)terephthalamide, N,N'-bis(4-aminophenyl)isophthalamide, N,N'-bis(3-aminophenyl)isophthalamide 9,10-bis(4-aminophenyl)anthracene, 4,4'-bis(4-aminophenoxy)diphenylanthracene, 2,2'-bis[4-(4-amino group Phenoxy)phenyl]propane, 2,2'-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2'-bis(4-aminophenyl)hexafluoro Propane, 2,2'-bis(3-aminophenyl)hexafluoropropane, 2,2'-bis(3-amino-4-methylphenyl)hexafluoropropane, 2,2'-bis ( 4-aminophenyl)propane, 2,2'-bis(3-aminophenyl)propane, 2,2'-bis(3-amino-4-methylphenyl)propane, 3,5- Diaminobenzoic acid, 2,5-diaminobenzoic acid, 1,3-bis(4-aminophenoxy)propane, 1,3-bis(3-aminophenoxy)propane, 1, 4-bis(4-aminophenoxy)butane, 1,4-bis(3-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane, 1 , 5-bis(3-aminophenoxy)pentane, 1,6-bis(4-aminophenoxy)hexane, 1,6-bis(3-aminophenoxy)hexane, 1,7-bis(4-aminophenoxy)heptane, 1,7-(3-aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane, 1,8-bis(3-aminobenzene Oxy)octane, 1,9-bis(4-aminophenoxy)decane, 1,9-bis(3-aminophenoxy)decane, 1,10-(4-aminobenzene Oxy) decane, 1,10-(3-aminophenoxy)decane, 1,11-(4-aminophenoxy)undecane, 1,11-(3-aminophenoxyl) An aromatic diamine compound such as undecane, 1,12-(4-aminophenoxy)dodecane, 1,12-(3-aminophenoxy)dodecane, or the like -Aminocyclohexyl)methane, alicyclic diamine compound such as bis(4-amino-3-methylcyclohexyl)methane, 1,3-diaminopropane, 1,4-diaminobutane 1,5-Diaminopentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminodecane , An aliphatic diamine compound such as 1,10-diaminodecane, 1,11-diaminoundecane or 1,12-diaminododecane.

又,無損本發明之效果下,可使用二胺支鏈具有烷基或含氟之烷基的二胺化合物。 Further, without impairing the effects of the present invention, a diamine compound having a dialkyl branched chain having an alkyl group or a fluorine-containing alkyl group can be used.

具體例如,下述式〔DA1〕至式〔DA12〕所表示之二胺化合物。 Specifically, for example, a diamine compound represented by the following formula [DA1] to formula [DA12].

(式〔DA1〕至式〔DA5〕中,A1為碳數1至22之直鏈狀或支鏈狀烷基,或碳數1至22的直鏈狀或支鏈狀含氟之烷基)。 (In the formula [DA1] to the formula [DA5], A 1 is a linear or branched alkyl group having 1 to 22 carbon atoms, or a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms; ).

(式〔DA6〕至式〔DA11〕中,A2表示-COO-、-OCO-、CONH-、-NHCO-、-CH2-、-O-、-CO-或-NH-。A3表示碳數1至22之直鏈狀或支鏈狀烷基,或碳數1至22的直鏈狀或支鏈狀含氟之烷基)。 (In the formula [DA6] to the formula [DA11], A 2 represents -COO-, -OCO-, CONH-, -NHCO-, -CH 2 -, -O-, -CO- or -NH-. A 3 represents A linear or branched alkyl group having 1 to 22 carbon atoms or a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms.

(式〔DA12〕中,p為1至10之整數)。 (In the formula [DA12], p is an integer of 1 to 10).

無損本發明之效果下,也可使用下述式〔DA13〕至式〔DA20〕所表示之二胺化合物。 The diamine compound represented by the following formula [DA13] to formula [DA20] can also be used without impairing the effects of the present invention.

(式〔DA17〕中,m為0至3之整數,式〔DA20〕中,n為1至5之整數)。 (In the formula [DA17], m is an integer of 0 to 3, and in the formula [DA20], n is an integer of 1 to 5).

另外無損本發明之效果下,也可使用下述式〔DA21〕至式〔DA25〕所表示的分子內具有羧基之二胺化合物。 Further, in addition to the effects of the present invention, a diamine compound having a carboxyl group in the molecule represented by the following formula [DA21] to formula [DA25] can also be used.

(式〔DA21〕中,m1為1至4之整數。式〔DA22〕中,A4為單鍵、-CH2-、-C2H4-、-C(CH3)2-、-CF2-、-C(CF3)-、-O-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCH2-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-。m2及m3各自為0至4之整數,且m2+m3為1至4之整數。式〔DA23〕中,m4及m5各自為1至5之整數。式〔DA24〕中,A5為碳數1至5之直鏈狀或支鏈狀烷基。m6為1至5之整數。式〔DA25〕中,A6為單鍵、-CH2-、-C2H4-、-C(CH3)2-、-CF2-、-C(CF3)-、-O-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCH2-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-。m7為1至4之整數)。 (In the formula [DA21], m 1 is an integer of 1 to 4. In the formula [DA22], A 4 is a single bond, -CH 2 -, -C 2 H 4 -, -C(CH 3 ) 2 -, - CF 2 -, -C(CF 3 )-, -O-, -CO-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -OCH 2 - , -COO-, -OCO-, -CON(CH 3 )- or -N(CH 3 )CO-.m 2 and m 3 are each an integer of 0 to 4, and m 2 +m 3 is 1 to 4 In the formula [DA23], m 4 and m 5 are each an integer of 1 to 5. In the formula [DA24], A 5 is a linear or branched alkyl group having 1 to 5 carbon atoms; m 6 is 1 An integer of 5. In the formula [DA25], A 6 is a single bond, -CH 2 -, -C 2 H 4 -, -C(CH 3 ) 2 -, -CF 2 -, -C(CF 3 )- , -O-, -CO-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -OCH2-, -COO-, -OCO-, -CON( CH 3 )- or -N(CH 3 )CO-.m 7 is an integer from 1 to 4).

另外無損本發明之效果下,也可使用下述式〔DA26〕所表示之二胺化合物。 Further, the diamine compound represented by the following formula [DA26] can also be used without impairing the effects of the present invention.

(式〔DA26〕中,A1為由-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCO-、-CON(CH3)-或-N(CH3)CO-中選出的二價之有機基。A2為單鍵、碳數1至20之脂肪族烴基、非芳香族環式烴基或芳香族烴基。A3為由單鍵、-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-COO-、-OCO-、-CON(CH3)-、-N(CH3)CO-或-O(CH2)m-(m為1至5之整數)中選出。A4為含氮之芳香族雜環。n為1至4之整數)。 (In the formula [DA26], A 1 is -O-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -OCO-, -CON(CH 3 ) - or -N (CH 3) CO- is selected from a divalent organic group of 2 .A single bond, a carbon number of aliphatic hydrocarbon group, non-aromatic cyclic hydrocarbon group or an aromatic hydrocarbon group of 3 to 20 .A From a single bond, -O-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-, -COO-, -OCO-, -CON(CH 3 )-, -N(CH 3 ) CO- or -O(CH 2 ) m - (m is an integer of 1 to 5). A 4 is a nitrogen-containing aromatic heterocyclic ring. n is an integer of 1 to 4).

又,無損本發明之效果下,也可使用下述式〔DA27〕或式〔DA28〕所表示的具有巢類骨架之二胺化合物。 Further, without impairing the effects of the present invention, a diamine compound having a nest skeleton represented by the following formula [DA27] or formula [DA28] can also be used.

上述其他二胺化合物可因應作為本發明之聚合物用時相對於溶劑之溶解性,使用於聚醯亞胺膜時之聚醯亞胺膜的排水性,及作為液晶配向膜用時之液晶配向性、電壓保持率、蓄積電荷等之特性,可使用一種或二種以上混合使用。 The above other diamine compound can be used as the solubility of the polymer of the present invention with respect to a solvent, the drainage property of the polyimide film used in the polyimide film, and the liquid crystal alignment when used as a liquid crystal alignment film. The characteristics of the properties, the voltage holding ratio, the accumulated charge, and the like may be used alone or in combination of two or more.

<特定四羧酸二酐> <Specific tetracarboxylic dianhydride>

為了得到本發明之聚合物,較佳為以下述式〔3〕所表示之四羧酸二酐(也稱為特定四羧酸二酐)作為原料之一部分用。 In order to obtain the polymer of the present invention, tetracarboxylic dianhydride (also referred to as specific tetracarboxylic dianhydride) represented by the following formula [3] is preferably used as a part of the raw material.

式〔3〕中,Z1為下述式〔3a〕至式〔3j〕所表示的四價之基。 In the formula [3], Z 1 is a tetravalent group represented by the following formula [3a] to formula [3j].

式〔3a〕中,Z2至Z5為由氫原子、甲基、氯原子及苯環所成群中選出之基,可各自相同或相異,式〔3g〕中,Z6及Z7為氫原子或甲基,可各自相同或相異。 In the formula [3a], Z 2 to Z 5 are groups selected from the group consisting of a hydrogen atom, a methyl group, a chlorine atom and a benzene ring, and may be the same or different, in the formula [3g], Z 6 and Z 7 The hydrogen atom or the methyl group may be the same or different.

式〔3〕中,Z1之特佳構造就聚合反應性及易合成性為式〔3a〕、式〔3c〕、式〔3d〕、式〔3e〕、式〔3f〕或式〔3g〕。其中又以式〔3a〕、式〔3e〕、式〔3f〕或式〔3g〕為佳。 In the formula [3], the excellent structure of Z 1 is such that the polymerization reactivity and the easily synthesizable property are the formula [3a], the formula [3c], the formula [3d], the formula [3e], the formula [3f] or the formula [3g]. . Among them, the formula [3a], the formula [3e], the formula [3f] or the formula [3g] is preferred.

<其他四羧酸二酐> <Other tetracarboxylic dianhydride>

本發明中無損本發明之效果下,可使用特定四羧酸二酐以外之其他四羧酸二酐(也稱為其他四羧酸二酐)。其他四羧酐二酐如,下述四羧酸之四羧酸二酐。 In the present invention, other tetracarboxylic dianhydrides (also referred to as other tetracarboxylic dianhydrides) other than the specific tetracarboxylic dianhydride can be used without impairing the effects of the present invention. Other tetracarboxylic anhydride dianhydrides such as the tetracarboxylic dianhydride of the following tetracarboxylic acid.

均苯四酸、2,3,6,7-萘四羧酐、1,2,5,6-萘四羧酸、1,4,5,8-萘四羧酐、2,3,6,7-蒽四羧酸、1,2,5,6-蒽四羧酸、3,3’,4,4’-聯苯四羧酸、2,3,3’,4-聯苯四羧酸、雙(3,4-二羧基苯基)醚、3,3’,4,4’-二苯甲酮四羧酸、雙(3,4-二羧 基苯基)碸、雙(3,4-二羧基苯基)甲烷、2,2-雙(3,4-二羧基苯基)丙烷、1,1,1,3,3,3-六氟-2,2-雙(3,4-二羧基苯基)丙烷、雙(3,4-二羧基苯基)二甲基矽烷、雙(3,4-二羧基苯基)二苯矽烷、2,3,4,5-吡啶四羧酸、2,6-雙(3,4-二羧基苯基)吡啶、3,3’,4,4’-二苯基碸四羧酸、3,4,9,10-二苝四羧酸或1,3-二苯基-1,2,3,4-環丁烷四羧酸。 Pyromellitic acid, 2,3,6,7-naphthalenetetracarboxylic anhydride, 1,2,5,6-naphthalenetetracarboxylic acid, 1,4,5,8-naphthalenetetracarboxylic anhydride, 2,3,6, 7-decanetetracarboxylic acid, 1,2,5,6-nonanetetracarboxylic acid, 3,3',4,4'-biphenyltetracarboxylic acid, 2,3,3',4-biphenyltetracarboxylic acid , bis(3,4-dicarboxyphenyl)ether, 3,3',4,4'-benzophenonetetracarboxylic acid, bis(3,4-dicarboxyl) Phenyl, bis(3,4-dicarboxyphenyl)methane, 2,2-bis(3,4-dicarboxyphenyl)propane, 1,1,1,3,3,3-hexafluoro -2,2-bis(3,4-dicarboxyphenyl)propane, bis(3,4-dicarboxyphenyl)dimethyl decane, bis(3,4-dicarboxyphenyl)diphenyl decane, 2 ,3,4,5-pyridinetetracarboxylic acid, 2,6-bis(3,4-dicarboxyphenyl)pyridine, 3,3',4,4'-diphenylphosphonium tetracarboxylic acid, 3,4 9,10-dioxatetracarboxylic acid or 1,3-diphenyl-1,2,3,4-cyclobutanetetracarboxylic acid.

上述特定四羧酸二酐及其他四羧酸二酐可因應作為本發明之聚合物用時相對於溶劑之溶解性,使用於聚醯亞胺膜時之聚醯亞胺膜的排水性,及作為液晶配向膜用時之液晶配向性、電壓保持率、蓄積電荷等之特性,使用一種或二種以上混合使用。 The above-mentioned specific tetracarboxylic dianhydride and other tetracarboxylic dianhydride can be used for the solubility of the polymer of the present invention with respect to a solvent, the drainage property of the polyimide film used in the polyimide film, and The characteristics of the liquid crystal alignment property, the voltage holding ratio, and the accumulated charge when used as the liquid crystal alignment film are used singly or in combination of two or more kinds.

<聚合物‧定聚合物> <Polymer ‧ Ding Polymer>

本發明之(B)成分的聚合物為,由聚醯亞胺先驅物或聚醯亞胺中選出的至少一種之聚合物。 The polymer of the component (B) of the present invention is at least one polymer selected from the group consisting of a polyimide precursor or a polyimine.

聚醯亞胺先驅物為,下述式〔A〕所表示之構造。 The polyimine precursor is a structure represented by the following formula [A].

(式(A)中,R1為四價之有機基,R2為二價之有機基,A1及A2為氫原子或碳數1至8之烷基,可各自相同或相異,n表示正整數)。 (In the formula (A), R 1 is a tetravalent organic group, R 2 is a divalent organic group, and A 1 and A 2 are a hydrogen atom or an alkyl group having 1 to 8 carbon atoms, which may be the same or different. n represents a positive integer).

本發明之聚合物因以下述式〔B〕所表示之二胺成分與下述式〔C〕所表示之四羧酸二酐為原料時可較簡便製造,故較佳為由下述式〔D〕所表示之重覆單位的構造式所形成之聚醯胺酸或該聚醯胺酸經醯亞胺化所得之聚醯亞胺。 The polymer of the present invention can be easily produced by using a diamine component represented by the following formula [B] and a tetracarboxylic dianhydride represented by the following formula [C] as a raw material, and therefore it is preferably of the following formula [ D] The polylysine formed by the structural formula of the repeating unit represented by the above or the polyimine obtained by imidization of the polyglycolic acid.

(式〔B〕及式〔C〕中,R1及R2為與式〔A〕之定義相同)。 (In the formula [B] and the formula [C], R 1 and R 2 are the same as defined in the formula [A]).

(式〔D〕中,R1及R2為與式〔A〕之定義相同)。 (In the formula [D], R 1 and R 2 are the same as defined in the formula [A]).

本發明中合成聚合物之方法無特別限定。一般為,使二胺成分與四羧酸成分反應所得。一般係使由四羧酸及其衍生物所成群中選出的至少一種之四羧酸成分,與由一種或複數種之二胺化合物所形成的二胺成分反應,得聚醯胺酸。具體上可使用,使四羧酸二酐與二胺成分聚縮合而得聚醯胺酸之方法、使四羧酸與二胺成分脫水聚縮合反應而得聚醯胺酸之方法,或四羧酸二鹵化物與二胺成分聚縮合而得聚醯胺酸之方法。 The method of synthesizing the polymer in the present invention is not particularly limited. Generally, a diamine component is reacted with a tetracarboxylic acid component. Generally, at least one of the tetracarboxylic acid components selected from the group consisting of tetracarboxylic acids and derivatives thereof is reacted with a diamine component formed from one or a plurality of diamine compounds to obtain a polyamic acid. Specifically, a method of polycondensing a tetracarboxylic dianhydride with a diamine component to obtain a poly-proline, a method of dehydrating polycondensation of a tetracarboxylic acid and a diamine component to obtain a poly-proline, or a tetracarboxylic acid can be used. A method in which an acid dihalide is condensed with a diamine component to obtain a polyamic acid.

製造聚醯胺酸烷基酯時可使用,使羧酸基經二烷基酯化所得之四羧酸與二胺成分聚縮合之方法,使羧酸基經二烷基酯化所得之四羧酸二鹵化物與二胺成分聚縮合之方法,或使聚醯胺酸之羧基轉換為酯之方法。 When the polyalkyl phthalate is produced, a tetracarboxylic acid obtained by dialkyl esterifying a carboxylic acid group can be used by polycondensing a tetracarboxylic acid obtained by dialkyl esterification of a carboxylic acid group with a diamine component. A method of polycondensing an acid dihalide with a diamine component, or a method of converting a carboxyl group of polylysine to an ester.

製造聚醯亞胺時可使用,使前述聚醯胺酸或聚醯胺酸烷基酯閉環而得聚醯亞胺之方法。 When the polyimine is produced, a method in which the polylysine or the polyalkyl amide is ring-closed to obtain a polyimine is used.

本發明之特定聚合物為,由具有前述式〔2〕所表示之支鏈的聚醯亞胺先驅物或聚醯亞胺中選出的至少一種之聚合物。 The specific polymer of the present invention is a polymer of at least one selected from the group consisting of a branched polyimine precursor represented by the above formula [2] or a polyimine.

其中使用本發明之特定聚合物所得的液晶配向膜為,上述二胺成分中前述式〔2〕所表示之特定支鏈構造的含有比例較高時,可提高作為液晶配向膜用時之排水性與液晶之預傾角。此時二胺成分較佳為使用前述式〔2a〕所表示之特定支鏈型二胺化合物。特佳為使用前述式〔2-1〕至式〔2-6〕或式〔2-9〕至式〔2-13〕所表示之特定支鏈型二胺化合物。其中又以式〔2-1〕至式〔2-6〕、式〔2-9〕至式〔2-12〕或式〔2-22〕至式〔2-31〕所表示之特定支鏈型二胺化合物為佳。 In the liquid crystal alignment film obtained by using the specific polymer of the present invention, when the content ratio of the specific branched structure represented by the above formula [2] is high in the diamine component, the drainage property as a liquid crystal alignment film can be improved. Pretilt angle with liquid crystal. In this case, the diamine component is preferably a specific branched diamine compound represented by the above formula [2a]. Particularly, a specific branched diamine compound represented by the above formula [2-1] to formula [2-6] or formula [2-9] to formula [2-13] is used. The specific branch represented by the formula [2-1] to the formula [2-6], the formula [2-9] to the formula [2-12] or the formula [2-22] to the formula [2-31] A diamine compound is preferred.

為了提高該特性較佳為,二胺成分之5莫耳%以上80莫耳%以下為特定支鏈型二胺化合物。其中就液晶配向處理劑之塗佈性及作為液晶配向膜用之電特性的觀點,二胺成分之5莫耳%以上60莫耳%以下較佳為特定支鏈型二胺化合物。更佳為二胺成分之10莫耳%以上60莫耳%以下。 In order to improve this characteristic, it is preferable that 5 mol% or more and 80 mol% or less of the diamine component is a specific branched diamine compound. Among them, from the viewpoint of the coatability of the liquid crystal alignment agent and the electrical properties for the liquid crystal alignment film, a specific branched type diamine compound is preferably 5 mol% or more and 60 mol% or less of the diamine component. More preferably, it is 10 mol% or more and 60 mol% or less of the diamine component.

製造本發明之聚合物時較佳為,四羧酸成分使用前述式〔3〕所表示之特定四羧酸二酐。特佳為使用式〔3〕中之Z1為前述式〔3a〕至式〔3j〕所表示之構造基的四羧酸二酐。此時較佳為,四羧酸成分之1莫耳%以上為特定四羧酸二酐,又以5莫耳%以上為佳,更佳為10莫耳%以上。又可為,四羧酸成分之100莫耳%為四羧酸二酐。 When the polymer of the present invention is produced, it is preferred to use the specific tetracarboxylic dianhydride represented by the above formula [3] as the tetracarboxylic acid component. Particularly, tetracarboxylic dianhydride in which Z 1 in the formula [3] is a structural group represented by the above formula [3a] to formula [3j] is used. In this case, it is preferred that 1 mol% or more of the tetracarboxylic acid component is a specific tetracarboxylic dianhydride, more preferably 5 mol% or more, still more preferably 10 mol% or more. Further, 100 mol% of the tetracarboxylic acid component may be tetracarboxylic dianhydride.

二胺成分與四羧酸成分之反應一般為,二胺成分與四羧酸成分於有機溶劑中進行。此時所使用之有機溶劑可為,能溶解所生成之聚醯亞胺先驅物之物無特別限定。其具體例如下所述。 The reaction between the diamine component and the tetracarboxylic acid component is generally carried out by allowing the diamine component and the tetracarboxylic acid component to be carried out in an organic solvent. The organic solvent to be used in this case is not particularly limited as long as it can dissolve the produced polyimide precursor. This is specifically described below.

例如,N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯烷酮、二甲基亞碸、γ-丁內酯、1,3-二甲基-咪唑啉酮、甲基乙基酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮等。 For example, N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl hydrazine, γ-butyrolactone, 1,3-two Methyl-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone, and the like.

該等可單獨使用,或混合使用。又,既使為無法溶解聚醯亞胺先驅物之溶劑,於不會析出所生成之聚醯亞胺先驅物的範圍內,可混合上述溶劑使用。又,有機溶劑中之水分會阻礙聚合反應,且成為所生成之聚醯亞胺先驅物水解之原因,因此較佳為使用將有機溶劑脫水乾燥所得之物。 These may be used alone or in combination. Further, even if it is a solvent in which the polyimide precursor is not dissolved, the above solvent can be used in a range in which the produced polyimide precursor is not precipitated. Further, since the water in the organic solvent hinders the polymerization reaction and causes hydrolysis of the produced polyimide precursor, it is preferred to use a product obtained by dehydrating and drying the organic solvent.

於有機溶劑中使二胺成分與四羧酸成分反應時可如,攪拌二胺成分分散或溶解於有機溶劑所得之溶液下,直接加入四羧酸成分,或分散或溶解於有機溶劑後加入之方法。或相反地將二胺成分加入四羧酸成分分散或溶 解於有機溶劑所得之溶液之方法、交互添加四羧酸成分與二胺成分之方法等,可使用該等之任何方法。又,各自使用複數種二胺成分及四羧酸成分進行反應時,可以預先混合之狀態進行反應,或各自依序進行反應,另可為將各自反應所得之低分子量物混合反應所得之聚合物。此時之聚合溫度可選用-20至150℃之任意溫度,但較佳為-5至100℃之範圍。又,可以任意濃度進行反應,但濃度太低時難製造高分子量之聚合物,濃度太高時會提高反應液之黏性而難均勻攪拌。因此較佳為1至50質量%,更佳為5至30質量%。反應初期可以高濃度進行,其後追加有機溶劑。 When the diamine component and the tetracarboxylic acid component are reacted in an organic solvent, for example, the diamine component is stirred or dissolved in an organic solvent to obtain a tetracarboxylic acid component, or dispersed or dissolved in an organic solvent, and then added. method. Or conversely adding the diamine component to the tetracarboxylic acid component to disperse or dissolve Any of these methods can be used as a method of dissolving a solution obtained in an organic solvent, a method of mutually adding a tetracarboxylic acid component and a diamine component, and the like. Further, when a plurality of kinds of the diamine component and the tetracarboxylic acid component are used for the reaction, the reaction may be carried out in a state of being mixed in advance, or the reaction may be carried out in sequence, or the polymer obtained by mixing the low molecular weight substances obtained by the respective reactions may be used. . The polymerization temperature at this time may be any temperature of from -20 to 150 ° C, but preferably from -5 to 100 ° C. Further, the reaction can be carried out at any concentration. However, when the concentration is too low, it is difficult to produce a polymer having a high molecular weight. When the concentration is too high, the viscosity of the reaction liquid is increased and it is difficult to uniformly stir. Therefore, it is preferably from 1 to 50% by mass, more preferably from 5 to 30% by mass. The initial stage of the reaction can be carried out at a high concentration, and then an organic solvent is added.

聚醯亞胺先驅物之聚合反應中,二胺成分之合計莫耳數與四羧酸成分之合計莫耳數的比值較佳為0.8至1.2。與一般之聚縮合反應相同,該莫耳比接近1.0時所生成之聚醯亞胺先驅物分子量較大。 In the polymerization reaction of the polyimide precursor, the ratio of the total number of moles of the diamine component to the total number of moles of the tetracarboxylic acid component is preferably from 0.8 to 1.2. As with the general polycondensation reaction, the molecular weight of the polyimine precursor formed when the molar ratio is close to 1.0 is large.

本發明之聚醯亞胺為前述聚醯亞胺先驅物經閉環所得之聚醯亞胺,適用為製造聚醯亞胺膜或液晶配向膜用之聚合物。 The polyimine of the present invention is a polyimine obtained by subjecting the polyimine precursor to ring closure, and is suitable for use in a polymer for producing a polyimide film or a liquid crystal alignment film.

本發明之聚醯亞胺中,醯胺酸基之閉環率(也稱為醯亞胺化率)非需為100%,可因應用途及目的任意調整。 In the polyimine of the present invention, the ring closure ratio (also referred to as the oxime imidization ratio) of the amidino group is not required to be 100%, and can be arbitrarily adjusted depending on the purpose and purpose.

將聚醯亞胺先驅物醯亞胺化之方法如,直接加熱聚醯亞胺先驅物之溶液的熱醯亞胺化或將觸媒加入聚醯亞胺先驅物之溶液的觸媒醯亞胺化。 A method for imidating a polyimine precursor, for example, by directly heating a solution of a polyimide precursor, or by adding a catalyst to a solution of a polyimide precursor Chemical.

於溶液中將聚醯亞胺先驅物熱醯亞胺化時之溫度為 100至400℃,較佳為120至250℃,又以將醯亞胺化反應所生成之水排出系外的同時進行為佳。 The temperature at which the polyamidene precursor is thermally imidized in solution is It is preferably 100 to 400 ° C, preferably 120 to 250 ° C, and it is preferably carried out while discharging the water formed by the oxime imidization reaction.

醯亞胺先驅物之觸媒醯亞胺化可藉由,將鹼性觸媒與酸酐加入聚醯亞胺先驅物之溶液內,於-20至250℃,較佳於0至180℃下攪拌進行。鹼性觸媒之量為醯胺酸基之0.5至30莫耳倍,較佳為2至20莫耳倍,酸酐之量為醯胺酸基之1至50莫耳倍,較佳為3至30莫耳倍。鹼性觸媒如,吡啶、三乙基胺、三甲基胺、三丁基胺或三辛基胺等,其中又以吡啶於反應進行中可持有適當鹼性而為佳。酸酐如,乙酸酐、偏苯三酸酐或均苯四酸酐等,其中又以使用乙酸酐時結束反應後易精製而為佳。利用觸媒醯亞胺化之醯亞胺化率可藉由調節觸媒量與反應溫度、反應時間而控制。 The imidization of the quinone imine precursor can be carried out by adding a basic catalyst and an acid anhydride to the solution of the polyimide precursor, and stirring at -20 to 250 ° C, preferably 0 to 180 ° C. get on. The amount of the basic catalyst is 0.5 to 30 moles, preferably 2 to 20 moles, of the prolyl group, and the amount of the anhydride is 1 to 50 moles, preferably 3 to the amidate group. 30 moles. The basic catalyst is, for example, pyridine, triethylamine, trimethylamine, tributylamine or trioctylamine, and the like, wherein pyridine is preferably held in an appropriate basic state during the reaction. The acid anhydride is, for example, acetic anhydride, trimellitic anhydride or pyromellitic anhydride. Among them, it is preferred to use an acetic anhydride to complete the reaction and then to refine it. The imidization ratio of the ruthenium imidized by the catalyst can be controlled by adjusting the amount of the catalyst, the reaction temperature, and the reaction time.

由聚醯亞胺先驅物或聚醯亞胺之反應溶液中回收所生成的聚醯亞胺先驅物或聚醯亞胺時可為,將反應溶液投入溶劑而沈澱。沈澱用之溶液如,甲醇、乙醇、異丙基醇、丙酮、己烷、丁基溶纖劑、庚烷、甲基乙基酮、甲基異丁基酮、甲苯、苯、水等。投入溶劑而沈澱所得之聚合物可於過濾回收後,常壓或減壓下以常溫或加熱而乾燥。又,重覆2至10次的將沈澱回收之聚合物再溶解於有機溶劑內,再沈澱回收之操作,可減少聚合物中之不純物。此時之溶劑如,醇類、酮類或烴等,使用由其中選出的三種以上之溶劑時,可進一步提升精製效率而為佳。 When the produced polyimine precursor or polyimine is recovered from the reaction solution of the polyimine precursor or the polyimine, the reaction solution may be added to a solvent to precipitate. The solution for precipitation is, for example, methanol, ethanol, isopropyl alcohol, acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, toluene, benzene, water, and the like. The polymer obtained by the introduction of the solvent and precipitated can be dried by filtration at normal temperature or under heating under reduced pressure or reduced pressure. Further, the re-dissolution of the precipitate-recovered polymer in the organic solvent by repeating 2 to 10 times can be carried out to reduce the impurities in the polymer. In the case of a solvent such as an alcohol, a ketone or a hydrocarbon, etc., when three or more solvents selected from the above are used, the purification efficiency can be further improved.

本發明之聚合物的分子量就考量由其所得之聚醯亞胺 膜的強度、聚醯亞胺膜形成時之作業性、聚醯亞胺膜之塗膜性時,以GPC(Gel Permeation Chromatography)法測得之重量平均分子量較佳為5,000至1,000,000,更佳為10,000至150,000。 The molecular weight of the polymer of the present invention is determined by the polyimine obtained therefrom. The weight average molecular weight measured by a GPC (Gel Permeation Chromatography) method is preferably 5,000 to 1,000,000, more preferably in the case of the strength of the film, the workability at the time of formation of the polyimide film, and the film coating property of the polyimide film. 10,000 to 150,000.

<組成物‧液晶配向處理劑> <Composition ‧ Liquid crystal alignment treatment agent>

本發明之組成物或使用其之液晶配向處理劑為,形成聚醯亞胺膜或液晶配向膜(也統稱為樹脂被膜)用之塗佈溶液,及形成含有特定溶劑與聚合物之樹脂被膜用的塗佈溶液。 The composition of the present invention or the liquid crystal alignment treatment agent using the same is a coating solution for forming a polyimide film or a liquid crystal alignment film (also collectively referred to as a resin film), and a resin film containing a specific solvent and a polymer. Coating solution.

本發明之組成物或使用其之液晶配向處理劑中,全部之聚合物成分可為本發明之聚合物,或本發明之聚合物混合其他聚合物。此時之聚合物中,其他聚合物之含量為0.5至15質量%,較佳為1至10質量%。其他聚合物如,聚醯亞胺先驅物及聚醯亞胺以外之聚合物,具體例如,丙烯酸基聚合物、甲基丙烯酸基聚合物、聚苯乙烯、聚醯胺或矽氧烷系聚合物等。 In the composition of the present invention or the liquid crystal alignment treatment agent using the same, all of the polymer components may be the polymer of the present invention, or the polymer of the present invention may be mixed with other polymers. In the polymer at this time, the content of the other polymer is from 0.5 to 15% by mass, preferably from 1 to 10% by mass. Other polymers such as polyimine precursors and polymers other than polyimine, such as acrylic based polymers, methacrylic based polymers, polystyrene, polydecylamine or decane based polymers Wait.

又,以本發明之組成物作為液晶配向處理劑用形成液晶配向膜時,聚合物中較佳為使用特定聚合物。此時全部之聚合物成分可全為本發明之特定聚合物,或本發明之特定聚合物混合其他聚合物。此時特定聚合物中之其他聚合物的含量為0.5至15質量%,較佳為1至10質量%。其他聚合物如,由不含特定支鏈型二胺化合物之二胺成分與不含特定四羧酸二酐之四羧酸成分所得的聚醯亞 胺先驅物或聚醯亞胺。另外聚醯亞胺先驅物及聚醯亞胺以外之聚合物具體如,丙烯酸基聚合物、甲基丙烯酸基聚合物、聚苯乙烯、聚醯胺或矽氧烷系聚合物等。 Further, when the liquid crystal alignment film is formed by using the composition of the present invention as a liquid crystal alignment treatment agent, it is preferred to use a specific polymer in the polymer. At this time, all of the polymer components may be all of the specific polymers of the present invention, or the specific polymers of the present invention may be mixed with other polymers. The content of the other polymer in the specific polymer at this time is from 0.5 to 15% by mass, preferably from 1 to 10% by mass. Other polymers such as those obtained from a diamine component which does not contain a specific branched diamine compound and a tetracarboxylic acid component which does not contain a specific tetracarboxylic dianhydride Amine precursor or polyimine. Further, the polymer other than the polyimide precursor and the polyimine is, for example, an acrylic polymer, a methacryl polymer, a polystyrene, a polyamine or a siloxane polymer.

本發明之組成物或使用其之液晶配向處理劑中的有機溶劑,就形成塗佈更均勻之樹脂被膜的觀點,有機溶劑之含量較佳為70至99.9質量%,更佳為70至98質量%。該含量可依目的之聚醯亞胺膜或液晶配向膜的膜厚適當變更。此時之有機溶劑可為,能溶解本發明之聚合物的有機溶劑無特別限定。其具體例如下所述。 The composition of the present invention or the organic solvent in the liquid crystal alignment treatment agent used therein forms a viewpoint of coating a more uniform resin film, and the content of the organic solvent is preferably from 70 to 99.9% by mass, more preferably from 70 to 98% by mass. %. The content can be appropriately changed depending on the film thickness of the intended polyimide film or the liquid crystal alignment film. The organic solvent at this time may be an organic solvent capable of dissolving the polymer of the present invention, and is not particularly limited. This is specifically described below.

例如,N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、二甲基亞碸、γ-丁內酯、1,3-二甲基-咪唑啉酮、甲基乙基酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮等。 For example, N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, dimethyl hydrazine, γ- Butyrolactone, 1,3-dimethyl-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone, and the like.

其中較佳為使用N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮或γ-丁內酯(以上也稱為成分(C))。 Among them, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone or γ-butyrolactone (hereinafter also referred to as component (C)) is preferably used.

該等成分(C)較佳為,組成物或使用其之液晶配向處理劑所含的有機溶劑全體之20至90質量%。其中較佳為30至80質量%,又以40至80質量%為佳,更佳為40至70質量%。 The component (C) is preferably 20 to 90% by mass based on the entire organic solvent contained in the composition or the liquid crystal alignment treatment agent using the same. It is preferably 30 to 80% by mass, more preferably 40 to 80% by mass, still more preferably 40 to 70% by mass.

本發明之組成物或使用其之液晶配向處理劑於無損本發明之效果下,可使用塗佈組成物或使用其之液晶配向處理劑時能提升樹脂被膜之塗膜性及表面平滑性的有機溶劑,即弱溶劑。 The composition of the present invention or the liquid crystal alignment treatment agent using the same can be used to improve the coating property and surface smoothness of the resin film when the composition or the liquid crystal alignment treatment agent is used without using the effect of the present invention. Solvent, ie weak solvent.

提升樹脂被膜之塗膜性及表面平滑性用的弱溶劑之具 體例如下所述。 A weak solvent for improving the coating properties and surface smoothness of a resin film The body is as described below.

例如,乙醇、異丙基醇、1-丁醇、2-丁醇、異丁基醇、tert-丁基醇、1-戊醇、2-戊醇、3-戊醇、2-甲基-1-丁醇、異戊基醇、tert-戊基醇、3-甲基-2-丁醇、新戊基醇、1-己醇、2-甲基-1-戊醇、2-甲基-2-戊醇、2-乙基-1-丁醇、1-庚醇、2-庚醇、3-庚醇、1-辛醇、2-辛醇、2-乙基-1-己醇、環己醇、1-甲基環己醇、2-甲基環己醇、3-甲基環己醇、1,2-乙二醇、1,2-丙二醇、1,3-丙二醇、1,2-丁二醇、1,3-丁二醇、1,4-丁二醇、2,3-丁二醇、1,5-戊二醇、2-甲基-2,4-戊二醇、2-乙基-1,3-己二醇、二丙基醚、二丁基醚、二己基醚、二噁烷、乙二醇二甲基醚、乙二醇二乙基醚、乙二醇二丁基醚、1,2-丁氧乙烷、二乙二醇二甲基醚、二乙二醇二乙基醚、二乙二醇甲基乙基醚、二乙二醇二丁基醚、2-戊酮、3-戊酮、2-己酮、2-庚酮、4-庚酮、3-乙氧基丁基乙酸酯、1-甲基戊基乙酸酯、2-乙基丁基乙酸酯、2-乙基己基乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、碳酸丙烯酯、碳酸乙烯酯、乙二醇單甲基醚、乙二醇單乙基醚、2-(甲氧基甲氧基)乙醇、乙二醇異丙基醚、乙二醇單丁基醚、乙二醇單異戊基醚、乙二醇之己基醚、2-(己氧基)乙醇、糖醇、二乙二醇、二乙二醇單甲基醚、二乙二醇單乙基醚、二乙二醇單丁基醚、丙二醇、丙二醇單甲基醚、丙二醇單乙基醚、丙二醇單丁基醚、1-(丁氧基乙氧基)丙醇、丙二醇單甲基醚乙酸酯、二丙二醇、二丙二醇單甲基醚、二丙二醇單乙基醚、三丙二醇單 甲基醚、乙二醇單甲基醚乙酸酯、乙二醇單乙基醚乙酸酯、乙二醇單丁基醚乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、二乙二醇單乙基醚乙酸酯、二乙二醇單丁基醚乙酸酯、2-(2-乙氧基乙氧基)乙基乙酸酯、二乙二醇乙酸酯、三乙二醇、三乙二醇單甲基醚、三乙二醇單乙基醚、乳酸甲酯、乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸n-丁酯、乙酸丙二醇單乙基醚、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、乳酸甲基酯、乳酸乙基酯、乳酸n-丙基酯、乳酸n-丁基酯、乳酸異戊基酯等之溶劑的表面張力較低之有機溶劑。 For example, ethanol, isopropyl alcohol, 1-butanol, 2-butanol, isobutyl alcohol, tert-butyl alcohol, 1-pentanol, 2-pentanol, 3-pentanol, 2-methyl- 1-butanol, isoamyl alcohol, tert-pentyl alcohol, 3-methyl-2-butanol, neopentyl alcohol, 1-hexanol, 2-methyl-1-pentanol, 2-methyl 2-pentanol, 2-ethyl-1-butanol, 1-heptanol, 2-heptanol, 3-heptanol, 1-octanol, 2-octanol, 2-ethyl-1-hexanol , cyclohexanol, 1-methylcyclohexanol, 2-methylcyclohexanol, 3-methylcyclohexanol, 1,2-ethanediol, 1,2-propanediol, 1,3-propanediol, 1 , 2-butanediol, 1,3-butanediol, 1,4-butanediol, 2,3-butanediol, 1,5-pentanediol, 2-methyl-2,4-pentane Alcohol, 2-ethyl-1,3-hexanediol, dipropyl ether, dibutyl ether, dihexyl ether, dioxane, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, B Diol dibutyl ether, 1,2-butoxyethane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol methyl ethyl ether, diethylene glycol dibutyl Ether, 2-pentanone, 3-pentanone, 2-hexanone, 2-heptanone, 4-heptanone, 3-ethoxybutyl acetate, 1-methylpentyl acetate, 2 -ethylbutyl acetate, 2- Ethylhexyl acetate, ethylene glycol monoacetate, ethylene glycol diacetate, propylene carbonate, ethylene carbonate, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, 2-( Methoxymethoxy)ethanol, ethylene glycol isopropyl ether, ethylene glycol monobutyl ether, ethylene glycol monoisoamyl ether, ethylene glycol hexyl ether, 2-(hexyloxy)ethanol, Sugar alcohol, diethylene glycol, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol Monobutyl ether, 1-(butoxyethoxy)propanol, propylene glycol monomethyl ether acetate, dipropylene glycol, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, tripropylene glycol single Methyl ether, ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether acetate, ethylene glycol monoacetate, ethylene glycol diethyl Acid ester, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, 2-(2-ethoxyethoxy) ethyl acetate, diethylene glycol Acid ester, triethylene glycol, triethylene glycol monomethyl ether, triethylene glycol monoethyl ether, methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol acetate Monoethyl ether, methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate, methyl ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-B Oxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, methyl lactate, ethyl lactate, n-propyl lactate, An organic solvent having a low surface tension of a solvent such as n-butyl ester lactate or isoamyl lactate.

其中較佳為使用1-己醇、環己醇、1,2-乙二醇、1,2-丙二醇、乙二醇單甲基醚、乙二醇單乙基醚、乙二醇單丁基醚、二乙二醇單甲基醚、二乙二醇單乙基醚、二乙二醇單丁基醚、丙二醇單甲基醚、丙二醇單乙基醚、丙二醇單丁基醚(以上也稱為成分(D))。 Among them, 1-hexanol, cyclohexanol, 1,2-ethanediol, 1,2-propanediol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, and ethylene glycol monobutyl are preferably used. Ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monobutyl ether (also referred to above For ingredient (D)).

該等弱溶劑較佳為,組成物或使用其之液晶配向處理劑所含的有機溶劑全體之1至60質量%。其中又以1至50質量%為佳,更佳為5至45質量%。 The weak solvent is preferably from 1 to 60% by mass based on the total of the organic solvent contained in the composition or the liquid crystal alignment treatment agent using the same. Among them, it is preferably from 1 to 50% by mass, more preferably from 5 to 45% by mass.

本發明之組成物或使用其之液晶配向處理劑於無損本發明之效果下,可導入具有環氧基、異氰酸酯基、環氧丙烷基或環碳酸酯基之交聯性化合物、具有由羥基、羥基烷基及低級烷氧基烷基所成群中選出的至少一種 之取代基的交聯性化合物,或具有聚合性不飽和鍵之交聯性化合物。該等取代基或聚合性不飽和鍵需為,交聯性化合物中具有2個以上。 The composition of the present invention or the liquid crystal alignment treatment agent using the same can be introduced into a crosslinkable compound having an epoxy group, an isocyanate group, an oxypropylene group or a cyclic carbonate group, having a hydroxyl group, without impairing the effects of the present invention. At least one selected from the group consisting of a hydroxyalkyl group and a lower alkoxyalkyl group A crosslinkable compound of a substituent or a crosslinkable compound having a polymerizable unsaturated bond. The substituent or the polymerizable unsaturated bond needs to be two or more of the crosslinkable compounds.

具有環氧基或異氰酸酯基之交聯性化合物如,雙酚丙酮縮水甘油醚、苯酚酚醛清漆環氧樹脂、甲酚酚醛清漆環氧樹脂、三縮水甘油基三聚異氰酸酯、四縮水甘油基胺基二伸苯酯、四縮水甘油基-m-二甲苯二胺、四縮水甘油基-1,3-雙(胺基乙基)環己烷、四苯基縮水甘油醚乙烷、三苯基縮水甘油醚乙烷、雙酚六氟乙醯二縮水甘油醚、1,3-雙(1-(2,3-環氧丙氧基)-1-三氟甲基-2,2,2-三氟甲基)苯、4,4-雙(2,3-環氧丙氧基)八氟聯苯、三縮水甘油基-p-胺基苯酚、四縮水甘油基間二甲苯二胺、2-(4-(2,3-環氧丙氧基)苯基)-2-(4-(1,1-雙(4-(2,3-環氧丙氧基)苯基)乙基)苯基)丙烷、1,3-雙(4-(1-(4-(2,3-環氧丙氧基)苯基)-1-(4-(1-(4-(2,3-環氧丙氧基)苯基)-1-甲基乙基)苯基)乙基)苯氧基)-2-丙醇等。 a crosslinkable compound having an epoxy group or an isocyanate group such as bisphenol acetone glycidyl ether, phenol novolac epoxy resin, cresol novolac epoxy resin, triglycidyl trimer isocyanate, tetraglycidylamino group Diphenyl ester, tetraglycidyl-m-xylylenediamine, tetraglycidyl-1,3-bis(aminoethyl)cyclohexane, tetraphenyl glycidyl ether ethane, triphenyl shrinkage Glycerol ether, bisphenol hexafluoroacetic acid diglycidyl ether, 1,3-bis(1-(2,3-epoxypropoxy)-1-trifluoromethyl-2,2,2-three Fluoromethyl)benzene, 4,4-bis(2,3-epoxypropoxy)octafluorobiphenyl, triglycidyl-p-aminophenol, tetraglycidyl-m-xylenediamine, 2- (4-(2,3-epoxypropoxy)phenyl)-2-(4-(1,1-bis(4-(2,3-epoxypropoxy)phenyl)ethyl)benzene Propane, 1,3-bis(4-(1-(4-(2,3-epoxypropoxy)phenyl)-1-(4-(1-(4-(2,3-) ring) Oxypropoxy)phenyl)-1-methylethyl)phenyl)ethyl)phenoxy)-2-propanol and the like.

具有環氧丙烷基之交聯性化合物為,具有至少2個下述式〔4〕所表示之環氧丙烷基之交聯性化合物。 The crosslinkable compound having an oxypropylene group is a crosslinkable compound having at least two oxypropylene groups represented by the following formula [4].

具體如,國際公開公報WO2011/132751(2011.10.27公開)之58項至59項所揭示的式〔4a〕至式〔4k〕所表 示之交聯性化合物。 Specifically, for example, the formula [4a] to the formula [4k] disclosed in items 58 to 59 of the international publication WO2011/132751 (2011.10.27 publication) A cross-linking compound is shown.

具有環碳酸酯基之交聯性化合物為,具有至少2個下述式〔5〕所表示之環碳酸酯基的交聯性化合物。 The crosslinkable compound having a cyclic carbonate group is a crosslinkable compound having at least two cyclic carbonate groups represented by the following formula [5].

具體如,國際公開公報WO2012/014898(2012.2.2公開)之76項至82項所揭示的式〔5-1〕至式〔5-42〕所表示之交聯性化合物。 Specifically, the crosslinkable compound represented by the formula [5-1] to the formula [5-42] disclosed in 76 to 82 of the International Publication No. WO2012/014898 (published in 2012.2.2).

具有由羥基及烷氧基所成群中選出的至少一種之取代基的交聯性化合物如,具有羥基或烷氧基之胺基樹脂,例如三聚氰胺樹脂、尿素樹脂、鳥糞胺樹脂、甘脲-甲醛樹脂、丁二醯胺-甲醛樹脂或伸乙基尿素-甲醛樹脂等。具體上可使用胺基之氫原子被羥甲基或烷氧基甲基或雙方所取代之三聚氰胺衍生物、苯并鳥糞胺衍生物或甘脲。該三聚氰胺衍生物或苯并鳥糞胺衍生物可以二聚物或三聚物之形態存在。該等較佳為每個三嗪環具有平均3個以上6個以下之羥甲基或烷氧基甲基之物。 a crosslinkable compound having at least one substituent selected from the group consisting of a hydroxyl group and an alkoxy group, for example, an amine-based resin having a hydroxyl group or an alkoxy group, such as a melamine resin, a urea resin, a guanamine resin, and a glycoluril - Formaldehyde resin, butylene amine-formaldehyde resin or ethyl urea-formaldehyde resin. Specifically, a melamine derivative, a benzoguanamine derivative or a glycoluril in which a hydrogen atom of an amine group is substituted with a methylol group or an alkoxymethyl group or both can be used. The melamine derivative or the benzoguanamine derivative may exist in the form of a dimer or a trimer. These are preferably those having an average of 3 or more and 6 or less hydroxymethyl groups or alkoxymethyl groups per triazine ring.

該類三聚氰胺衍生物或苯并鳥糞胺衍生物如,市售品的每個三嗪環被平均3.7個甲氧基甲基取代之MX-750、每個三嗪環被平均5.8個甲氧基甲基取代之MW-30(以下為三和化學公司製),或賽美爾300、301、303、350、370、771、325、327、703、712等之甲 氧基甲基化三聚氰胺、賽美爾235、236、238、212、253、254等之甲氧基甲基化丁氧基甲基化三聚氰胺、賽美爾506、508等之丁氧基甲基化三聚氰胺、賽美爾1141般含有羧基之甲氧基甲基化異丁氧基甲基化三聚氰胺、賽美爾1123般甲氧基甲基化乙氧基甲基化苯并鳥糞胺、賽美爾1123-10般甲氧基甲基化丁氧基甲基化苯并鳥糞胺、賽美爾1128般丁氧基甲基化苯并鳥糞胺、賽美爾1125-80般含有羧基之甲氧基甲基化乙氧基甲基化苯并鳥糞胺(以上為三井賽那蜜公司製)。又,甘脲如,賽美爾1170般丁氧基甲基化甘脲、賽美爾1172般羥甲基化甘脲等、帕達林1174般甲氧基羥甲基化甘脲等。 Such melamine derivatives or benzoguanamine derivatives such as MX-750 in which each triazine ring of the commercial product is substituted with an average of 3.7 methoxymethyl groups, and an average of 5.8 methoxy groups per triazine ring Methyl substituted MW-30 (hereinafter referred to as Sanwa Chemical Co., Ltd.), or Semel 300, 301, 303, 350, 370, 771, 325, 327, 703, 712, etc. Oxyoxymethylated melamine, SEMEL 235, 236, 238, 212, 253, 254, etc. methoxymethylated butoxymethylated melamine, Semel 506, 508, etc. Melamine, Semel 1141-containing methoxymethylated isobutoxymethylated melamine, Semel 1123-like methoxymethylated ethoxymethylated benzoguanamine, race Meier 1123-10-like methoxymethylated butoxymethylated benzoguanamine, Semel 1128-butoxymethylated benzoguanamine, Semel 1125-80 contains carboxyl Methoxymethylated ethoxymethylated benzoguanamine (above is manufactured by Mitsui Saina Honey Co., Ltd.). Further, glycoluril such as Semel 1170-butoxymethylated glycoluril, Semel 1172-like methylolated glycoluril, and Pardarin 1174-like methoxymethylolated glycoluril.

具有羥基或烷氧基之苯或苯酚性化合物如,1,3,5-三(甲氧基甲基)苯、1,2,4-三(異丙氧基甲基)苯、1,4-雙(sec-丁氧基甲基)苯或2,6-二羥基甲基-p-tert-丁基苯酚等。 a benzene or phenolic compound having a hydroxyl group or an alkoxy group such as 1,3,5-tris(methoxymethyl)benzene, 1,2,4-tris(isopropoxymethyl)benzene, 1,4 - bis(sec-butoxymethyl)benzene or 2,6-dihydroxymethyl-p-tert-butylphenol.

更具體如,國際公開公報WO2011/132751(2011.10.27公開)之62頁至66頁所揭示的式〔6-1〕至式〔6-48〕所表示之交聯性化合物。 More specifically, the crosslinkable compound represented by the formula [6-1] to the formula [6-48] disclosed on pages 62 to 66 of International Publication WO2011/132751 (2011.10.27 publication).

具有聚合性不飽和鍵之交聯性化合物如,三羥甲基丙烷三(甲基)丙烯酸酯、季戊四醇三(甲基)丙烯酸酯、二季戊四醇五(甲基)丙烯酸酯、三(甲基)丙烯醯氧基乙氧基三羥甲基丙烷、甘油聚縮水甘油醚聚(甲基)丙烯酸酯等之分子內具有3個聚合性不飽和基之交聯性化合物,又如,乙二醇二(甲基)丙烯酸酯、二乙二醇 二(甲基)丙烯酸酯、四乙二醇二(甲基)丙烯酸酯、聚乙二醇二(甲基)丙烯酸酯、丙二醇二(甲基)丙烯酸酯、聚丙二醇二(甲基)丙烯酸酯、丁二醇二(甲基)丙烯酸酯、新戊二醇二(甲基)丙烯酸酯、環氧乙烷雙酚A型二(甲基)丙烯酸酯、環氧丙烷雙酚A型二(甲基)丙烯酸酯、1,6-己二醇二(甲基)丙烯酸酯、甘油二(甲基)丙烯酸酯、季戊四醇二(甲基)丙烯酸酯、乙二醇二縮水甘油醚二(甲基)丙烯酸酯、二乙二醇二縮水甘油醚二(甲基)丙烯酸酯、酞酸二縮水甘油醚二(甲基)丙烯酸酯、羥基三甲基乙酸新戊二醇二(甲基)丙烯酸酯等之分子內具有2個聚合性不飽和基之交聯性化合物,另如,2-羥基乙基(甲基)丙烯酸酯、2-羥基丙基(甲基)丙烯酸酯、2-羥基丁基(甲基)丙烯酸酯、2-苯氧基-2-羥基丙基(甲基)丙烯酸酯、2-(甲基)丙烯醯氧基-2-羥基丙基酞酸酯、3-氯-2-羥基丙基(甲基)丙烯酸酯、甘油單(甲基)丙烯酸酯、2-(甲基)丙烯醯氧基乙基磷酸酯、N-羥甲基(甲基)丙烯醯胺等之分子內具有1個聚合性不飽和基的交聯性化合物。 a crosslinkable compound having a polymerizable unsaturated bond such as trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, dipentaerythritol penta(meth)acrylate, tris(methyl) a cross-linking compound having three polymerizable unsaturated groups in the molecule such as propylene methoxy ethoxy trimethylolpropane or glycerol polyglycidyl ether poly(meth) acrylate, and, for example, ethylene glycol (meth) acrylate, diethylene glycol Di(meth)acrylate, tetraethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylate , butanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, ethylene oxide bisphenol A di(meth)acrylate, propylene oxide bisphenol A type II Acrylate, 1,6-hexanediol di(meth)acrylate, glycerol di(meth)acrylate, pentaerythritol di(meth)acrylate, ethylene glycol diglycidyl ether di(methyl) Acrylate, diethylene glycol diglycidyl ether di(meth)acrylate, decanoic acid diglycidyl ether di(meth)acrylate, hydroxytrimethylacetic acid neopentyl glycol di(meth)acrylate, etc. a crosslinkable compound having two polymerizable unsaturated groups in the molecule, for example, 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (meth) acrylate, 2-hydroxy butyl ( Methyl) acrylate, 2-phenoxy-2-hydroxypropyl (meth) acrylate, 2-(methyl) propylene oxy-2-hydroxypropyl phthalate, 3-chloro-2- Hydroxypropyl (meth) acrylate A glycerol mono(meth)acrylate, 2-(meth)acryloyloxyethyl phosphate, N-hydroxymethyl(meth)acrylamide or the like having one polymerizable unsaturated group in the molecule A combination compound.

另外可使用下述式〔7〕所表示之化合物。 Further, a compound represented by the following formula [7] can be used.

(式(7)中,E1為由環己烷環、二環己烷環、苯環、聯苯環、聯三苯環、萘環、芴環、蒽環及菲環所成群中所選出之基,E2為由下述式〔7a〕及式〔7b〕所成群中 選出之基,n為1至4之整數)。 (In the formula (7), E 1 is a group consisting of a cyclohexane ring, a bicyclohexane ring, a benzene ring, a biphenyl ring, a terphenyl ring, a naphthalene ring, an anthracene ring, an anthracene ring, and a phenanthrene ring. The selected group, E 2 is a group selected from the group consisting of the following formulas [7a] and [7b], and n is an integer of 1 to 4).

上述化合物為交聯性化合物之一例,但非限定於該等。又,本發明之組成物或使用其之液晶配向處理劑所使用的交聯性化合物可為一種、或二種以上組合。 The above compound is an example of a crosslinkable compound, but is not limited thereto. Further, the cross-linking compound used in the composition of the present invention or the liquid crystal alignment treatment agent using the same may be used alone or in combination of two or more.

本發明之組成物或使用其之液晶配向處理劑中,交聯性化合物之含量相對於全部聚合物成分100質量份,較佳為0.1至150質量份。為了使進行交聯反應可發現目的之效果,相對於全部聚合物成分100質量份更佳為0.1至100質量份,最佳為1至50質量份。 In the composition of the present invention or the liquid crystal alignment treatment agent using the same, the content of the crosslinkable compound is preferably from 0.1 to 150 parts by mass based on 100 parts by mass of the total polymer component. The effect of the purpose of the crosslinking reaction is preferably from 0.1 to 100 parts by mass, preferably from 1 to 50 parts by mass, per 100 parts by mass of the total of the polymer component.

使用由本發明之組成物所得的液晶配向劑作為液晶配向膜用時,可促進液晶配向膜中之電荷移動,而促進使用該液晶配向膜之液晶單元去除電荷的化合物如,國際公開公報WO2011/132751(2011.10.27公開)之69頁至73頁所揭示的式〔M1〕至〔M156〕所表示之含氮之雜環胺化合物。 When a liquid crystal alignment agent obtained from the composition of the present invention is used as a liquid crystal alignment film, a charge shift in a liquid crystal alignment film can be promoted, and a compound which removes a charge using a liquid crystal cell of the liquid crystal alignment film can be promoted. For example, International Publication WO2011/132751 The nitrogen-containing heterocyclic amine compound represented by the formulas [M1] to [M156] disclosed on pages 69 to 73 of (2011.10.27).

其中較佳為式〔M1〕、式[M7〕、式〔M16〕至式〔20〕、式〔M24〕、式〔M35〕、式〔M36〕、式〔M40〕、式〔M49〕、式〔M50〕、式〔M52〕、式〔M60〕至式〔M62〕、式〔M68〕、式〔M69〕、式〔M76〕、式〔M77〕、式〔M82〕、式〔M100〕、式〔M101〕、式〔M108〕、式[M109〕、式〔M118〕至 式〔M121〕、式〔M128〕、式〔M134〕至式〔M136〕或式〔M140〕。 Preferably, it is a formula [M1], a formula [M7], a formula [M16] to a formula [20], a formula [M24], a formula [M35], a formula [M36], a formula [M40], a formula [M49], and a formula. [M50], formula [M52], formula [M60] to formula [M62], formula [M68], formula [M69], formula [M76], formula [M77], formula [M82], formula [M100], formula [M101], formula [M108], formula [M109], formula [M118] to Formula [M121], formula [M128], formula [M134] to formula [M136] or formula [M140].

該等胺化合物可直接加入組成物,但可以適當溶劑使其成為濃度0.1質量%至10質量%,較佳為1質量%至7質量%之溶液再添加。該溶劑可為,能溶解上述聚合物之有機溶劑,無特別限定。 These amine compounds may be directly added to the composition, but may be added to a solution having a concentration of 0.1% by mass to 10% by mass, preferably 1% by mass to 7% by mass, in a suitable solvent. The solvent may be an organic solvent capable of dissolving the above polymer, and is not particularly limited.

本發明之組成物或使用其之液晶配向處理劑於無損本發明之效果下,可使用提升塗佈組成物或使用其之液晶配向處理劑所得的樹脂被膜之膜厚均勻性及表面平滑性用的化合物。又,可使用提升樹脂被膜與基板之密合性用的化合物。 In the composition of the present invention or the liquid crystal alignment treatment agent using the same, the film thickness uniformity and surface smoothness of the resin film obtained by using the coating composition or the liquid crystal alignment treatment agent using the coating composition can be used without impairing the effects of the present invention. compound of. Further, a compound for improving the adhesion between the resin film and the substrate can be used.

提升樹脂被膜之膜厚均勻性及表面平滑性用的化合物如,氟系表面活性劑、聚矽氧系表面活性劑、非離子系表面活性劑等。 A compound for improving the film thickness uniformity and surface smoothness of the resin film, for example, a fluorine-based surfactant, a polyoxyxide-based surfactant, a nonionic surfactant, or the like.

更具體如,耶佛特EF301、EF303、EF352(特肯姆公司製)、美加發F171、F173、R-30(大日本油墨公司製)、佛洛拉FC430、FC431(住友3M公司製)、艾薩西AG710、薩佛隆S-382、SC101、SC102、SC103、SC104、SC105、SC106(把硝子公司製)等。該等表面活性劑之含有比例相對於組成物或液晶配向處理劑所含的全部聚合物成分100質量份,較佳為0.01至2質量份,更佳為0.01至1質量份。 More specifically, Yvette EF301, EF303, EF352 (made by Tekken Co., Ltd.), Mikafa F171, F173, R-30 (made by Dainippon Ink Co., Ltd.), Flora FC430, FC431 (manufactured by Sumitomo 3M Co., Ltd.), Isaishi AG710, Saffron S-382, SC101, SC102, SC103, SC104, SC105, SC106 (made by the company). The content of the surfactant is preferably 0.01 to 2 parts by mass, more preferably 0.01 to 1 part by mass, per 100 parts by mass of the total polymer component contained in the composition or the liquid crystal alignment treatment agent.

提升樹脂被膜與基板之密合性用的化合物之具體例如,下述含有官能性矽烷之化合物或含有環氧基之 化合物。 Specific examples of the compound for improving the adhesion between the resin film and the substrate are, for example, the following compounds containing a functional decane or containing an epoxy group. Compound.

例如,3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基三甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基丙基三伸乙基三胺、N-三甲氧基矽烷基丙基三伸乙基三胺、10-三甲氧基矽烷基-1,4,7-三氮雜癸烷、10-三乙氧基矽烷基-1,4,7-三氮雜癸烷、9-三甲氧基矽烷基-3,6-二氮雜壬基乙酸酯、9-三乙氧基矽烷基-3,6-二氮雜壬基乙酸酯、N-苄基-3-胺基丙基三甲氧基矽烷、N-苄基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三甲氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三乙氧基矽烷、乙二醇二縮水甘油醚、聚乙二醇二縮水甘油醚、丙二醇二縮水甘油醚、三丙二醇二縮水甘油醚、聚丙二醇二縮水甘油醚、新戊二醇二縮水甘油醚、1,6-己二醇二縮水甘油醚、甘油二縮水甘油醚、2,2-二溴新戊二醇二縮水甘油醚、1,3,5,6-四縮水甘油基-2,4-己二醇、N,N,N’,N’-四縮水甘油基-m-二甲苯二胺、1,3-雙(N,N-二縮水甘油基胺基甲基)環己烷或N,N,N’,N’-四縮水甘油基-4,4’-二胺基二苯基甲烷等。 For example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2-aminopropyltriethoxydecane, N- (2-Aminoethyl)-3-aminopropyltrimethoxydecane, N-(2-aminoethyl)-3-aminopropylmethyltrimethoxydecane, 3-ureidopropyl Trimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyltrimethoxydecane, N-ethoxycarbonyl-3-aminopropyltriethyl Oxydecane, N-triethoxydecylpropyltriethylamine, N-trimethoxydecylpropyltriethylamine, 10-trimethoxydecyl-1,4,7 - triazadecane, 10-triethoxydecyl-1,4,7-triazadecane, 9-trimethoxydecyl-3,6-diazadecyl acetate, 9 -triethoxydecyl-3,6-diazaindolyl acetate, N-benzyl-3-aminopropyltrimethoxydecane, N-benzyl-3-aminopropyltriethyl Oxydecane, N-phenyl-3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyltriethoxydecane, N-bis(ethylene oxide)-3-aminopropyl Trimethoxy decane, N-bis(ethylene oxide)-3- Aminopropyl triethoxy decane, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl Alcohol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl Base-2,4-hexanediol, N,N,N',N'-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diglycidylaminomethyl) Cyclohexane or N,N,N',N'-tetraglycidyl-4,4'-diaminodiphenylmethane, and the like.

使用該等與基板密合之化合物時,其含量相 對於組成物或使用其之液晶配向處理劑所含的全部聚合物成分100質量份,較佳為0.1至30質量份,更佳為1至20質量份。未達0.1質量份時無法期待提升密合性之效果,多於30質量份時會使組成物或使用其之液晶配向處理劑的保存安定性變差。 When using these compounds in close contact with the substrate, the content of the compound It is preferably 0.1 to 30 parts by mass, more preferably 1 to 20 parts by mass, based on 100 parts by mass of all the polymer components contained in the composition or the liquid crystal alignment treatment agent using the same. When the amount is less than 0.1 part by mass, the effect of improving the adhesion cannot be expected, and when it is more than 30 parts by mass, the storage stability of the composition or the liquid crystal alignment treatment agent using the same may be deteriorated.

本發明之組成物或使用其之液晶配向處理劑中,除了上述弱溶劑、交聯性化合物、提升樹脂被膜之膜厚均勻性及表面平滑性用的化合物及密合基板用之化合物,無損本發明之效果的範圍內,可添加改變聚醯亞胺膜或液晶配向膜之電容率及導電性等之電特性用的介電體或導電物質。 In the composition of the present invention or the liquid crystal alignment treatment agent using the same, the weak solvent, the crosslinkable compound, the compound for improving the film thickness uniformity and surface smoothness of the resin film, and the compound for the adhesion substrate are not destructive. Within the range of the effects of the invention, a dielectric or a conductive material for changing the electrical properties such as the permittivity and conductivity of the polyimide film or the liquid crystal alignment film may be added.

<聚醯亞胺膜> <Polyimide film>

將本發明之組成物塗佈於基板上,焙燒後可作為聚醯亞胺膜用。此時所使用之基板可因應目的之裝置,使用玻璃基板、矽電路板、丙烯酸基板或聚碳酸酯等之塑料基板等。組成物之塗佈方法無特別限定,一般為工業上以浸漬法、輥塗法、縫塗法、旋塗法、噴霧法、網版印刷、膠版印刷、柔版印刷或噴墨印刷法等進行之方法。該等可因應目的使用。 The composition of the present invention is applied onto a substrate and, after firing, can be used as a polyimide film. In the substrate to be used at this time, a glass substrate, a tantalum board, an acrylic substrate, a plastic substrate such as polycarbonate, or the like can be used depending on the intended device. The coating method of the composition is not particularly limited, and is generally industrially carried out by dipping, roll coating, slit coating, spin coating, spray, screen printing, offset printing, flexographic printing or ink jet printing. The method. These may be used for the purpose.

將組成物塗佈於基板後,藉由熱循環型烤箱或IR(紅外線)型烤箱等之加熱手段以50至300℃,較佳以80至250℃蒸發溶劑可得樹脂被膜。焙燒後樹脂被膜之厚度可因應目的調整為0.01至50μm。 After the composition is applied to the substrate, the resin film is obtained by evaporating the solvent at 50 to 300 ° C, preferably 80 to 250 ° C by a heating means such as a heat cycle type oven or an IR (infrared) type oven. The thickness of the resin film after baking can be adjusted to 0.01 to 50 μm in accordance with the purpose.

<液晶配向膜、液晶顯示元件> <Liquid alignment film, liquid crystal display element>

將使用本發明之組成物所得的液晶配向處理劑塗佈於基板上,焙燒後以摩擦處理或光照射等進行配向處理,可作為液晶配向膜用。又,垂直配向用途中既使無配向處理也可作為液晶配向膜用。此時所使用之基板可為透明性較高之基板無特別限定,除了玻璃基板,可使用丙烯酸基板或聚碳酸酯基板等之塑料基板。就步驟簡單化之觀點,較佳為使用形成液晶驅動用之ITO電極等的基板。又,反射型液晶顯示元件中,也可僅單側之基板使用矽電路板等之不透明基板,此時之電極也可使用鋁等反射光之材料。 The liquid crystal alignment treatment agent obtained by using the composition of the present invention is applied onto a substrate, and after firing, it is subjected to alignment treatment by rubbing treatment or light irradiation, and can be used as a liquid crystal alignment film. Further, in the vertical alignment use, it can be used as a liquid crystal alignment film even without alignment treatment. The substrate to be used at this time is not particularly limited as long as the substrate having high transparency, and a plastic substrate such as an acrylic substrate or a polycarbonate substrate can be used as the glass substrate. From the viewpoint of simplification of the steps, it is preferred to use a substrate on which an ITO electrode or the like for driving a liquid crystal is used. Further, in the reflective liquid crystal display device, an opaque substrate such as a ruthenium circuit board may be used as the substrate on one side, and a material such as aluminum or the like may be used as the electrode.

液晶配向處理劑之塗佈方法無特別限定,一般為工業上以網版印刷、膠版印刷、柔版印刷或噴墨印刷法等進行之方法。其他之塗佈方法如,浸漬法、輥塗法、縫塗法、旋塗法或噴霧法等,可因應目的使用該等。 The coating method of the liquid crystal alignment treatment agent is not particularly limited, and is generally a method which is industrially carried out by screen printing, offset printing, flexographic printing or ink jet printing. Other coating methods such as a dipping method, a roll coating method, a slit coating method, a spin coating method, or a spray method can be used depending on the purpose.

將液晶配向處理劑塗佈於基板後,藉由熱板、熱循環型烤箱或IR(紅外線)型烤箱等之加熱手段以50至300℃,較佳以80至250℃蒸發溶劑可得液晶配向膜。焙燒後液晶配向膜之厚度太厚時將不利於液晶顯示元件之消費電力方面,太薄時會降低液晶顯示元件之信賴性,因此較佳為5至300nm,更佳為10至100nm。為了使液晶水平配向或傾斜配向,焙燒後可以摩擦或偏光紫外線照射等處理液晶配向膜。 After the liquid crystal alignment treatment agent is applied to the substrate, the liquid crystal alignment can be obtained by evaporating the solvent at 50 to 300 ° C, preferably 80 to 250 ° C by heating means such as a hot plate, a heat cycle type oven or an IR (infrared) type oven. membrane. When the thickness of the liquid crystal alignment film after baking is too thick, it is disadvantageous in terms of power consumption of the liquid crystal display element, and when it is too thin, the reliability of the liquid crystal display element is lowered, so it is preferably 5 to 300 nm, more preferably 10 to 100 nm. In order to align the liquid crystal horizontally or obliquely, the liquid crystal alignment film may be treated by rubbing or polarized ultraviolet irradiation or the like after baking.

本發明之液晶顯示元件為,藉由上述方法由本發明之液晶配向處理劑得附液晶配向膜之基板後,以已知方法製 作液晶單元所得的作為液晶顯示元件用之物。 The liquid crystal display element of the present invention is obtained by a known method from the substrate to which the liquid crystal alignment film is attached by the liquid crystal alignment treatment agent of the present invention. A liquid crystal display element obtained by using a liquid crystal cell.

液晶單元製作方法如,準備一對形成液晶配向膜之基板,將調距物散佈於單方基板之液晶配向膜上,以液晶配向膜面為內側方式貼合另一方基板後,減壓注入液晶再密封之方法,或將液晶滴入已散佈調距物之液晶配向膜面後貼合基板再密封之方法等。 In the liquid crystal cell manufacturing method, for example, a pair of substrates for forming a liquid crystal alignment film are prepared, and the distance adjustment substance is spread on the liquid crystal alignment film of the single substrate, and the other substrate is bonded to the inner side of the liquid crystal alignment film surface, and then the liquid crystal is injected under reduced pressure. A method of sealing, or a method of re-sealing a liquid crystal by dropping a liquid crystal into a liquid crystal alignment film surface on which a distance adjustment object has been dispensed.

又,本發明之液晶配向處理劑較佳為使用於一對備有電極之基板之間具有液晶層,且一對基板之間配置含有藉由活性能量線及熱中至少一方而聚合之聚合性化合物的液晶組成物,經由電壓施加於電極間且藉由照射活性能量線及加熱中至少一方使聚合性化合物聚合之步驟製造的液晶顯示元件。此時之活性能量線較佳為紫外線。紫外線之波長為300至400nm,較佳為310至360nm。藉由加熱聚合時,加熱溫度為40至120℃,較佳為60至80℃。又,可同時進行紫外線與加熱。 Moreover, it is preferable that the liquid crystal alignment treatment agent of the present invention has a liquid crystal layer between a pair of substrates having electrodes, and a polymerizable compound which is polymerized by at least one of an active energy ray and heat is disposed between the pair of substrates. A liquid crystal display device produced by a step of applying a voltage to a polymer and irradiating a polymerizable compound by at least one of an active energy ray and a heating. The active energy ray at this time is preferably ultraviolet ray. The ultraviolet light has a wavelength of 300 to 400 nm, preferably 310 to 360 nm. When the polymerization is carried out by heating, the heating temperature is 40 to 120 ° C, preferably 60 to 80 ° C. Moreover, ultraviolet rays and heating can be simultaneously performed.

上述液晶顯示元件為,藉由PSA(Polymer Sustained Alignment)方式控制液晶分子之預傾之物。PSA方式為,液晶材料中混入少量之光聚合性化合物,例如光聚合性單體,組裝液晶單元後,以一定電壓施加於液晶層之狀態下將紫外線等照射於光聚合性化合物,藉由所生成之聚合物控制液晶分子之預傾。因去除電壓後仍可記憶聚合物生成時之液晶分子的配向狀態,故藉由控制形成於液晶層之電場等,可調整液晶分子之預傾。又,PSA方式中無需摩擦處理,因此適用於形成難藉由摩擦處理控制 預傾之垂直配向型液晶層。 The liquid crystal display element is a pre-dip object for controlling liquid crystal molecules by a PSA (Polymer Sustained Alignment) method. In the PSA method, a small amount of a photopolymerizable compound, for example, a photopolymerizable monomer, is added to the liquid crystal material, and after the liquid crystal cell is assembled, ultraviolet rays or the like is applied to the photopolymerizable compound while being applied to the liquid crystal layer with a constant voltage. The resulting polymer controls the pretilt of the liquid crystal molecules. Since the alignment state of the liquid crystal molecules at the time of polymer formation can be memorized after the voltage is removed, the pretilt of the liquid crystal molecules can be adjusted by controlling the electric field formed in the liquid crystal layer or the like. Moreover, there is no need for friction treatment in the PSA method, so it is suitable for forming difficult to control by friction treatment. Pre-tilted vertical alignment type liquid crystal layer.

即,本發明之液晶顯示元件可為,藉由上述方法由本發明之液晶配向處理劑得附液晶配向膜之基板後,製作液晶單元,再藉由照射紫外線及加熱中至少一方使聚合性化合物聚合而控制液晶分子之配向之物。 In the liquid crystal display device of the present invention, the liquid crystal cell is produced by the liquid crystal alignment film of the liquid crystal alignment agent of the present invention, and the polymerizable compound is polymerized by irradiating at least one of ultraviolet rays and heating. And controlling the alignment of the liquid crystal molecules.

舉PSA方式之液晶單元製作例時可如,準備一對形成液晶配向膜之基板,將調距物散佈於單方之基板之液晶配向膜上,以液晶配向膜面為內側之方式貼合另一方基板後,減壓注入液晶再密封之方法,或將液晶滴入已散佈調距物之液晶配向膜面後貼合基板再密封之方法等。 In the case of the PSA liquid crystal cell fabrication example, a pair of substrates for forming a liquid crystal alignment film may be prepared, and the distance adjustment substance may be spread on the liquid crystal alignment film of the single substrate, and the other side of the liquid crystal alignment film surface may be attached to the other side. After the substrate, the liquid crystal is re-sealed by decompression, or the liquid crystal is dropped into the liquid crystal alignment film surface on which the distance adjustment object has been dispensed, and the substrate is resealed.

液晶中係混合藉由熱或紫外線照射而聚合之聚合性化合物。聚合性化合物如,分子內具有1個以上之丙烯酸酯或甲基丙烯酸酯等之聚合性不飽和基的化合物。此時聚合性化合物相對於液晶成分100質量份較佳為0.01至10質量份,更佳為0.1至5質量份。聚合性化合物未達0.01質量份時,無法聚合聚合性化合物而無法控制液晶之配向,多於10質量份時會增加未反應之聚合性化合物,而降低液晶顯示元件之燒結特性。 A polymerizable compound which is polymerized by irradiation with heat or ultraviolet rays is mixed in the liquid crystal. The polymerizable compound is a compound having one or more polymerizable unsaturated groups such as acrylate or methacrylate in the molecule. In this case, the polymerizable compound is preferably 0.01 to 10 parts by mass, more preferably 0.1 to 5 parts by mass, per 100 parts by mass of the liquid crystal component. When the amount of the polymerizable compound is less than 0.01 parts by mass, the polymerizable compound cannot be polymerized, and the alignment of the liquid crystal cannot be controlled. When the amount is more than 10 parts by mass, the unreacted polymerizable compound is increased, and the sintering characteristics of the liquid crystal display element are lowered.

製作液晶單元後,將交流或直流之電壓施加於液晶單元的同時,照射熱或紫外線使聚合性化合物聚合。藉此可控制液晶分子之配向。 After the liquid crystal cell is produced, a voltage of alternating current or direct current is applied to the liquid crystal cell, and the polymerizable compound is polymerized by irradiation with heat or ultraviolet rays. Thereby, the alignment of the liquid crystal molecules can be controlled.

又,本發明之液晶配向處理劑較佳為使用於一對備有電極之基板之間具有液晶層,且前述一對基板之間配置含有藉由活性能量線及熱之至少一方而聚合之聚合性基的液 晶配向膜,經由電壓施加於電極內之步驟製造的液晶顯示元件。此時之活性能量線較佳為紫外線。紫外線之波長為300至400nm,較佳為310至360nm。藉由加熱而聚合時,加熱溫度為40至120℃,較佳為60至80℃。又,可同時進行紫外線與加熱。 Moreover, it is preferable that the liquid crystal alignment treatment agent of the present invention has a liquid crystal layer between a pair of substrates provided with electrodes, and a polymerization polymerization of at least one of an active energy ray and heat is disposed between the pair of substrates. Sex-based fluid A liquid crystal display element produced by a step of applying a voltage to a film via a voltage. The active energy ray at this time is preferably ultraviolet ray. The ultraviolet light has a wavelength of 300 to 400 nm, preferably 310 to 360 nm. When the polymerization is carried out by heating, the heating temperature is 40 to 120 ° C, preferably 60 to 80 ° C. Moreover, ultraviolet rays and heating can be simultaneously performed.

為了得到含有藉由活性能量線及熱中至少一方而聚合之聚合性基的液晶配向膜可如,將含有該聚合性基之化合物加入液晶配向處理劑中之方法,或含有含聚合性基之聚合物成分的方法。 In order to obtain a liquid crystal alignment film containing a polymerizable group polymerized by at least one of an active energy ray and heat, for example, a method of adding a compound containing the polymerizable group to a liquid crystal alignment treatment agent, or a polymerization containing a polymerizable group may be used. Method of composition of matter.

本發明之液晶配向處理劑為,含有持有藉由熱或紫外線照射而反應的雙鍵部位之特定化合物,因此可藉由紫外線照射及加熱中至少一方控制液晶分子之配向。 Since the liquid crystal alignment agent of the present invention contains a specific compound having a double bond site which is reacted by heat or ultraviolet irradiation, at least one of ultraviolet light irradiation and heating can control the alignment of liquid crystal molecules.

舉液晶單元製作例可如,準備一對形成液晶配向膜之基板,將調距物散佈於單方基板之液晶配向膜上,以液晶配向膜面為內側之方式貼合另一方基板後,減壓注入液晶再密封之方法,或將液晶滴入已散佈調距物之液晶配向膜面後貼合基板再密封之方法等。 In the liquid crystal cell production example, a pair of substrates for forming a liquid crystal alignment film may be prepared, and the distance adjustment substance may be spread on the liquid crystal alignment film of the single substrate, and the other substrate may be bonded to the inner side of the liquid crystal alignment film surface, and then decompressed. A method of injecting liquid crystal and resealing, or a method of re-sealing a liquid crystal by dropping a liquid crystal into a liquid crystal alignment film surface on which a distance adjustment object has been dispensed.

製作液晶單元後,將交流或直流之電壓施加於液晶單元的同時照射熱或紫外線,可控制液晶分子之配向。 After the liquid crystal cell is fabricated, the voltage of the alternating current or direct current is applied to the liquid crystal cell while irradiating heat or ultraviolet rays, and the alignment of the liquid crystal molecules can be controlled.

如上述由本發明之液晶配向處理劑製作的液晶顯示元件為,具有優良信賴性之物,適用於大畫面且高精細之液晶電視等。 The liquid crystal display element produced by the liquid crystal alignment treatment agent of the present invention has excellent reliability and is suitable for a large-screen and high-definition liquid crystal television.

實施例 Example

下面將舉實施例更詳細說明本發明,但非限定以該等解釋。 The invention will now be described in more detail by way of examples, without limitation.

實施例所使用之化合物的代號如下所述。 The symbols of the compounds used in the examples are as follows.

(四羧酸二酐) (tetracarboxylic dianhydride)

CBDA:1,2,3,4-環丁烷四羧酸二酐 CBDA: 1,2,3,4-cyclobutane tetracarboxylic dianhydride

BODA:二環〔3,3,0〕辛烷-2,4,6,8-四羧酸二酐 BODA: bicyclo[3,3,0]octane-2,4,6,8-tetracarboxylic dianhydride

TCA:下述式所表示之四羧酸二酐 TCA: tetracarboxylic dianhydride represented by the following formula

TDA:下述式所表示之四羧酸二酐 TDA: tetracarboxylic dianhydride represented by the following formula

(二胺化合物) (diamine compound)

p-PDA:p-伸苯基二胺 p-PDA: p-phenylenediamine

m-PDA:m-伸苯基二胺 m-PDA: m-phenylene diamine

DBA:3,5-二胺基苯甲酸 DBA: 3,5-diaminobenzoic acid

AP18:1,3-二胺基-4-十八烷氧基苯 AP18: 1,3-diamino-4-octadecyloxybenzene

(特定支鏈型二胺化合物) (specific branched diamine compound)

PCH7DAB:1,3-二胺基-4-〔4-(反-4-n-庚基環己基)苯氧基〕苯 PCH7DAB: 1,3-diamino-4-[4-(trans-4-n-heptylcyclohexyl)phenoxy]benzene

PBCH5DAB:1,3-二胺基-4-{4-〔反-4-(反-4-n-戊基環己基)環己基〕苯氧基}苯 PBCH5DAB: 1,3-diamino-4-{4-[trans-4-(trans-4-n-pentylcyclohexyl)cyclohexyl]phenoxy}benzene

m-PBCH5DABz:1,3-二胺-5-{4-〔4-(反-4-n-戊基環己基)苯基〕苯氧基甲基}苯 m-PBCH5DABz: 1,3-diamine-5-{4-[4-(trans-4-n-pentylcyclohexyl)phenyl]phenoxymethyl}benzene

CoIDAB-1:下述式所表示之特定支鏈型二胺化合物 CoIDAB-1: a specific branched diamine compound represented by the following formula

CoIDAB-2:下述式所表示之特定支鏈型二胺化合物 CoIDAB-2: a specific branched diamine compound represented by the following formula

(特定溶劑(成分(A)) (Specific solvent (ingredient (A))

下述式〔1a〕所表示之二丙二醇二甲基醚 Dipropylene glycol dimethyl ether represented by the following formula [1a]

(成分(C)) (ingredient (C))

NMP:N-甲基-2-吡咯烷酮 NMP: N-methyl-2-pyrrolidone

NEP:N-乙基-2-吡咯烷酮 NEP: N-ethyl-2-pyrrolidone

γ-BL:γ-丁內酯 γ-BL: γ-butyrolactone

(成分(D)) (ingredient (D))

BCS:乙二醇單丁基醚 BCS: ethylene glycol monobutyl ether

MC:二乙二醇單甲基醚 MC: diethylene glycol monomethyl ether

EC:二乙二醇單乙基醚 EC: diethylene glycol monoethyl ether

(聚醯亞胺先驅物及聚醯亞胺之分子量測定) (Measurement of molecular weight of polyimide precursors and polyimine)

使用常溫凝膠浸透色譜法(GPC)裝置(GPC-101,昭和電工公司製)、管柱(KD-803、KD-805)(Shodex公司製),以下述方法測定。 Using a room temperature gel permeation chromatography (GPC) apparatus (GPC-101, manufactured by Showa Denko Co., Ltd.) and a column (KD-803, KD-805) (manufactured by Shodex Co., Ltd.), the measurement was carried out by the following method.

管柱溫度:50℃ Column temperature: 50 ° C

溶離液:N,N’-二甲基甲醯胺(添加劑為溴化鋰-水合物(LiBr‧H2O)30mmol/L(升)、磷酸‧酐結晶(o-磷酸)30mmol/L、四氫呋喃(THF)10ml/L) Dissolution: N,N'-dimethylformamide (additive is lithium bromide-hydrate (LiBr‧H 2 O) 30 mmol/L (liter), phosphoric acid ‧ anhydride crystal (o-phosphoric acid) 30 mmol/L, tetrahydrofuran ( THF) 10ml/L)

流速:1.0ml/分 Flow rate: 1.0ml/min

檢量線製作用標準樣品:TSK標準聚環氧乙烷(分子量約900,000、150,000、100,000及30,000)(東索公 司製)及聚乙二醇(分子量:約12,000、4,000及1,000)(聚合物拉波拉公司製)。 Standard sample for the production of calibration lines: TSK standard polyethylene oxide (molecular weight of about 900,000, 150,000, 100,000 and 30,000) Manufactured) and polyethylene glycol (molecular weight: about 12,000, 4,000 and 1,000) (manufactured by Polymer Rabola).

(醯亞胺化率測定) (Measurement of hydrazine imidation rate)

將聚醯亞胺粉末20mg放入NMR樣品管(NMR取樣管標準,5(草野科學公司製))內,加入氘化二甲基亞碸(DMSO-d6,0.05%TMS(四甲基矽烷)混合品)(0.53ml)後施加超音波使其完全溶解。使用NMR測定機(JNW-ECA500,日本電子材料公司製)以500MHz之質子NMR測定該溶液。醯亞胺化率係以來自醯亞胺化前後未變化之構造的質子為基準質子而決定,其係使用該質子之峰積算值,與出現於9.5ppm至10.0ppm附近來自醯胺酸之NH基的質子峰積算值由下述式求取。 20 mg of polyimine powder was placed in an NMR sample tube (NMR sampling tube standard, 5 (manufactured by Kusano Scientific Co., Ltd.) was added with deuterated dimethyl hydrazine (DMSO-d6, 0.05% TMS (tetramethyl decane) mixture) (0.53 ml), and ultrasonic waves were applied thereto to completely dissolve. This solution was measured by a proton NMR of 500 MHz using an NMR measuring machine (JNW-ECA500, manufactured by JEOL Ltd.). The ruthenium imidization rate is determined by protons derived from unstructured structures before and after imidization, using the peak product of the protons and NH from proline at 9.5 ppm to 10.0 ppm. The proton peak product value of the base is obtained by the following formula.

醯亞胺化率(%)=(1-α‧x/y)×100 醯 imidization rate (%) = (1-α‧x/y) × 100

上述式中,x為來自醯胺酸之NH基的質子峰積算值,y為基準質子之峰積算值,α為聚醯胺酸(醯亞胺化率為0%)時相對於醯胺酸之NH基質子1個的基準質子之個數比例。 In the above formula, x is the proton peak product value of the NH group derived from proline, y is the peak product calculation value of the reference proton, and α is the polyamine acid (the imidization ratio is 0%) relative to the proline acid. The ratio of the number of reference protons of one NH matrix.

<合成例1> <Synthesis Example 1>

於NMP(28.8g)中混合BODA(5.74g,22.9mmol)、DBA(2.79g,18.3mmol)及m-PDA(2.98g,27.6mmol),60℃下反應2小時後,加入CBDA(4.50g,23.0mmol)與NMP(19.2g),40℃下反應4小時,得樹 脂固體成分濃度為25.0質量%之聚醯胺酸溶液(1)。該聚醯胺酸之數平均分子量為28,800,重量平均分子量為82,400。 BODA (5.74 g, 22.9 mmol), DBA (2.79 g, 18.3 mmol) and m-PDA (2.98 g, 27.6 mmol) were mixed in NMP (28.8 g), and reacted at 60 ° C for 2 hours, then CBDA (4.50 g) was added. , 23.0 mmol) and NMP (19.2 g), reacted at 40 ° C for 4 hours to obtain a tree A polyamic acid solution (1) having a lipid solid content concentration of 25.0% by mass. The polyamic acid had a number average molecular weight of 28,800 and a weight average molecular weight of 82,400.

<合成例2> <Synthesis Example 2>

將NMP加入合成例1所得的樹脂固體成分濃度為25.0質量%之聚醯胺酸溶液(1)(45.0g)稀釋為6質量%後,加入醯亞胺化觸媒用之乙酸酐(5.75g)及吡啶(4.20g),80℃下反應4小時。將該反應溶液投入甲醇(900ml)中,濾取所得之沈澱物。以甲醇洗淨該沈澱物後,100℃下減壓乾燥得聚醯亞胺粉末(2)。該聚醯亞胺之醯亞胺化率為55%,數平均分子量為24,600,重量平均分子量為60,100。 After the NMP was added to the polyamic acid solution (1) (45.0 g) having a resin solid content concentration of 25.0% by mass obtained in Synthesis Example 1 and diluted to 6 mass%, acetic anhydride (5.75 g) for the ruthenium catalyst was added. And pyridine (4.20 g), and reacted at 80 ° C for 4 hours. The reaction solution was poured into methanol (900 ml), and the resulting precipitate was collected by filtration. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (2). The polyimine had a hydrazine imidation ratio of 55%, a number average molecular weight of 24,600, and a weight average molecular weight of 60,100.

<合成例3> <Synthesis Example 3>

於NMP(29.1g)中混合CBDA(4.32g,22.0mmol)、PCH7DAB(4.19g,11.0mmol)及p-PDA(1.19g,11.0mmol),40℃下反應6小時,得樹脂固體成分濃度為25.0質量%之聚醯胺酸溶液(3)。該聚醯胺酸之數平均分子量為25,800,重量平均分子量為72,200。 CBDA (4.32 g, 22.0 mmol), PCH7DAB (4.19 g, 11.0 mmol) and p-PDA (1.19 g, 11.0 mmol) were mixed with NMP (29.1 g), and reacted at 40 ° C for 6 hours to obtain a solid concentration of the resin. 25.0% by mass of a polyaminic acid solution (3). The polyamic acid had a number average molecular weight of 25,800 and a weight average molecular weight of 72,200.

<合成例4> <Synthesis Example 4>

於NMP(29.5g)中混合BODA(7.14g,28.5mmol)、PCH7DAB(4.08g,10.7mmol)及DBA (3.79g,24.9mmol),80℃下反應5小時後,加入CBDA(1.40g,7.1mmol)與NMP(19.7g),40℃下反應6小時,得樹脂固體成分濃度為25.0質量%之聚醯胺酸溶液。 BODA (7.14g, 28.5mmol), PCH7DAB (4.08g, 10.7mmol) and DBA were mixed in NMP (29.5g) (3.79 g, 24.9 mmol), after reacting at 80 ° C for 5 hours, CBDA (1.40 g, 7.1 mmol) and NMP (19.7 g) were added and reacted at 40 ° C for 6 hours to obtain a solid concentration of the resin of 25.0% by mass. Proline solution.

將NMP加入所得之聚醯胺酸溶液(40.0g)稀釋為6質量%後,加入醯亞胺化觸媒用之乙酸酐(4.84g)及吡啶(3.78g),80℃下反應4小時。將該反應溶液投入甲醇(800ml)中,濾取所得之沈澱物。以甲醇洗淨該沈澱物後,100℃下減壓乾燥得聚醯亞胺粉末(4)。該聚醯亞胺之醯亞胺化率為54%,數平均分子量為22,500,重量平均分子量為53,900。 After the NMP was added to the obtained polyamic acid solution (40.0 g) to be diluted to 6 mass%, acetic anhydride (4.84 g) and pyridine (3.78 g) for the ruthenium catalyst were added, and the mixture was reacted at 80 ° C for 4 hours. The reaction solution was poured into methanol (800 ml), and the resulting precipitate was collected by filtration. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (4). The polyimine had a hydrazine imidation ratio of 54%, a number average molecular weight of 22,500, and a weight average molecular weight of 53,900.

<合成例5> <Synthesis Example 5>

於NMP(32.5g)中混合BODA(7.14g,28.5mmol)、PCH7DAB(6.79g,17.8mmol)及DBA(2.71g,17.8mmol),80℃下反應5小時後,加入CBDA(1.40g,7.1mmol)與NMP(21.7g),40℃下反應6小時,得樹脂固體成分濃度為25.0質量%之聚醯胺酸溶液。 BODA (7.14 g, 28.5 mmol), PCH7DAB (6.79 g, 17.8 mmol) and DBA (2.71 g, 17.8 mmol) were mixed in NMP (32.5 g), and reacted at 80 ° C for 5 hours, then CBDA (1.40 g, 7.1) was added. Methyl) was reacted with NMP (21.7 g) at 40 ° C for 6 hours to obtain a polyaminic acid solution having a resin solid concentration of 25.0% by mass.

將NMP加入所得之聚醯胺酸溶液(40.0g)稀釋為6質量%後,加入醯亞胺化觸媒用之乙酸酐(9.02g)及吡啶(6.52g),90℃下反應3.5小時。將該反應溶液入甲醇(800ml)中,濾取所得之沈澱物。以甲醇洗淨該沈澱物後,100℃下減壓乾燥得聚醯亞胺粉末(5)。該聚醯亞胺之醯亞胺化率為80%,數平均分子量為20,100,重量平均分子量為50,100。 After the NMP was added to the obtained polyamic acid solution (40.0 g) to be diluted to 6 mass%, acetic anhydride (9.02 g) and pyridine (6.52 g) for the ruthenium catalyst were added, and the mixture was reacted at 90 ° C for 3.5 hours. The reaction solution was poured into methanol (800 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (5). The polyimine had a hydrazine imidation ratio of 80%, a number average molecular weight of 20,100, and a weight average molecular weight of 50,100.

<合成例6> <Synthesis Example 6>

於NMP(24.4g)中混合BODA(4.91g,19.6mmol)、PBCH5DAB(4.25g,9.8mmol)及DBA(2.77g,18.2mmol),80℃下反應5小時後,加入CBDA(1.65g,8.4mmol)與NMP(16.3g),40℃下反應6小時,得樹脂固體成分濃度為25.0質量%之聚醯胺酸溶液。 BODA (4.91 g, 19.6 mmol), PBCH5DAB (4.25 g, 9.8 mmol) and DBA (2.77 g, 18.2 mmol) were mixed in NMP (24.4 g), and reacted at 80 ° C for 5 hours, then CBDA (1.65 g, 8.4) was added. Methyl) was reacted with NMP (16.3 g) at 40 ° C for 6 hours to obtain a polyaminic acid solution having a resin solid concentration of 25.0% by mass.

將NMP加入所得之聚醯胺酸溶液(40.0g)稀釋為6質量%後,加入醯亞胺化觸媒用之乙酸酐(9.00g)及吡啶(6.50),90℃下反應3小時。將該反應溶液投入甲醇(800ml)中,濾取所得之沈澱物。以甲醇洗淨該沈澱物後,100℃下減壓乾燥得聚醯亞胺粉末(6)。該聚醯亞胺之醯亞胺化率為79%,數平均分子量為19,500,重量平均分子量為48,800。 After the NMP was added to the obtained polyamic acid solution (40.0 g) to be diluted to 6 mass%, acetic anhydride (9.00 g) and pyridine (6.50) for the ruthenium catalyst were added, and the mixture was reacted at 90 ° C for 3 hours. The reaction solution was poured into methanol (800 ml), and the resulting precipitate was collected by filtration. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (6). The polyimine had a hydrazine imidation ratio of 79%, a number average molecular weight of 19,500, and a weight average molecular weight of 48,800.

<合成例7> <Synthesis Example 7>

於NMP(21.0g)中混合BODA(4.61g,18.4mmol)、m-PBCH5DABz(3.53g,7.9mmol)及m-PDA(1.99g,18.4mmol),80℃下反應4.5小時後,加入CBDA(1.55g,7.9mmol)與NMP(14.0g),40℃下反應6小時,得樹脂固體成分濃度為25.0質量%之聚醯胺酸溶液。 BODA (4.61 g, 18.4 mmol), m-PBCH5DABz (3.53 g, 7.9 mmol) and m-PDA (1.99 g, 18.4 mmol) were mixed in NMP (21.0 g), and reacted at 80 ° C for 4.5 hours, then added CBDA ( 1.55 g, 7.9 mmol) and NMP (14.0 g) were reacted at 40 ° C for 6 hours to obtain a polyaminic acid solution having a resin solid content concentration of 25.0% by mass.

將NMP加入所得之聚醯胺酸溶液(40.5g)稀釋為6質量%後,加入醯亞胺化觸媒用之乙酸酐(9.05g)及吡啶 (6.50g),90℃下反應3小時。將該反應溶液投入甲醇(900ml)中,濾取所得之沈澱物。以甲醇洗淨該沈澱後,100℃下減壓乾燥得聚醯亞胺粉末(7)。該聚醯亞胺之醯亞胺化率為80%,數平均分子量為21,900,重量平均分子量為55,100。 After the NMP was added to the obtained polyamic acid solution (40.5 g) to be diluted to 6 mass%, acetic anhydride (9.05 g) and pyridine for the ruthenium catalyst were added. (6.50 g), the reaction was carried out at 90 ° C for 3 hours. The reaction solution was poured into methanol (900 ml), and the resulting precipitate was collected by filtration. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (7). The polyimine had a hydrazine imidation ratio of 80%, a number average molecular weight of 21,900, and a weight average molecular weight of 55,100.

<合成例8> <Synthesis Example 8>

於NMP(30.8g)中混合BODA(7.65g,30.6mmol)、CoIDAB-1(3.00g,5.7mmol)及DBA(4.96g,32.6mmol),80℃下反應5.5小時後,加入CBDA(1.50g,7.7mmol)與NMP(20.5g),40℃下反應7小時,得樹脂固體成分濃度為25.0質量%之聚醯胺酸溶液。 BODA (7.65 g, 30.6 mmol), CoIDAB-1 (3.00 g, 5.7 mmol) and DBA (4.96 g, 32.6 mmol) were mixed in NMP (30.8 g), and reacted at 80 ° C for 5.5 hours, then CBDA (1.50 g) was added. 7.7 mmol) and NMP (20.5 g) were reacted at 40 ° C for 7 hours to obtain a polyaminic acid solution having a resin solid content concentration of 25.0% by mass.

將NMP加入所得之聚醯胺酸溶液(40.0g)稀釋為6質量%後,加入醯亞胺化觸媒用之乙酸酐(4.90g)及吡啶(3.70g),80℃下反應3.5小時。將該反應溶液投入甲醇(1000ml)中,濾取所得之沈澱物。以甲醇洗淨該沈澱物後,100℃下減壓乾燥得聚醯亞胺粉末(8)。該聚醯亞胺之醯亞胺化率為55%,數平均分子量為20,500,重量平均分子量為57,300。 After the NMP was added to the obtained polyamic acid solution (40.0 g) to be diluted to 6 mass%, acetic anhydride (4.90 g) and pyridine (3.70 g) for the ruthenium catalyst were added, and the mixture was reacted at 80 ° C for 3.5 hours. The reaction solution was poured into methanol (1000 ml), and the resulting precipitate was collected by filtration. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (8). The polyimine had a hydrazine imidation ratio of 55%, a number average molecular weight of 20,500, and a weight average molecular weight of 57,300.

<合成例9> <Synthesis Example 9>

於NMP(26.6g)中混合BODA(7.65g,30.6mmol)、CoIDAB-2(1.88g,3.8mmol)及p-PDA (3.73g,34.5mmol),80℃下反應5.5小時後,加入CBDA(1.50g,7.7mmol)與NMP(17.7g),40℃下反應7小時,得樹脂固體成分濃度為25.0質量%之聚醯胺酸溶液。 BODA (7.65g, 30.6mmol), CoIDAB-2 (1.88g, 3.8mmol) and p-PDA were mixed in NMP (26.6g) (3.73 g, 34.5 mmol), after reacting at 80 ° C for 5.5 hours, CBDA (1.50 g, 7.7 mmol) and NMP (17.7 g) were added and reacted at 40 ° C for 7 hours to obtain a solid concentration of the resin of 25.0% by mass. Proline solution.

將NMP加入所得之聚醯胺酸溶液(40.0g)稀釋為6質量%後,加入醯亞胺化觸媒用之乙酸酐(4.91g)及吡啶(3.70g),80℃下反應3.5小時。將該反應溶液投入甲醇(1000ml)中,濾取所得之沈澱物。以甲醇洗淨該沈澱物後,100℃下減壓乾燥得聚醯亞胺粉末(9),該聚醯亞胺之醯亞胺化率為53%,數平均分子量為17,800,重量平均分子量為48,900。 After the NMP was added to the obtained polyamic acid solution (40.0 g) to be diluted to 6 mass%, acetic anhydride (4.91 g) and pyridine (3.70 g) for the ruthenium catalyst were added, and the mixture was reacted at 80 ° C for 3.5 hours. The reaction solution was poured into methanol (1000 ml), and the resulting precipitate was collected by filtration. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (9) having a ruthenium imidization ratio of 53% and a number average molecular weight of 17,800. The weight average molecular weight was 48,900.

<合成例10> <Synthesis Example 10>

於NMP中混合BODA(7.91g,31.6mmol)、AP18(4.47g,11.9mmol)及DBA(4.20g,27.6mmol),80℃下反應4.5小時後,加入CBDA(1.55g,7.9mmol)與NMP(21.8g),40℃下反應6.5小時,得樹脂固體成分濃度為25.0質量%之聚醯胺酸溶液。 BODA (7.91 g, 31.6 mmol), AP18 (4.47 g, 11.9 mmol) and DBA (4.20 g, 27.6 mmol) were mixed in NMP. After reacting at 80 ° C for 4.5 hours, CBDA (1.55 g, 7.9 mmol) and NMP were added. (21.8 g), the reaction was carried out at 40 ° C for 6.5 hours to obtain a polyamic acid solution having a resin solid content concentration of 25.0% by mass.

將NMP加入所得之聚醯胺酸溶液(40.0g)稀釋為6質量%後,加入醯亞胺化觸媒用之乙酸酐(5.00g)及吡啶(3.71g),80℃下反應4小時。將該反應溶液投入甲醇(800ml)中,濾取所得之沈澱物。以甲醇洗淨該沈澱物後,100℃下減壓乾燥得聚醯亞胺粉末(10)。該聚醯亞胺之醯亞胺化率為54%,數平均分子量為17,100,重量平 均分子量為44,800。 After the NMP was added to the obtained polyamic acid solution (40.0 g) to be diluted to 6 mass%, acetic anhydride (5.00 g) and pyridine (3.71 g) for the ruthenium catalyst were added, and the mixture was reacted at 80 ° C for 4 hours. The reaction solution was poured into methanol (800 ml), and the resulting precipitate was collected by filtration. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (10). The polyamidimide has a ruthenium iodide ratio of 54%, a number average molecular weight of 17,100, and a flat weight. The average molecular weight was 44,800.

<合成例11> <Synthesis Example 11>

於NMP中混合TCA(5.50g,24.8mmol)、PBCH5DAB(3.21g,7.4mmol)及DBA(2.64g,17.4mmol),40℃下反應6小時,得樹脂固體成分濃度為25.0質量%之聚醯胺酸溶液。 TCA (5.50 g, 24.8 mmol), PBCH5DAB (3.21 g, 7.4 mmol) and DBA (2.64 g, 17.4 mmol) were mixed in NMP, and reacted at 40 ° C for 6 hours to obtain a polythene having a resin solid concentration of 25.0% by mass. Amino acid solution.

將NMP加入所得之聚醯胺酸溶液(40.0g)稀釋為6質量%後,加入醯亞胺化觸媒用之乙酸酐(4.80g)及吡啶(3.71g),80℃下反應4小時。將該反應溶液投入甲醇(900ml)中,濾取所得之沈澱物。以甲醇洗淨該沈澱物後,100℃下減壓乾燥得聚醯亞胺粉末(11)。該聚醯亞胺之醯亞胺化率為55%,數平均分子量為22,200,重量平均分子量為57,900。 After the NMP was added to the obtained polyamic acid solution (40.0 g) to be diluted to 6 mass%, acetic anhydride (4.80 g) and pyridine (3.71 g) for the ruthenium catalyst were added, and the mixture was reacted at 80 ° C for 4 hours. The reaction solution was poured into methanol (900 ml), and the resulting precipitate was collected by filtration. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (11). The polyimine had a hydrazine imidation ratio of 55%, a number average molecular weight of 22,200, and a weight average molecular weight of 57,900.

<合成例12> <Synthesis Example 12>

於NMP中混合TDA(5.36g,17.9mmol),PCH7DAB(4.08g,10.7mmol)及m-PDA(2.70g,25.0mmol),80℃下反應5小時後,加入CBDA(3.50g,17.8mmol)與NMP(18.8g),40℃下反應6小時,得樹脂固體成分濃度為25.0質量%之聚醯胺酸溶液。 TDA (5.36 g, 17.9 mmol), PCH7DAB (4.08 g, 10.7 mmol) and m-PDA (2.70 g, 25.0 mmol) were mixed in NMP, and reacted at 80 ° C for 5 hours, then CBDA (3.50 g, 17.8 mmol) was added. The mixture was reacted with NMP (18.8 g) at 40 ° C for 6 hours to obtain a polyamic acid solution having a resin solid content concentration of 25.0% by mass.

將NMP加入所得之聚醯胺酸溶液(40.0g)稀釋為6質量%後,加入醯亞胺化觸媒用之乙酸酐(8.85g)及吡啶(6.45g),90℃下反應3小時。將該反應溶液投入甲醇 (1000ml)中,濾取所得之沈澱物。以甲醇洗淨該沈澱物後,100℃下減壓乾燥得聚醯亞胺粉末(12)。該聚醯亞胺之醯亞胺化率為78%,數平均分子量為20,500,重量平均分子量為51,600。 After the NMP was added to the obtained polyamic acid solution (40.0 g) to be diluted to 6 mass%, acetic anhydride (8.85 g) and pyridine (6.45 g) for the ruthenium catalyst were added, and the mixture was reacted at 90 ° C for 3 hours. The reaction solution is put into methanol In (1000 ml), the resulting precipitate was collected by filtration. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (12). The polyimine had a hydrazine imidation ratio of 78%, a number average molecular weight of 20,500, and a weight average molecular weight of 51,600.

合成例所得之聚醯胺酸及聚醯亞胺、合成用之各成分的組成,與醯亞胺化率合併如表1所示。 The composition of the polyamic acid and the polyimine obtained in the synthesis example and the composition of each component for synthesis were combined with the ruthenium imidation ratio as shown in Table 1.

〔調製組成物及液晶配向處理劑〕 [Modulation Composition and Liquid Crystal Alignment Treatment Agent]

實施例1至34,及比較例1至8為組成物之調製例。又,所得之組成物也使用於評估液晶配向處理劑之各特性。 Examples 1 to 34, and Comparative Examples 1 to 8 are preparation examples of the composition. Further, the obtained composition was also used to evaluate various characteristics of the liquid crystal alignment treatment agent.

實施例及比較例所得之組成物、液晶配向處理劑及調製用之各成分合併如表2至4所示。 The compositions obtained in the examples and the comparative examples, the liquid crystal alignment treatment agent, and the components for preparation were combined as shown in Tables 2 to 4.

使用實施例及比較例所得之組成物或液晶配向處理劑進行「組成物及液晶配向處理劑之印刷性評估」、「液晶配向處理劑之噴墨印刷塗佈性評估」、「製作液晶單元(一般單元)」、「液晶配向性評估(一般單元)」、「預傾角評估(一般單元)」、「製作液晶單元(PSA單元)」,及「液晶配向性評估(PSA單元)」。其條件如下所述。 "Evaluation of the printability of the composition and the liquid crystal alignment treatment agent", "Evaluation of the inkjet printing coating property of the liquid crystal alignment treatment agent", and "Production of the liquid crystal cell" were carried out using the composition obtained in the examples and the comparative examples or the liquid crystal alignment treatment agent. "General Units", "Liquid Crystal Alignment Evaluation (General Unit)", "Pretilt Evaluation (General Unit)", "Production Liquid Crystal Cell (PSA Unit)", and "Liquid Crystal Alignment Evaluation (PSA Unit)". The conditions are as follows.

「組成物及液晶配向處理劑之印刷性評估」 "Evaluation of the printability of the composition and liquid crystal alignment agent"

使用實施例及比較例所得之組成物進行印刷性評估。所使用之印刷機為簡易印刷機S15型(日本寫真印刷公司製)。印刷時於未洗淨之鉻蒸鍍基板上,以印刷面積為80mm×80mm、印壓為0.2mm、拋棄基板為5枚、由印刷至假乾燥之時間為90秒、熱板上以70℃假乾燥5分鐘之條件進行。 The composition obtained in the examples and the comparative examples was used for the evaluation of printability. The printing machine used was a simple printing machine S15 type (manufactured by Nippon Photo Printing Co., Ltd.). On the unwashed chrome-vapor-deposited substrate, the printing area was 80 mm × 80 mm, the printing pressure was 0.2 mm, the discarded substrate was 5 pieces, the printing to false drying time was 90 seconds, and the hot plate was 70 ° C. Fake drying was carried out for 5 minutes.

進行所得的聚醯亞胺膜之針孔評估、聚醯亞胺膜之端部直線性評估及聚醯亞胺膜之端部隆起評估。 The pinhole evaluation of the obtained polyimide film, the linearity evaluation of the end of the polyimide film, and the evaluation of the end ridge of the polyimide film were carried out.

聚醯亞胺膜之針孔評估係以目視觀察鈉燈下聚醯亞胺膜之方法進行。具體上係計算聚醯亞胺膜上被確認之針孔數,將針孔數較少者視為優良。 The pinhole evaluation of the polyimide film was carried out by visually observing the polyimide film under the sodium lamp. Specifically, the number of pinholes confirmed on the polyimide film was counted, and those having a small number of pinholes were regarded as excellent.

聚醯亞胺膜之端部直線性評估係藉由,以光學顯微鏡觀察相對於印刷方向之右側端部的聚醯亞胺之方法進行。具體上係測定光學顯微鏡倍率為25倍所觀察到的聚醯亞胺膜影像之圖1中(1)與(2)之差值,即圖1中之A之長度全部之聚醯亞胺膜影像係以同一倍率測定所得。該A之長度較短時,視聚醯亞胺膜之端部直線性為優良。 The linearity evaluation of the end portion of the polyimide film was carried out by observing the polyimine with respect to the right end portion in the printing direction by an optical microscope. Specifically, the difference between (1) and (2) in Fig. 1 of the image of the polyimine film observed by the optical microscope magnification is 25 times, that is, the polyimine film of the length of A in Fig. 1 The images were measured at the same magnification. When the length of the A is short, the linearity of the end portion of the polyimide film is excellent.

聚醯亞胺膜之端部隆起評估係藉由,以光學顯微鏡觀察相對於印刷方向之右側端部的聚醯亞胺膜之方法進行。具體上係測定光學顯微鏡倍率為25倍所觀察到的聚醯亞胺膜影像之圖2中B之長度。全部之聚醯亞胺膜影像係以同一倍率測定所得。該B之長度較短時,視聚醯亞胺膜之端部隆起為優良。 The evaluation of the end bulge of the polyimide film was carried out by observing the polyimide film on the right end of the printing direction with an optical microscope. Specifically, the length of B in FIG. 2 of the polyimine film image observed by the optical microscope magnification is 25 times. All of the polyimine film images were obtained at the same magnification. When the length of B is short, the end portion of the polyimide film is excellent in bulging.

又,實施例及比較例所得之組成物可使用於調製液晶配向處理劑用,因此實施例及比較例所得的聚醯亞胺膜之印刷性評估結果,與液晶配向膜之印刷性評估結果同等。 Further, since the compositions obtained in the examples and the comparative examples can be used for preparing a liquid crystal alignment treatment agent, the results of evaluation of the printability of the polyimide film obtained in the examples and the comparative examples are the same as those of the liquid crystal alignment film. .

實施例及比較例所得的聚醯亞胺膜(液晶配向膜)之針孔數、A之長度及B之長度如表5至表7所示。 The number of pinholes, the length of A, and the length of B of the polyimide film (liquid crystal alignment film) obtained in the examples and the comparative examples are shown in Tables 5 to 7.

〔液晶配向處理劑之噴墨印刷塗佈性評估〕 [Evaluation of inkjet printing coatability of liquid crystal alignment treatment agent]

使用實施例4所得之液晶配向處理劑(4)、實施例 9所得之液晶配向處理劑(9)、實施例12所得之液晶配向劑(12)、實施例18所得之液晶配向劑(18)及實施例27所得之液晶配向處理劑(27)進行噴墨印刷塗佈性評估。所使用之噴墨印刷塗佈機為HIS-200(日本裝置技術公司製)。塗佈時係於洗淨後之ITO(氧化銦錫)蒸鍍基板上,以塗佈面積為70mm×70mm、噴嘴間距為0.423mm、描掃間距為0.5mm、塗佈速度為40mm/秒、由塗佈至假乾燥之時間為60秒、熱板上以70℃假乾燥5分鐘之條件進行。 Using the liquid crystal alignment treatment agent (4) obtained in Example 4, examples 9 obtained liquid crystal alignment treatment agent (9), liquid crystal alignment agent (12) obtained in Example 12, liquid crystal alignment agent (18) obtained in Example 18, and liquid crystal alignment treatment agent (27) obtained in Example 27 were ink-jetted. Printability evaluation. The inkjet printing coater used was HIS-200 (manufactured by Nippon Denso Co., Ltd.). The coating was applied to the ITO (Indium Tin Oxide) vapor-deposited substrate after washing, and the coating area was 70 mm × 70 mm, the nozzle pitch was 0.423 mm, the scanning pitch was 0.5 mm, and the coating speed was 40 mm/sec. The coating was applied to a pseudo-drying time of 60 seconds, and a hot plate was dried at 70 ° C for 5 minutes.

又,評估噴墨印刷塗佈性時,簡易上可對應所得的液晶配向膜之針孔數。 Moreover, when evaluating the inkjet printing coatability, the number of pinholes of the obtained liquid crystal alignment film can be easily matched.

評估所得的液晶配向膜之針孔可以與「組成物及液晶配向處理劑之印刷性評估」相同之條件進行。 The pinhole of the obtained liquid crystal alignment film can be evaluated under the same conditions as the "evaluation of the printability of the composition and the liquid crystal alignment agent".

實施例所得之液晶配向膜的針孔數如表5及6所示。 The number of pinholes of the liquid crystal alignment film obtained in the examples is shown in Tables 5 and 6.

「製作液晶單元(一般單元)」 "Making a Liquid Crystal Cell (General Unit)"

將實施例及比較例所得之液晶配向處理劑旋塗於附30mm×40mm ITO電極之基板的ITO面後,於熱板上以80℃進行5分鐘、熱循環型淨化烤箱中以220℃進行30分鐘之加熱處理,得膜厚為100nm之附聚醯亞胺液晶配向膜的ITO基板。使用輥徑為120mm之摩擦裝置以人造絲,於輥回轉數為1000rpm、輥行進速度為50mm/sec、擠入量為0.1mm之條件下進行摩擦處理。 The liquid crystal alignment treatment agents obtained in the examples and the comparative examples were spin-coated on the ITO surface of a substrate having a 30 mm × 40 mm ITO electrode, and then subjected to a hot plate at 80 ° C for 5 minutes, and in a heat cycle type purification oven at 220 ° C. After a minute of heat treatment, an ITO substrate of an agglomerated quinone liquid crystal alignment film having a film thickness of 100 nm was obtained. The rayon was rubbed with a friction device having a roll diameter of 120 mm, and subjected to rubbing treatment under the conditions of a roll rotation number of 1000 rpm, a roll travel speed of 50 mm/sec, and an extrusion amount of 0.1 mm.

準備2枚所得的附液晶配向膜之ITO基板,以液晶配 向膜面為內側之方式挾持組合6μm之調距物後,以密封劑接合四周製作空單元。藉由減壓注入法將液晶注入該空單元內,密封注入口得液晶單元(一般單元)。 Prepare two pieces of the obtained ITO substrate with liquid crystal alignment film to match the liquid crystal After the 6 μm-positioned object was held in such a manner that the film surface was inside, an empty unit was formed by bonding the sealant around. The liquid crystal is injected into the empty cell by a vacuum injection method, and the liquid crystal cell (general cell) is sealed by the injection port.

又,使用實施例1至3所得之液晶配向處理劑(1)至(3),及比較例1至2所得之液晶配向處理劑(35)至(36)的液晶單元中,液晶係使用MLC-2003(美爾庫日本公司製)。 Further, in the liquid crystal cells of the liquid crystal alignment treatment agents (1) to (3) obtained in Examples 1 to 3 and the liquid crystal alignment treatment agents (35) to (36) obtained in Comparative Examples 1 to 2, the liquid crystal system used MLC. -2003 (Merku Japan Co., Ltd.).

另外使用實施例5至8所得之液晶配向處理劑(5)至(8)、實施例10至11所得之液晶配向處理劑(10)至(11)、實施例13至17所得之液晶配向處理劑(13)至(17)、實施例19至26所得之液晶配向處理劑(19)至(26)、實施例28至34所得之液晶配向處理劑(28)至(34)及比較例3至8所得之液晶配向處理劑(37)至(42)的液晶單元中,液晶係使用MLC-6608(美爾庫日本公司製)。 Further, the liquid crystal alignment treatment agents (5) to (8) obtained in Examples 5 to 8 and the liquid crystal alignment treatment agents (10) to (11) obtained in Examples 10 to 11 and the liquid crystal alignment treatments obtained in Examples 13 to 17 were used. Liquid crystal alignment treatment agents (28) to (26) obtained in Examples (13) to (17), and liquid crystal alignment treatment agents (28) to (34) obtained in Examples 19 to 26, and liquid crystal alignment treatment agents (28) to (34) obtained in Examples 28 to 34 and Comparative Example 3 In the liquid crystal cell of the liquid crystal alignment treatment agents (37) to (42) obtained in the above, the liquid crystal system was MLC-6608 (manufactured by Mercury Japan Co., Ltd.).

「液晶配向性評估(一般單元)」 "Liquid alignment evaluation (general unit)"

使用所得之液晶單元進行液晶配向性評估。液晶配向性係以偏光顯微鏡觀察液晶單元,確認有無配向缺陷。 The liquid crystal alignment was evaluated using the obtained liquid crystal cell. In the liquid crystal alignment, the liquid crystal cell was observed with a polarizing microscope to confirm the presence or absence of an alignment defect.

實施例及比較例所得之液晶配向性的評估結果如表8至10所示。 The evaluation results of the liquid crystal alignment obtained in the examples and the comparative examples are shown in Tables 8 to 10.

「預傾角評估(一般單元)」 "Pretilt assessment (general unit)"

使用所得之液晶單元進行預傾角評估。預傾角為,注 入液晶後,95℃下加熱處理5分鐘後,及120℃下加熱處理5小時後再測定。又,注入液晶後,95℃下加熱處理5分鐘,對所得之液晶單元照射365nm換算下10J/cm2之紫外線後再測定。 The pre-tilt evaluation was performed using the obtained liquid crystal cell. The pretilt angle was measured by injecting liquid crystal, heat treatment at 95 ° C for 5 minutes, and heat treatment at 120 ° C for 5 hours. Further, after the liquid crystal was injected, the film was heat-treated at 95 ° C for 5 minutes, and the obtained liquid crystal cell was irradiated with ultraviolet rays of 10 J/cm 2 in terms of 365 nm, and then measured.

相對於95℃下加熱處理5分鐘後之預傾角,120℃下加熱處理5小時後或照射紫外線後之預傾角變化較小時,相對於熱或紫外線的預傾角之安定性較高。 The pretilt angle after heat treatment at 95 ° C for 5 minutes, the heat treatment at 120 ° C for 5 hours or the change in the pretilt angle after irradiation with ultraviolet rays is small, and the stability with respect to the pretilt angle of heat or ultraviolet rays is high.

又,預傾角係使用PAS-301(ELSICON公司製)於室溫下測定。另外,紫外線照射係使用桌上型UV硬化裝置(HCT3B28HEX-1,森來特公司製)進行。 Further, the pretilt angle was measured at room temperature using PAS-301 (manufactured by ELSICON Co., Ltd.). In addition, ultraviolet irradiation was performed using a desktop type UV curing device (HCT3B28HEX-1, manufactured by Moritech Co., Ltd.).

實施例及比較例所得之預傾角的評估結果如表8至10所示。 The evaluation results of the pretilt angles obtained in the examples and comparative examples are shown in Tables 8 to 10.

「製作液晶單元及評估液晶配向性(PSA單元)」 "Making LCD Units and Evaluating Liquid Crystal Alignment (PSA Units)"

將實施例8所得之液晶配向處理劑(8)、實施例10所得之液晶配向處理劑(10)、實施例17所得之液晶配向處理劑(17)及實施例26所得之液晶配向處理劑(26)旋塗於中心附10mm×10mm之圖型間隔20μm的ITO電極之基板,與中心附10mm×40mm之ITO電極的基板之ITO面上,其次於熱板上以80℃加熱處理5分鐘後,於熱循環型淨化烤箱中以220℃加熱處理30分鐘,得膜厚100nm之聚醯亞胺塗膜。以純水洗淨塗膜面後,於熱循環型淨化烤箱中心100℃加熱處理15分鐘,得附液晶配向膜之基板。 The liquid crystal alignment treatment agent (8) obtained in Example 8, the liquid crystal alignment treatment agent (10) obtained in Example 10, the liquid crystal alignment treatment agent (17) obtained in Example 17, and the liquid crystal alignment treatment agent obtained in Example 26 ( 26) Spin-coated on a substrate with an ITO electrode of 10 mm × 10 mm with a pattern interval of 20 μm, and an ITO surface of a substrate with a 10 mm × 40 mm ITO electrode attached to the center, followed by heat treatment at 80 ° C for 5 minutes on a hot plate. The film was heat-treated at 220 ° C for 30 minutes in a heat cycle type purification oven to obtain a polyimide film having a film thickness of 100 nm. After washing the surface of the coating film with pure water, it was heat-treated at 100 ° C for 15 minutes in the center of the heat cycle type purification oven to obtain a substrate with a liquid crystal alignment film.

將該附液晶配向膜之基板,以液晶配向膜面為內側之方式挾持組合6μm之調距物後,以密封劑接合四周製作空單元。藉由減壓注入法將MLC-6608(美爾庫日本公司製)中混合相對於MLC-6608為10質量%之下述式所表示之聚合性化合物(1)0.3質量%所得的液晶注入該空單元中,密封注入口,得液晶單元。 The substrate with the liquid crystal alignment film was placed on the substrate with the liquid crystal alignment film surface inside, and a distance of 6 μm was adjusted. Then, an empty cell was formed by bonding the sealing agent. Into the MLC-6608 (manufactured by Mercury Co., Ltd.), a liquid crystal obtained by mixing 0.3% by mass of the polymerizable compound (1) represented by the following formula with respect to MLC-6608 was injected into the mold by a vacuum injection method. In the empty cell, the injection port is sealed to obtain a liquid crystal cell.

將交流5V之電壓施加於所得之液晶單元的同時,使用亮度60mW之金屬鹵素燈,於攔截350nm以下之波長下,進行365nm換算下20J/cm2之紫外線照射,得液晶之配向方向受控制的液晶單元(PSA單元)。將紫外線照射於液晶單元時之照射裝置的溫度為50℃。 A voltage of 5 V was applied to the obtained liquid crystal cell, and a metal halide lamp having a brightness of 60 mW was used to intercept ultraviolet light of 20 J/cm 2 at a wavelength of 350 nm or less at a wavelength of 350 nm or less to obtain a liquid crystal alignment direction controlled. Liquid crystal cell (PSA unit). The temperature of the irradiation device when ultraviolet rays were irradiated to the liquid crystal cell was 50 °C.

測定該液晶單元之紫外線照射前與紫外線照射後的液晶應答速度。應答速度為,測定由透光率90%至透光率10%之T90→T10所得。 The liquid crystal response speed of the liquid crystal cell before ultraviolet irradiation and after ultraviolet irradiation was measured. The response speed was determined by measuring T90→T10 from a light transmittance of 90% to a light transmittance of 10%.

實施例所得之PSA單元比較紫外線照射前之液晶單元時,因紫外線照射後之液晶單元的應答速度較快,故確認液晶之配向方向受控制。又,藉由偏光顯微鏡觀察,確認任何液晶單元之液晶為均均勻配向。 When the PSA unit obtained in the examples was compared with the liquid crystal cell before the ultraviolet irradiation, the response speed of the liquid crystal cell after the ultraviolet irradiation was faster, and it was confirmed that the alignment direction of the liquid crystal was controlled. Further, it was confirmed by a polarizing microscope that the liquid crystal of any liquid crystal cell was uniformly uniformly aligned.

<實施例1> <Example 1>

將NMP(19.2g)及〔1a〕(12.5g)加入合成例1之合成方法所得的樹脂固體成分濃度25.0質量%之聚醯胺酸溶液(1)(10.0g)中,25℃下攪拌2小時得組成物(1)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(1)也作為評估用之液晶配向處理劑(1)用。 NMP (19.2 g) and [1a] (12.5 g) were added to a polyamic acid solution (1) (10.0 g) having a resin solid content concentration of 25.0% by mass obtained by the synthesis method of Synthesis Example 1, and stirred at 25 ° C. The composition of the hour (1). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (1) was also used as the liquid crystal alignment treatment agent (1) for evaluation.

使用所得之組成物(1)或液晶配向處理劑(1),以上述條件製作單元及進行各種評估。 Using the obtained composition (1) or the liquid crystal alignment treatment agent (1), the unit was produced under the above conditions and various evaluations were carried out.

<實施例2> <Example 2>

將NMP(22.5g)加入合成例2之合成方法所得的聚醯亞胺粉末(2)(2.50g)中,70℃下攪拌24小時使用溶解。將〔1a〕(8.30g)及BCS(8.30g)加入該溶液中,50℃下攪拌10小時得組成物(2)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(2)也作為評估用之液晶配向處理劑(2)用。 NMP (22.5 g) was added to the polyimine powder (2) (2.50 g) obtained by the synthesis method of Synthesis Example 2, and the mixture was stirred at 70 ° C for 24 hours to dissolve. [1a] (8.30 g) and BCS (8.30 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (2). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (2) was also used as the liquid crystal alignment treatment agent (2) for evaluation.

使用所得之組成物(2)或液晶配向處理劑(2),以上述條件製作單元及進行各種評估。 Using the obtained composition (2) or the liquid crystal alignment treatment agent (2), the unit was produced under the above conditions and various evaluations were carried out.

<實施例3> <Example 3>

將NEP(20.4g)加入合成例2之合成方法所得的聚醯亞胺粉末(2)(2.50g)中,70℃下攪拌24小時使其溶解。將〔1a〕(14.6g)及BCS(4.20g)加入該溶液中, 50℃下攪拌10小時得組成物(3)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(3)也作為評估用之液晶配向處理劑(3)用。 NEP (20.4 g) was added to the polyimine powder (2) (2.50 g) obtained by the synthesis method of Synthesis Example 2, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (14.6 g) and BCS (4.20 g) were added to the solution. The composition (3) was obtained by stirring at 50 ° C for 10 hours. No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (3) was also used as the liquid crystal alignment treatment agent (3) for evaluation.

使用所得之組成物(3)或液晶配向處理劑(3),以上述條件製作單元及進行各種評估。 Using the obtained composition (3) or the liquid crystal alignment treatment agent (3), the unit was produced under the above conditions and various evaluations were carried out.

<實施例4> <Example 4>

將NEP(22.8g)加入合成例2之合成方法所得的聚醯亞胺粉末(2)(1.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(15.5g)及BCS(4.40g)加入該溶液中,50℃下攪拌10小時得組成物(4)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(4)係作為評估用之液晶配向處理劑(4)用。 NEP (22.8 g) was added to the polyimine powder (2) (1.55 g) obtained by the synthesis method of Synthesis Example 2, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (15.5 g) and BCS (4.40 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (4). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (4) was used as a liquid crystal alignment treatment agent (4) for evaluation.

使用所得之液晶配向處理劑(4),以上述條件進行「液晶配向處理劑之噴墨印刷塗佈性評估」。 Using the obtained liquid crystal alignment treatment agent (4), "evaluation of inkjet printing coatability of liquid crystal alignment treatment agent" was carried out under the above conditions.

<實施例5> <Example 5>

將NMP(17.9g)及〔1a〕(15.3g)加入合成例3之合成方法所得的樹脂固體成分濃度25.0質量%之聚醯胺酸溶液(3)(10.5g)中,25℃下攪拌2小時得組成物(5)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(5)也作為評估用之液晶配向處理劑(5)用。 NMP (17.9 g) and [1a] (15.3 g) were added to a polyamic acid solution (3) (10.5 g) having a resin solid content concentration of 25.0% by mass obtained by the synthesis method of Synthesis Example 3, and stirred at 25 ° C. The composition of the hour (5). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (5) was also used as a liquid crystal alignment treatment agent (5) for evaluation.

使用所得之組成物(5)或液晶配向處理劑(5),以 上述條件製作單元及進行各種評估。 Using the obtained composition (5) or liquid crystal alignment treatment agent (5), The above conditions are produced by the unit and various evaluations are performed.

<實施例6> <Example 6>

將NMP(20.7g)加入合成例4之合成方法所得的聚醯亞胺粉末(4)(2.54g)中,70℃下攪拌24小時使其溶液。將〔1a〕(19.1g)加入該溶液中,50℃下攪拌10小時得組成物(6)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(6)也作為評估用之液晶配向處理劑(6)用。 NMP (20.7 g) was added to the polyimine powder (4) (2.54 g) obtained by the synthesis method of Synthesis Example 4, and the solution was stirred at 70 ° C for 24 hours. [1a] (19.1 g) was added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (6). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (6) was also used as a liquid crystal alignment treatment agent (6) for evaluation.

使用所得之組成物(6)或液晶配向處理劑(6),以上述條件製作單元及進行各種評估。 Using the obtained composition (6) or the liquid crystal alignment treatment agent (6), the unit was produced under the above conditions and various evaluations were carried out.

<實施例7> <Example 7>

將NMP(16.3g)加入合成例4之合成方法所得的聚醯亞胺粉末(4)(2.50g)中,70℃下攪拌24小時使其溶解。將〔1a〕(8.30g)及BCS(14.6g)加入該溶液中,50℃下攪拌10小時得組成物(7)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(7)也作為評估用之液晶配向處理劑(7)用。 NMP (16.3 g) was added to the polyimine powder (4) (2.50 g) obtained by the synthesis method of Synthesis Example 4, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (8.30 g) and BCS (14.6 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (7). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (7) was also used as a liquid crystal alignment treatment agent (7) for evaluation.

使用所得之組成物(7)或液晶配向處理劑(7),以上述條件製作單元及進行各種評估。 Using the obtained composition (7) or the liquid crystal alignment treatment agent (7), the unit was produced under the above conditions and various evaluations were carried out.

<實施例8> <Example 8>

將NEP(16.6g)加入合成例4之合成方法所得的聚 醯亞胺粉末(4)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(6.40g)及BCS(17.0g)加入該溶液中,50℃下攪拌10小時得組成物(8)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(8)也作為評估用之液晶配向處理劑(8)用。 Addition of NEP (16.6 g) to the synthesis method of Synthesis Example 4 The quinone imine powder (4) (2.55 g) was stirred at 70 ° C for 24 hours to be dissolved. [1a] (6.40 g) and BCS (17.0 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (8). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (8) was also used as a liquid crystal alignment treatment agent (8) for evaluation.

使用所得之組成物(8)或液晶配向處理劑(8),以上述條件製作單元及進行各種評估。 Using the obtained composition (8) or the liquid crystal alignment treatment agent (8), the unit was produced under the above conditions and various evaluations were carried out.

<實施例9> <Example 9>

將NMP(4.90g)及NEP(12.9g)加入合成例4之合成方法所得的聚醯亞胺粉末(4)(1.50g)中,70℃下攪拌24小時使其溶解。將〔1a〕(6.40g)及BCS(17.1g)加入該溶液中,50℃下攪拌10小時得組成物(9)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(9)係作為評估用之液晶配向處理劑(9)用。 NMP (4.90 g) and NEP (12.9 g) were added to the polyimine powder (4) (1.50 g) obtained by the synthesis method of Synthesis Example 4, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (6.40 g) and BCS (17.1 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (9). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (9) was used as a liquid crystal alignment treatment agent (9) for evaluation.

使用所得之液晶配向處理劑(9),以上述條件進行「液晶配向處理劑之噴墨印刷塗佈性評估」。 Using the obtained liquid crystal alignment treatment agent (9), "evaluation of inkjet printing coatability of liquid crystal alignment treatment agent" was carried out under the above conditions.

<實施例10> <Example 10>

將NMP(20.8g)加入合成例5之合成方法所得的聚醯亞胺粉末(5)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(12.8g)及BCS(6.40g)加入該溶液中,50℃下攪拌10小時得組成物(10)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物 (10)也作為評估用之液晶配向處理劑(10)用。 NMP (20.8 g) was added to the polyimine powder (5) (2.55 g) obtained by the synthesis method of Synthesis Example 5, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (12.8 g) and BCS (6.40 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (10). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Again, the composition (10) It is also used as a liquid crystal alignment treatment agent (10) for evaluation.

使用所得之組成物(10)或液晶配向處理劑(10),以上述條件製作單元及進行各種評估。 Using the obtained composition (10) or the liquid crystal alignment treatment agent (10), the unit was produced under the above conditions and various evaluations were carried out.

<實施例11> <Example 11>

將NMP(14.5g)及NEP(8.50g)加入合成例5之合成方法所得的聚醯亞胺粉末(5)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(12.8g)及BCS(4.30g)加入該溶液中,50℃下攪拌10小時得組成物(11)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(11)也作為評估用之液晶配向處理劑(11)用。 NMP (14.5 g) and NEP (8.50 g) were added to the polyimine powder (5) (2.55 g) obtained by the synthesis method of Synthesis Example 5, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (12.8 g) and BCS (4.30 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (11). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (11) was also used as a liquid crystal alignment treatment agent (11) for evaluation.

使用所得之組成物(11)或液晶配向處理劑(11),以上述條件製作單元及進行各種評估。 Using the obtained composition (11) or liquid crystal alignment treatment agent (11), the unit was produced under the above conditions and various evaluations were carried out.

<實施例12> <Example 12>

將NMP(16.2g)及NEP(8.90g)加入合成例5之合成方法所得的聚醯亞胺粉末(5)(1.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(13.3g)及BCS(4.40g)加入該溶液中,50℃下攪拌10小時得組成物(12)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。 又,該組成物(12)係作為評估用之液晶配向處理劑(12)用。 NMP (16.2 g) and NEP (8.90 g) were added to the polyimine powder (5) (1.55 g) obtained by the synthesis method of Synthesis Example 5, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (13.3 g) and BCS (4.40 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (12). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (12) was used as a liquid crystal alignment treatment agent (12) for evaluation.

使用所得之液晶配向處理劑(12),以上述條件進行 「液晶配向處理劑之噴墨印刷塗佈性評估」。 Using the obtained liquid crystal alignment treatment agent (12), under the above conditions "Evaluation of inkjet printing coatability of liquid crystal alignment agent".

<實施例13> <Example 13>

將NMP(20.8g)加入合成例5之合成方法所得的聚醯亞胺粉末(5)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(8.50g)、BCS(8.50g)及MC(2.10g)加入該溶液中,50℃下攪拌10小時得組成物(13)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(13)也作為評估用之液晶配向處理劑(13)用。 NMP (20.8 g) was added to the polyimine powder (5) (2.55 g) obtained by the synthesis method of Synthesis Example 5, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (8.50 g), BCS (8.50 g) and MC (2.10 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (13). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (13) was also used as a liquid crystal alignment treatment agent (13) for evaluation.

使用所得之組成物(13)或液晶配向處理劑(13),以上述條件製作單元及進行各種評估。 Using the obtained composition (13) or the liquid crystal alignment treatment agent (13), the unit was produced under the above conditions and various evaluations were carried out.

<實施例14> <Example 14>

將NMP(23.0g)加入合成例5之合成方法所得的聚醯亞胺粉末(5)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(6.40g)、BCS(8.50g)及EC(2.10g)加入該溶液中,50℃下攪拌10小時得組成物(14)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(14)也作為評估用之液晶配向處理劑(14)用。 NMP (23.0 g) was added to the polyimine powder (5) (2.55 g) obtained by the synthesis method of Synthesis Example 5, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (6.40 g), BCS (8.50 g) and EC (2.10 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (14). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (14) was also used as a liquid crystal alignment treatment agent (14) for evaluation.

使用所得之組成物(14)或液晶配向處理劑(14),以上述條件製作單元及進行各種評估。 Using the obtained composition (14) or the liquid crystal alignment treatment agent (14), the unit was produced under the above conditions and various evaluations were carried out.

<實施例15> <Example 15>

將NMP(21.0g)加入合成例6之合成方法所得的聚醯亞胺粉末(6)(2.57g)中,70℃下攪拌24小時使其溶解。將〔1a〕(12.9g)及BCS(6.40g)加入該溶液中,50℃下攪拌10小時得組成物(15)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(15)也作為評估用之液晶配向處理劑(15)用。 NMP (21.0 g) was added to the polyimine powder (6) (2.57 g) obtained by the synthesis method of Synthesis Example 6, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (12.9 g) and BCS (6.40 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (15). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (15) was also used as a liquid crystal alignment treatment agent (15) for evaluation.

使用所得之組成物(15)或液晶配向處理劑(15),以上述條件製作單元及進行各種評估。 Using the obtained composition (15) or the liquid crystal alignment treatment agent (15), the unit was produced under the above conditions and various evaluations were carried out.

<實施例16> <Example 16>

將NEP(16.4g)加入合成例6之合成方法所得的聚醯亞胺粉末(6)(2.53g)中,70℃下攪拌24小時使其溶解。將〔1a〕(4.20g)及BCS(19.0g)加入該溶液中,50℃下攪拌10小時得組成物(16)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(16)也作為評估用之液晶配向處理劑(16)用。 NEP (16.4 g) was added to the polyimine powder (6) (2.53 g) obtained by the synthesis method of Synthesis Example 6, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (4.20 g) and BCS (19.0 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (16). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (16) was also used as a liquid crystal alignment treatment agent (16) for evaluation.

使用所得之組成物(16)或液晶配向處理劑(16),以上述條件製作單元及進行各種評估。 Using the obtained composition (16) or liquid crystal alignment treatment agent (16), the unit was produced under the above conditions and various evaluations were carried out.

<實施例17> <Example 17>

將NMP(14.5g)及NEP(8.50g)加入合成例6之合成方法所得的聚醯亞胺粉末(6)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(4.30g)及BCS(12.8g) 加入該溶液中,50℃下攪拌10小時得組成物(17)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(17)也作為評估用之液晶配向處理劑(17)用。 NMP (14.5 g) and NEP (8.50 g) were added to the polyimine powder (6) (2.55 g) obtained by the synthesis method of Synthesis Example 6, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (4.30g) and BCS (12.8g) The solution was added to the solution and stirred at 50 ° C for 10 hours to obtain a composition (17). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (17) was also used as a liquid crystal alignment treatment agent (17) for evaluation.

使用所得之組成物(17)或液晶配向處理劑(17),以上述條件製作單元及進行各種評估。 Using the obtained composition (17) or liquid crystal alignment treatment agent (17), the unit was produced under the above conditions and various evaluations were carried out.

<實施例18> <Example 18>

將NMP(13.5g)及NEP(8.60g)加入合成例6之合成方法所得的聚醯亞胺粉末(6)(1.50g)中,70℃下攪拌24小時使其溶解。將〔1a〕(10.7g)及BCS(8.60g)加入該溶液中,50℃下攪拌10小時得組成物(18)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(18)係作為評估用之液晶配向處理劑(18)用。 NMP (13.5 g) and NEP (8.60 g) were added to the polyimine powder (6) (1.50 g) obtained by the synthesis method of Synthesis Example 6, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (10.7 g) and BCS (8.60 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (18). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (18) was used as a liquid crystal alignment treatment agent (18) for evaluation.

使用所得之液晶配向處理劑(18),以上述條件進行「液晶配向處理劑之噴墨印刷塗佈性評估」。 Using the obtained liquid crystal alignment treatment agent (18), "evaluation of inkjet printing coatability of liquid crystal alignment treatment agent" was carried out under the above conditions.

<實施例19> <Example 19>

將γ-BL(16.6g)加入合成例7之合成方法所得的聚醯亞胺粉末(7)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(8.50g)及BCS(14.9g)加入該溶液中,50℃下攪拌10小時得組成物(19)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物 (19)也作為評估用之液晶配向處理劑(19)用。 γ-BL (16.6 g) was added to the polyimine powder (7) (2.55 g) obtained by the synthesis method of Synthesis Example 7, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (8.50 g) and BCS (14.9 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (19). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Again, the composition (19) It is also used as a liquid crystal alignment treatment agent (19) for evaluation.

使用所得之組成物(19)或液晶配向處理劑(19),以上述條件製作單元及進行各種評估。 Using the obtained composition (19) or liquid crystal alignment treatment agent (19), the unit was produced under the above conditions and various evaluations were carried out.

<實施例20> <Example 20>

將NMP(14.5g)及γ-BL(2.10g)加入合成例7之合成方法所得的聚醯亞胺粉末(7)(2.56g)中,70℃下攪拌24小時使其溶解。將〔1a〕(6.40g)及BCS(17.1g)加入該溶液中,50℃下攪拌10小時得組成物(20)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(20)也作為評估用之液晶配向處理劑(20)用。 NMP (14.5 g) and γ-BL (2.10 g) were added to the polyimine powder (7) (2.56 g) obtained by the synthesis method of Synthesis Example 7, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (6.40 g) and BCS (17.1 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (20). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (20) was also used as a liquid crystal alignment treatment agent (20) for evaluation.

使用所得之組成物(20)或液晶配向處理劑(20),以上述條件製作單元及進行各種評估。 Using the obtained composition (20) or liquid crystal alignment treatment agent (20), the unit was produced under the above conditions and various evaluations were carried out.

<實施例21> <Example 21>

將NMP(20.8g)加入合成例7之合成方法所得的聚醯亞胺粉末(7)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(12.8g)及BCS(6.40g)加入該溶液中,50℃下攪拌10小時得組成物(21)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(21)也作為評估用之液晶配向處理劑(21)用。 NMP (20.8 g) was added to the polyimine powder (7) (2.55 g) obtained by the synthesis method of Synthesis Example 7, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (12.8 g) and BCS (6.40 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (21). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (21) was also used as a liquid crystal alignment treatment agent (21) for evaluation.

使用所得之組成物(21)或液晶配向處理劑(21),以上述條件製作單元及進行各種評估。 Using the obtained composition (21) or liquid crystal alignment treatment agent (21), the unit was produced under the above conditions and various evaluations were carried out.

<實施例22> <Example 22>

將NMP(20.8g)加入合成例7之合成方法所得的聚醯亞胺粉末(7)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(19.1g)加入該溶液中,50℃下攪拌10小時得組成物(22)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(22)也作為評估用之液晶配向處理劑(22)用。 NMP (20.8 g) was added to the polyimine powder (7) (2.55 g) obtained by the synthesis method of Synthesis Example 7, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (19.1 g) was added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (22). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (22) was also used as a liquid crystal alignment treatment agent (22) for evaluation.

使用所得之組成物(22)或液晶配向處理劑(22),以上述條件製作單元及進行各種評估。 Using the obtained composition (22) or liquid crystal alignment treatment agent (22), the unit was produced under the above conditions and various evaluations were carried out.

<實施例23> <Example 23>

將NMP(22.5g)加入合成例8之合成方法所得的聚醯亞胺粉末(8)(2.50g)中,70℃下攪拌24小時使其溶解。將〔1a〕(8.30g)及BCS(8.30g)加入該溶液中,50℃下攪拌10小時得組成物(23)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(23)也作為評估用之液晶配向處理劑(23)用。 NMP (22.5 g) was added to the polyimine powder (8) (2.50 g) obtained by the synthesis method of Synthesis Example 8, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (8.30 g) and BCS (8.30 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (23). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (23) was also used as a liquid crystal alignment treatment agent (23) for evaluation.

使用所得之組成物(23)或液晶配向處理劑(23),以上述條件製作單元及進行各種評估。 Using the obtained composition (23) or liquid crystal alignment treatment agent (23), the unit was produced under the above conditions and various evaluations were carried out.

<實施例24> <Example 24>

將NMP(12.2g)及NEP(8.40g)加入合成例8之合成方法所得的聚醯亞胺粉末(8)(2.52g)中,70℃下攪 拌24小時使其溶解。將〔1a〕(10.5g)及BCS(8.40g)加入該溶液中,50℃下攪拌10小時得組成物(24)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(24)也作為評估用之液晶配向處理劑(24)用。 NMP (12.2 g) and NEP (8.40 g) were added to the polyimine powder (8) (2.52 g) obtained by the synthesis method of Synthesis Example 8, and stirred at 70 ° C. Mix for 24 hours to dissolve. [1a] (10.5 g) and BCS (8.40 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (24). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (24) was also used as a liquid crystal alignment treatment agent (24) for evaluation.

使用所得之組成物(24)或液晶配向處理劑(24),以上述條件製作單元及進行各種評估。 Using the obtained composition (24) or liquid crystal alignment treatment agent (24), the unit was produced under the above conditions and various evaluations were carried out.

<實施例25> <Example 25>

將NMP(20.7g)加入合成例9之合成方法所得的聚醯亞胺粉末(9)(2.54g)中,70℃下攪拌24小時使其溶解。將〔1a〕(10.6g)及BCS(8.50g)加入該溶液中,50℃下攪拌10小時得組成物(25)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(25)也作為評估用之液晶配向處理劑(25)用。 NMP (20.7 g) was added to the polyimine powder (9) (2.54 g) obtained by the synthesis method of Synthesis Example 9, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (10.6 g) and BCS (8.50 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (25). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (25) was also used as a liquid crystal alignment treatment agent (25) for evaluation.

使用所得之組成物(25)或液晶配向處理劑(25),以上述條件製作單元及進行各種評估。 Using the obtained composition (25) or the liquid crystal alignment treatment agent (25), the unit was produced under the above conditions and various evaluations were carried out.

<實施例26> <Example 26>

將NMP(5.90g)及NEP(12.8g)加入合成例9之合成方法所得的聚醯亞胺粉末(9)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(10.6g)及BCS(10.6g)加入該溶液中,50℃下攪拌10小時得組成物(26)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。 又,該組成物(26)也作為評估用之液晶配向處理劑(26)用。 NMP (5.90 g) and NEP (12.8 g) were added to the polyimine powder (9) (2.55 g) obtained by the synthesis method of Synthesis Example 9, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (10.6 g) and BCS (10.6 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (26). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (26) was also used as a liquid crystal alignment treatment agent (26) for evaluation.

使用所得之組成物(26)或液晶配向處理劑(26),以上述條件製作單元及進行各種評估。 Using the obtained composition (26) or liquid crystal alignment treatment agent (26), the unit was produced under the above conditions and various evaluations were carried out.

<實施例27> <Example 27>

將NMP(11.4g)及NEP(12.9g)加入合成例9之合成方法所得的聚醯亞胺粉末(9)(1.50g)中,70℃下攪拌24小時使其溶解。將〔1a〕(8.60g)及BCS(8.60g)加入該溶液中,50℃下攪拌10小時得組成物(27)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(27)係作為評估用之液晶配向處理劑(27)用。 NMP (11.4 g) and NEP (12.9 g) were added to the polyimine powder (9) (1.50 g) obtained by the synthesis method of Synthesis Example 9, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (8.60 g) and BCS (8.60 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (27). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (27) was used as a liquid crystal alignment treatment agent (27) for evaluation.

使用所得之液晶配向處理劑(27),以上述條件進行「液晶配向處理劑之噴墨印刷塗佈性評估」。 Using the obtained liquid crystal alignment treatment agent (27), "evaluation of inkjet printing coatability of liquid crystal alignment treatment agent" was carried out under the above conditions.

<實施例28> <Example 28>

將NEP(16.3g)加入合成例10之合成方法所得的聚醯亞胺粉末(10)(2.50g)中,70℃下攪拌24小時使其溶解,將〔1a〕(6.30g)及BCS(16.7g)加入該溶液中,50℃下攪拌10小時得組成物(28)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(28)也作為評估用之液晶配向處理劑(28)用。 NEP (16.3 g) was added to the polyimine powder (10) (2.50 g) obtained by the synthesis method of Synthesis Example 10, and stirred at 70 ° C for 24 hours to dissolve [1a] (6.30 g) and BCS ( 16.7 g) was added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (28). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (28) was also used as a liquid crystal alignment treatment agent (28) for evaluation.

使用所得之組成物(28)或液晶配向處理劑(28), 以上述條件製作單元及進行各種評估。 Using the obtained composition (28) or liquid crystal alignment treatment agent (28), The unit was fabricated under the above conditions and various evaluations were performed.

<實施例29> <Example 29>

將NMP(18.7g)加入合成例10之合成方法所得的聚醯亞胺粉末(10)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(10.6g)及BCS(10.6g)加入該溶液中,50℃下攪拌10小時得組成物(29)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(29)也作為評估用之液晶配向處理劑(29)用。 NMP (18.7 g) was added to the polyimine powder (10) (2.55 g) obtained by the synthesis method of Synthesis Example 10, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (10.6 g) and BCS (10.6 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (29). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (29) was also used as a liquid crystal alignment treatment agent (29) for evaluation.

使用所得之組成物(29)或液晶配向處理劑(29),以上述條件製作單元及進行各種評估。 Using the obtained composition (29) or liquid crystal alignment treatment agent (29), the unit was produced under the above conditions and various evaluations were carried out.

<實施例30> <Example 30>

將NMP(23.0g)加入合成例11之合成方法所得的聚醯亞胺粉末(11)(2.56g)中,70℃下攪拌24小時使其溶解。將〔1a〕(8.50g)及MC(8.50g)加入該溶液中,50℃下攪拌10小時得組成物(30)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(30)也作為評估用之液晶配向處理劑(30)用。 NMP (23.0 g) was added to the polyimine powder (11) (2.56 g) obtained by the synthesis method of Synthesis Example 11, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (8.50 g) and MC (8.50 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (30). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (30) was also used as a liquid crystal alignment treatment agent (30) for evaluation.

使用所得之組成物(30)或液晶配向處理劑(30),以上述條件製作單元及進行各種評估。 Using the obtained composition (30) or liquid crystal alignment treatment agent (30), the unit was produced under the above conditions and various evaluations were carried out.

<實施例31> <Example 31>

將NEP(16.6g)加入合成例11之合成方法所得的聚 醯亞胺粉末(11)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(17.0g)及BCS(6.40g)加入該溶液中,50℃下攪拌10小時得組成物(31)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(31)也作為評估用之液晶配向處理劑(31)用。 Addition of NEP (16.6 g) to the synthesis method of Synthesis Example 11 The quinone imine powder (11) (2.55 g) was stirred at 70 ° C for 24 hours to be dissolved. [1a] (17.0 g) and BCS (6.40 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (31). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (31) was also used as a liquid crystal alignment treatment agent (31) for evaluation.

使用所得之組成物(31)或液晶配向處理劑(31),以上述條件製作單元及進行各種評估。 Using the obtained composition (31) or the liquid crystal alignment treatment agent (31), the unit was produced under the above conditions and various evaluations were carried out.

<實施例32> <Example 32>

將NEP(16.6g)及γ-BL(2.10g)加入合成例11之合成方法所得的聚醯亞胺粉末(11)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(12.8g)及BCS(8.50g)加入該溶液中,50℃下攪拌10小時得組成物(32)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(32)也作為液晶配向處理劑(32)用使用於評估。 NEP (16.6 g) and γ-BL (2.10 g) were added to the polyimine powder (11) (2.55 g) obtained by the synthesis method of Synthesis Example 11, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (12.8 g) and BCS (8.50 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (32). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (32) was also used for evaluation as a liquid crystal alignment treatment agent (32).

使用所得之組成物(32)或液晶配向處理劑(32),以上述條件製作單元及進行各種評估。 Using the obtained composition (32) or liquid crystal alignment treatment agent (32), the unit was produced under the above conditions and various evaluations were carried out.

<實施例33> <Example 33>

將NMP(22.5g)加入合成例12之合成方法所得的聚醯亞胺粉末(12)(2.50g)中,70℃下攪拌24小時使其溶解。將〔1a〕(14.6g)及EC(2.10g)加入該溶液中,50℃下攪拌10小時得組成物(33)。該組成物未發現混 濁或析出等之異常,確認為均勻溶液。又,該組成物(33)也作為評估用之液晶配向處理劑(33)用。 NMP (22.5 g) was added to the polyimine powder (12) (2.50 g) obtained by the synthesis method of Synthesis Example 12, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (14.6 g) and EC (2.10 g) were added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (33). The composition was not found to be mixed An abnormality such as turbidity or precipitation was confirmed as a homogeneous solution. Further, this composition (33) was also used as a liquid crystal alignment treatment agent (33) for evaluation.

使用所得之組成物(33)及液晶配向處理劑(33),以上述條件製作及進行各種評估。 Using the obtained composition (33) and the liquid crystal alignment treatment agent (33), various evaluations were carried out under the above conditions.

<實施例34> <Example 34>

將NEP(18.7g)加入合成例12之合成方法所得的聚醯亞胺粉末(12)(2.55g)中,70℃下攪拌24小時使其溶解。將〔1a〕(21.3g)加入該溶液中,50℃下攪拌10小時得組成物(34)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(34)也作為評估用之液晶配向處理劑(34)用。 NEP (18.7 g) was added to the polyimine powder (12) (2.55 g) obtained by the synthesis method of Synthesis Example 12, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. [1a] (21.3 g) was added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (34). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (34) was also used as a liquid crystal alignment treatment agent (34) for evaluation.

使用所得之組成物(34)或液晶配向處理劑(34),以上述條件製作單元及進行各種評估。 Using the obtained composition (34) or liquid crystal alignment treatment agent (34), the unit was produced under the above conditions and various evaluations were carried out.

<比較例1> <Comparative Example 1>

將NMP(19.2g)及BCS(12.5g)加入合成例1之合成方法所得的樹脂固體成分濃度25.0質量%之聚醯胺酸溶液(1)(10.0g)中,25℃下攪拌2小時得組成物(35)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(35)也作為評估用之液晶配向處理劑(35)用。 NMP (19.2 g) and BCS (12.5 g) were added to a polyamic acid solution (1) (10.0 g) having a resin solid content concentration of 25.0% by mass obtained by the synthesis method of Synthesis Example 1, and stirred at 25 ° C for 2 hours. Composition (35). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (35) was also used as a liquid crystal alignment treatment agent (35) for evaluation.

使用所得之組成物(35)或液晶配向處理劑(35),以上述條件製作單元及進行各種評估。 Using the obtained composition (35) or liquid crystal alignment treatment agent (35), the unit was produced under the above conditions and various evaluations were carried out.

<比較例2> <Comparative Example 2>

將NMP(22.5g)加入合成例2之合成方法所得的聚醯亞胺粉末(2)(2.50g)中,70℃下攪拌24小時使其溶解。將BCS(16.7g)加入該溶液中,50℃下攪拌10小時得組成物(36)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(36)也作為評估用之液晶配向處理劑(36)用。 NMP (22.5 g) was added to the polyimine powder (2) (2.50 g) obtained by the synthesis method of Synthesis Example 2, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. BCS (16.7 g) was added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (36). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (36) was also used as a liquid crystal alignment treatment agent (36) for evaluation.

使用所得之組成物(36)或液晶配向處理劑(36),以上述條件製作單元及進行各種評估。 Using the obtained composition (36) or liquid crystal alignment treatment agent (36), the unit was produced under the above conditions and various evaluations were carried out.

<比較例3> <Comparative Example 3>

將NMP(17.2g)及BCS(14.7g)加入合成例3之合成方法所得的樹脂固體成分濃度25.0質量%之聚醯胺酸溶液(3)(10.1g)中,25℃下攪拌2小時得組成物(37)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(37)也作為評估用之液晶配向處理劑(37)用。 NMP (17.2 g) and BCS (14.7 g) were added to a polyamic acid solution (3) (10.1 g) having a resin solid content concentration of 25.0% by mass obtained by the synthesis method of Synthesis Example 3, and stirred at 25 ° C for 2 hours. Composition (37). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (37) was also used as a liquid crystal alignment treatment agent (37) for evaluation.

使用所得之組成物(37)或液晶配向處理劑(37),以上述條件製作單元及進行各種評估。 Using the obtained composition (37) or liquid crystal alignment treatment agent (37), the unit was produced under the above conditions and various evaluations were carried out.

<比較例4> <Comparative Example 4>

將NMP(20.6g)加入合成例4之合成方法所得的聚醯亞胺粉末(4)(2.52g)中,70℃下攪拌24小時使其溶 解。將BCS(18.9g)加入該溶液中,50℃下攪拌10小時得組成物(38)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(38)也作為評估用之液晶配向處理劑(38)用。 NMP (20.6 g) was added to the polyimine powder (4) (2.52 g) obtained by the synthesis method of Synthesis Example 4, and stirred at 70 ° C for 24 hours to dissolve. solution. BCS (18.9 g) was added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (38). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (38) was also used as a liquid crystal alignment treatment agent (38) for evaluation.

使用所得之組成物(38)或液晶配向處理劑(38),以上述條件製作單元及進行各種評估。 Using the obtained composition (38) or liquid crystal alignment treatment agent (38), the unit was produced under the above conditions and various evaluations were carried out.

<比較例5> <Comparative Example 5>

將NMP(20.4g)加入合成例5之合成方法所得的聚醯亞胺粉末(5)(2.50g)中,70℃下攪拌24小時使其溶解。將BCS(18.8g)加入該溶液中,50℃下攪拌10小時得組成物(39)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(39)也作為評估用之液晶配向處理劑(39)用。 NMP (20.4 g) was added to the polyimine powder (5) (2.50 g) obtained by the synthesis method of Synthesis Example 5, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. BCS (18.8 g) was added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (39). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (39) was also used as a liquid crystal alignment treatment agent (39) for evaluation.

使用所得之組成物(39)或液晶配向處理劑(39),以上述條件製作單元及進行各種評估。 Using the obtained composition (39) or liquid crystal alignment treatment agent (39), the unit was produced under the above conditions and various evaluations were carried out.

<比較例6> <Comparative Example 6>

將NMP(20.8g)加入合成例6之合成方法所得的聚醯亞胺粉末(6)(2.55g)中,70℃下攪拌24小時使其溶解。將BCS(19.1g)加入該溶液中,50℃下攪拌10小時得組成物(40)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(40)也作為評估用之液晶配向處理劑(40)用。 NMP (20.8 g) was added to the polyimine powder (6) (2.55 g) obtained by the synthesis method of Synthesis Example 6, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. BCS (19.1 g) was added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (40). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (40) was also used as a liquid crystal alignment treatment agent (40) for evaluation.

使用所得之組成物(40)或液晶配向處理劑(40),以上述條件製作單元及進行各種評估。 Using the obtained composition (40) or liquid crystal alignment treatment agent (40), the unit was produced under the above conditions and various evaluations were carried out.

<比較例7> <Comparative Example 7>

將γ-BL(16.4g)加入合成例7之合成方法所得的聚醯亞胺粉末(7)(2.53g)中,70℃下攪拌24小時使其溶解。將BCS(23.2g)加入該溶液中,50℃下攪拌10小時得組成物(41)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(41)也作為評估用之液晶配向處理劑(41)用。 γ-BL (16.4 g) was added to the polyimine powder (7) (2.53 g) obtained by the synthesis method of Synthesis Example 7, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. BCS (23.2 g) was added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (41). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, this composition (41) was also used as a liquid crystal alignment treatment agent (41) for evaluation.

使用所得之組成物(41)或液晶配向處理劑(41),以上述條件製作單元及進行各種評估。 Using the obtained composition (41) or liquid crystal alignment treatment agent (41), the unit was produced under the above conditions and various evaluations were carried out.

<比較例8> <Comparative Example 8>

將NMP(18.3g)加入合成例10之合成方法所得的聚醯亞胺粉末(10)(2.50g)中,70℃下攪拌24小時使其溶解。將BCS(20.8g)加入該溶液中,50℃下攪拌10小時得組成物(42)。該組成物未發現混濁或析出等之異常,確認為均勻溶液。又,該組成物(42)也作為評估用之液晶配向處理劑(42)用。 NMP (18.3 g) was added to the polyimine powder (10) (2.50 g) obtained by the synthesis method of Synthesis Example 10, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. BCS (20.8 g) was added to the solution, and the mixture was stirred at 50 ° C for 10 hours to obtain a composition (42). No abnormality such as turbidity or precipitation was observed in the composition, and it was confirmed to be a homogeneous solution. Further, the composition (42) was also used as a liquid crystal alignment treatment agent (42) for evaluation.

使用所得之組成物(42)或液晶配向處理劑(42),以上述條件製作單元及進行各種評估。 Using the obtained composition (42) or liquid crystal alignment treatment agent (42), the unit was produced under the above conditions and various evaluations were carried out.

實施例及比較例所得之評估結果合併如表5至10所示。 The evaluation results obtained in the examples and comparative examples are combined as shown in Tables 5 to 10.

由上述結果得知,由本發明實施例之組成物所得的聚醯亞胺膜,比較由比較例之組成物所得的聚醯亞胺膜時,可得不會發生針孔之均勻塗膜性。又,可提高所形成的聚醯亞胺膜之端部的直線性,減少聚醯亞胺膜之端部隆起。 From the above results, it was found that when the polyimide film obtained from the composition of the present invention was compared with the polyimide film obtained from the composition of the comparative example, uniform coating property of pinholes did not occur. Further, the linearity of the end portion of the formed polyimide film can be improved, and the end portion of the polyimide film can be reduced.

又,由使用本發明之組成物的液晶配向處理劑所得之液晶配向膜也可得到相同之結果。特別是使用由具有支鏈之二胺化合物所得的聚醯胺酸或溶劑可溶性聚醯亞胺之液晶配向處理劑,結果也可同上述得到提升聚醯亞胺膜之端部的直線性,減少聚醯亞胺膜之端部隆起。 Further, the same results were obtained from the liquid crystal alignment film obtained by using the liquid crystal alignment treatment agent of the composition of the present invention. In particular, by using a liquid crystal alignment agent obtained from a polyamine or a solvent-soluble polyimine obtained by a branched diamine compound, the linearity of the end portion of the polyimide film can be improved as described above. The end of the polyimide film is raised.

對使用相同的聚醯胺酸或聚醯亞胺之組成物進行印刷性評估的結果,比較本發明之含有特定溶劑的實施例與不含特定溶劑之比較例,不含特定溶劑之比較例為,聚醯亞胺膜會發生較多針孔,降低聚醯亞胺膜之端部的直線性,及增加聚醯亞胺膜之端部隆起。 For the results of the printability evaluation using the composition of the same polylysine or polyimine, the comparative example containing the specific solvent of the present invention and the comparative example containing no specific solvent were compared, and the comparative example containing no specific solvent was The polyimine film will generate more pinholes, reduce the linearity of the end of the polyimide film, and increase the end bulge of the polyimide film.

具體上為實施例1與比較例1、實施例2與比較例2、實施例5與比較例3、實施例6與比較例4、實施例10與比較例5、實施例15與比較例6、實施例19與比較例7、及實施例29與比較例8進行比較。 Specifically, Example 1 and Comparative Example 1, Example 2 and Comparative Example 2, Example 5 and Comparative Example 3, Example 6 and Comparative Example 4, Example 10 and Comparative Example 5, Example 15 and Comparative Example 6 Example 19 was compared with Comparative Example 7, and Example 29 and Comparative Example 8.

又,對使用使用相同的聚醯胺酸或聚醯亞胺之液晶配向處理劑的液晶單元進行液晶配向性評估的結果,比較本發明之含有特定溶劑的實施例與不含特定溶劑之比較例,不含特定溶劑之比較例會發生較多的起因於針孔之配向缺陷。 Further, as a result of performing liquid crystal alignment evaluation on a liquid crystal cell using a liquid crystal alignment treatment agent using the same polyaminic acid or polyimine, a comparison example of the specific solvent-containing embodiment of the present invention and a specific solvent-free example was compared. Comparative examples containing no specific solvent may cause more alignment defects due to pinholes.

具體上為實施例1與比較例1、實施例2與比較例2、實施例5與比較例3、實施例6與比較例4、實施例10與比較例5、實施例15與比較例6、實施例19與比較例7、及實施例29與比較例8進行比較。 Specifically, Example 1 and Comparative Example 1, Example 2 and Comparative Example 2, Example 5 and Comparative Example 3, Example 6 and Comparative Example 4, Example 10 and Comparative Example 5, Example 15 and Comparative Example 6 Example 19 was compared with Comparative Example 7, and Example 29 and Comparative Example 8.

另外對液晶單元進行預傾角評估的結果,比較本發明之含有特定支鏈構造的液晶配向處理劑與不含特定支鏈構造之液晶配向處理劑,不含特定支鏈構造之液晶配向處理劑的預傾角安定性較低,即,相對於加熱或紫外線之變化較大。 Further, as a result of pre-tilt evaluation of the liquid crystal cell, the liquid crystal alignment treatment agent having a specific branched structure of the present invention and the liquid crystal alignment treatment agent having no specific branched structure are compared, and the liquid crystal alignment treatment agent having no specific branched structure is contained. The pretilt angle stability is low, that is, the change with respect to heating or ultraviolet rays is large.

具體上為實施例8與實施例28進行比較。 Specifically, Example 8 is compared with Example 28.

產業上利用可能性 Industrial use possibility

本發明之組成物具有不會發生針孔之均勻塗膜性,可形成端部之直線性較高、端部隆起較少之聚醯亞胺膜。又,同樣地使用本發明之組成物的液晶配向處理劑也具有不會發生針孔之均勻塗膜性,可形成端部之直線性較高、端部隆起較少,不會發生起因於針孔之配向缺陷的液晶配向膜。 The composition of the present invention has a uniform coating property in which pinholes do not occur, and a polyimine film having a high linearity at the end portion and a small amount of end bulging can be formed. Further, the liquid crystal alignment treatment agent using the composition of the present invention in the same manner also has uniform coating property without pinholes, and the linearity of the end portion can be formed high, and the end portion can be raised less, and the needle does not occur. The liquid crystal alignment film of the alignment of the holes.

即,具有由本發明之液晶配向處理劑所得的液晶配向膜之液晶顯示元件為,具有優良信賴性之物,適用於大畫面之高精細的液晶電視等,適用為TN元件、STN元件、TFT液晶元件,特別是垂直配向型之液晶顯示元件。 In other words, the liquid crystal display element having the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention has excellent reliability and is suitable for a high-definition liquid crystal television of a large screen, and is suitable for a TN element, an STN element, or a TFT liquid crystal. Components, especially vertical alignment type liquid crystal display elements.

另外使用由本發明之液晶配向處理劑所得的液晶配向膜製作液晶顯示元件時,相對於需照射紫外線之液晶顯示 元件也適用。 Further, when a liquid crystal display element is produced by using a liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention, a liquid crystal display is required to be irradiated with ultraviolet rays. The components are also suitable.

又,引用2012年2月22日所申請之日本特許出願2012-035918號說明書、專利申請範圍、圖面及摘要之全部內容,且納入本發明說明書中之揭示內容。 In addition, the entire contents of the specification, the patent application, the drawings and the abstract of the Japanese Patent Application No. 2012-035918, filed on Feb. 22, 2012, are hereby incorporated by reference.

Claims (16)

一種液晶配向處理劑,其特徵為含有下述成分(A)及成分(B),其中成分(A)為液晶配向處理劑所含的溶劑全體之5至70質量%,成分(B)為0.1至30質量%,成分(A):下述式〔1〕所表示之溶劑, (式〔1〕中,X1表示碳數1至3之烷基),成分(B):下述式〔2〕所表示之支鏈的二胺化合物作為原料之一部分用的聚醯亞胺先驅物及聚醯亞胺先驅物經醯亞胺化所得之聚醯亞胺所成群中選出的至少一種之聚合物, (式〔2〕中,Y1為單鏈、-(CH2)a-(a為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-;Y2為單鍵或-(CH2)b-(b為1至15之整數);Y3為單鍵、-(CH2)c-(c為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-;Y4為由苯環、環己烷環及雜環所成群中選出的二價之環狀基,或具有巢類骨架之碳數12至25的二價之 有機基,前述環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代;Y5為由苯環、環己烷環及雜環所成群中選出的二價之環狀基,該等環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代;n為0至4之整數;Y6為碳數1至18之烷基、碳數1至18的含氟之烷基、碳數1至18之烷氧基或碳數1至18的含氟之烷氧基)。 A liquid crystal alignment treatment agent comprising the following component (A) and component (B), wherein component (A) is 5 to 70% by mass of the solvent contained in the liquid crystal alignment treatment agent, and component (B) is 0.1. To 30% by mass, the component (A): a solvent represented by the following formula [1], (In the formula [1], X 1 represents an alkyl group having 1 to 3 carbon atoms), and the component (B): a branched diamine compound represented by the following formula [2] is used as a part of a raw material. a polymer of at least one selected from the group consisting of a precursor and a polyimine precursor obtained by quinone imidization of a polyimine. (In the formula [2], Y 1 is a single chain, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-; Y 2 Is a single bond or -(CH 2 ) b - (b is an integer from 1 to 15); Y 3 is a single bond, -(CH 2 ) c - (c is an integer from 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-; Y 4 is a divalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, or a carbon number 12 to 25 having a nest skeleton The divalent organic group, any hydrogen atom on the above cyclic group may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, or carbon a fluorine-containing alkoxy group or a fluorine atom substituted by 1 to 3; Y 5 is a divalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring, and a hetero ring, and the cyclic groups are Any hydrogen atom may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or fluorine. Atom substituted; n is an integer from 0 to 4; Y 6 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a carbon number of 1 to 18 Fluorinated alkoxy). 如申請專利範圍第1項之液晶配向處理劑,其中前述具有式〔2〕所表示之支鏈的二胺化合物為,下述式〔2a〕所表示之二胺化合物, (式〔2a〕中,Y1為單鍵、-(CH2)a-(a為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-;Y2為單鍵或-(CH2)b-(b為1至15之整數);Y3為單鍵、-(CH2)c-(c為1至15之整數)、-O-、-CH2O-、-COO-或-OCO-;Y4為由苯環、環己烷環及雜環所成群中選出的二價之環狀基,或具有巢類骨架之碳數12至25的二價之有機基,前述環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代;Y5為由苯環、 環己烷環及雜環所成群中選出的二價之環狀基,該等環狀基上之任意氫原子可被碳數1至3之烷基、碳數1至3之烷氧基、碳數1至3的含氟之烷基、碳數1至3的含氟之烷氧基或氟原子取代;n為0至4之整數;Y6為碳數1至18之烷基、碳數1至18的含氟之烷基、碳數1至18之烷氧基或碳數1至18的含氟之烷氧基;m為1至4之整數)。 The liquid crystal alignment treatment agent of the first aspect of the invention, wherein the branched diamine compound represented by the formula [2] is a diamine compound represented by the following formula [2a], (In the formula [2a], Y 1 is a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-; Y 2 Is a single bond or -(CH 2 ) b - (b is an integer from 1 to 15); Y 3 is a single bond, -(CH 2 ) c - (c is an integer from 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-; Y 4 is a divalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, or a carbon number 12 to 25 having a nest skeleton The divalent organic group, any hydrogen atom on the above cyclic group may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, or carbon a fluorine-containing alkoxy group or a fluorine atom substituted by 1 to 3; Y 5 is a divalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring, and the cyclic groups are Any hydrogen atom may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or fluorine. Atom substituted; n is an integer from 0 to 4; Y 6 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a carbon number of 1 to 18 Fluorinated alkoxy; m is an integer from 1 to 4. 如申請專利範圍第1或2項之液晶配向處理劑,其中前述具有式〔2〕所表示之支鏈的二胺化合物或式〔2a〕所表示之二胺化合物為,二胺成分中之5至80莫耳%。 The liquid crystal alignment treatment agent according to claim 1 or 2, wherein the branched diamine compound represented by the formula [2] or the diamine compound represented by the formula [2a] is 5 of the diamine component. Up to 80% by mole. 如申請專利範圍第3項之液晶配向處理劑,其中前述成分(B)為,使用含有下述式〔3〕所表示之四羧酸二酐的四羧酸二酐成分之聚合物, (式〔3〕中,Z1為由下述式〔3a〕至式〔3j〕所成群中選出的至少一種之構造) (式〔3a〕中,Z2至Z5為氫原子、甲基、氯原子或苯環,可各自相同或相異,式〔3g〕中,Z6及Z7為氫原子或甲基,可各自相同或相異)。 The liquid crystal alignment treatment agent of the third aspect of the invention, wherein the component (B) is a polymer containing a tetracarboxylic dianhydride component of a tetracarboxylic dianhydride represented by the following formula [3], (In the formula [3], Z 1 is a structure of at least one selected from the group consisting of the following formulas [3a] to [3j]) (In the formula [3a], Z 2 to Z 5 are a hydrogen atom, a methyl group, a chlorine atom or a benzene ring, and may be the same or different. In the formula [3g], Z 6 and Z 7 are a hydrogen atom or a methyl group. Can be the same or different). 如申請專利範圍第1或2項之液晶配向處理劑,其中含有成分(C)用,由N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮及γ-丁內酯所成群中選出的至少一種之溶劑。 A liquid crystal alignment treatment agent according to claim 1 or 2, which comprises component (C), which is grouped by N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone and γ-butyrolactone. At least one solvent selected. 如申請專利範圍第5項之液晶配向處理劑,其中含有成分(D)用,由1-己醇、環己醇、1,2-乙二醇、1,2-丙二醇、乙二醇單甲基醚、乙二醇單乙基醚、乙二醇單丁基醚、二乙二醇單甲基醚、二乙二醇單乙基醚、二乙二醇單丁基醚、丙二醇單甲基醚、丙二醇單乙基醚及丙二醇單丁基醚所成群中選出的至少一種之溶劑。 The liquid crystal alignment treatment agent of claim 5, which comprises the component (D), which is composed of 1-hexanol, cyclohexanol, 1,2-ethanediol, 1,2-propanediol, ethylene glycol monomethyl Ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl A solvent selected from the group consisting of ether, propylene glycol monoethyl ether, and propylene glycol monobutyl ether. 如申請專利範圍第1或2項之液晶配向處理劑,其中前述成分(A)為液晶配向處理劑所含的溶劑全體之5至60質量%。 The liquid crystal alignment treatment agent according to claim 1 or 2, wherein the component (A) is 5 to 60% by mass based on the total amount of the solvent contained in the liquid crystal alignment treatment agent. 如申請專利範圍第5項之液晶配向處理劑,其中前述成分(C)為液晶配向處理劑所含的溶劑全體之40至 80質量%。 The liquid crystal alignment treatment agent according to claim 5, wherein the component (C) is a solvent of the liquid crystal alignment treatment agent 80% by mass. 如申請專利範圍第6項之液晶配向處理劑,其中前述成分(D)為液晶配向處理劑所含的溶劑全體之1至50質量%。 The liquid crystal alignment treatment agent of the sixth aspect of the invention, wherein the component (D) is from 1 to 50% by mass based on the total amount of the solvent contained in the liquid crystal alignment treatment agent. 一種液晶配向膜,其為使用如申請專利範圍第1至9項中任何一項之液晶配向處理劑所得。 A liquid crystal alignment film obtained by using a liquid crystal alignment treatment agent according to any one of claims 1 to 9. 一種液晶配向膜,其為使用如申請專利範圍第1至9項中任何一項之液晶配向處理劑,由噴墨印刷法所得。 A liquid crystal alignment film obtained by an inkjet printing method using a liquid crystal alignment treatment agent according to any one of claims 1 to 9. 一種液晶顯示元件,其為具有如申請專利範圍第10或11項之液晶配向膜。 A liquid crystal display element which is a liquid crystal alignment film having a 10th or 11th aspect of the patent application. 如申請專利範圍第10或11項之液晶配向膜,其為使用於液晶顯示元件,該液晶顯示元件為一對備有電極之基板之間具有液晶層,且前述一對基板之間配置含有藉由活性能量線及熱中至少一方而聚合之聚合性化合物的液晶組成物,經由一邊將電壓施加於前述電極間且一邊使前述聚合性化合物聚合之步驟所製造。 The liquid crystal alignment element according to claim 10 or 11, which is used for a liquid crystal display element having a liquid crystal layer between a pair of electrodes provided with electrodes, and the arrangement between the pair of substrates is included A liquid crystal composition of a polymerizable compound polymerized by at least one of an active energy ray and a heat is produced by a step of polymerizing the polymerizable compound while applying a voltage between the electrodes. 一種液晶顯示元件,其為具有如申請專利範圍第13項之液晶配向膜。 A liquid crystal display element which is a liquid crystal alignment film having a thirteenth aspect of the patent application. 如申請專利範圍第10或11項之液晶配向膜,其為使用於液晶顯示元件,該液晶顯示元件為一對備有電極之基板之間具有液晶層,且前述一對基板之間配置含有藉由活性能量線及熱中至少一方而聚合之聚合性基的液晶配向膜,經由一邊將電壓施加於前述電極間且一邊使前述聚 合性基聚合之步驟所製造。 The liquid crystal alignment element according to claim 10 or 11, which is used for a liquid crystal display element having a liquid crystal layer between a pair of electrodes provided with electrodes, and the arrangement between the pair of substrates is included A liquid crystal alignment film of a polymerizable group polymerized by at least one of an active energy ray and a heat is applied to the electrode while applying a voltage therebetween Manufactured by the step of synthesizing the base. 一種液晶顯示元件,其為具有如申請專利範圍第15項之液晶配向膜。 A liquid crystal display element which is a liquid crystal alignment film having a fifteenth item of the patent application.
TW102106205A 2012-02-22 2013-02-22 A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device TWI568796B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012035918 2012-02-22

Publications (2)

Publication Number Publication Date
TW201343788A TW201343788A (en) 2013-11-01
TWI568796B true TWI568796B (en) 2017-02-01

Family

ID=49005777

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102106205A TWI568796B (en) 2012-02-22 2013-02-22 A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device

Country Status (5)

Country Link
JP (3) JPWO2013125595A1 (en)
KR (1) KR102035366B1 (en)
CN (1) CN104136542B (en)
TW (1) TWI568796B (en)
WO (1) WO2013125595A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6146135B2 (en) * 2012-08-30 2017-06-14 Jsr株式会社 Liquid crystal aligning agent, liquid crystal aligning film, method for producing liquid crystal aligning film, and liquid crystal display element
TWI547524B (en) * 2012-10-18 2016-09-01 Nissan Chemical Ind Ltd A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
KR20150070276A (en) * 2012-10-18 2015-06-24 닛산 가가쿠 고교 가부시키 가이샤 Composition, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
TWI542632B (en) * 2012-10-18 2016-07-21 Nissan Chemical Ind Ltd A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
KR20150067335A (en) * 2012-10-18 2015-06-17 닛산 가가쿠 고교 가부시키 가이샤 Composition, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
ES2769244T3 (en) * 2014-11-07 2020-06-25 Nissan Chemical Corp Liquid crystal display device
JP2016138236A (en) * 2014-12-26 2016-08-04 Jsr株式会社 Composition, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
JP6798550B2 (en) * 2016-03-31 2020-12-09 日産化学株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
CN110651221B (en) * 2017-05-22 2021-10-22 日产化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
JPWO2019022202A1 (en) * 2017-07-27 2020-05-28 日産化学株式会社 Resin composition, resin film and liquid crystal display device
KR20200079315A (en) * 2017-11-21 2020-07-02 닛산 가가쿠 가부시키가이샤 Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element
JP7375544B2 (en) * 2017-11-21 2023-11-08 日産化学株式会社 Liquid crystal alignment agent, liquid crystal alignment film, method for producing liquid crystal alignment film, and liquid crystal display element
CN111868620B (en) * 2018-03-19 2023-11-03 日产化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
WO2021065933A1 (en) 2019-10-02 2021-04-08 日産化学株式会社 Liquid crystal light control element
TW202130794A (en) 2019-11-26 2021-08-16 日商日產化學股份有限公司 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200900433A (en) * 2007-03-02 2009-01-01 Cheil Ind Inc Liquid crystal aligning agent and liquid crystal alignment layer formed using the same
WO2011132751A1 (en) * 2010-04-22 2011-10-27 日産化学工業株式会社 Liquid-crystal alignment agent, liquid-crystal alignment film, and liquid-crystal display element

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0237324A (en) 1988-07-27 1990-02-07 Sanyo Electric Co Ltd Production of polyimide oriented film
JP3561786B2 (en) * 1994-04-19 2004-09-02 チッソ株式会社 How to use varnish
JP3603289B2 (en) * 1996-02-20 2004-12-22 Jsr株式会社 Liquid crystal alignment agent and liquid crystal display device
JPH095753A (en) * 1995-06-26 1997-01-10 Sumitomo Bakelite Co Ltd Liquid crystal orienting agent
JPH10253965A (en) * 1997-03-14 1998-09-25 Sharp Corp Production of liquid crystal display device
US7303792B2 (en) * 2002-12-11 2007-12-04 Nissan Chemical Industries, Ltd. Diaminobenzene derivative, polyimide precursor and polyimide obtained therefrom, and aligning agent for liquid crystal
WO2004072719A1 (en) * 2003-02-12 2004-08-26 Nissan Chemical Industries, Ltd. Aligning agent for liquid crystal and liquid-crystal alignment film obtained with the same
JP4779339B2 (en) * 2003-11-05 2011-09-28 Jnc株式会社 Liquid crystal aligning agent and liquid crystal display element using the same
JP4806988B2 (en) * 2005-07-26 2011-11-02 Jnc株式会社 Varnish composition
WO2008153101A1 (en) * 2007-06-15 2008-12-18 Nissan Chemical Industries, Ltd. Resin composition for forming heat-cured film
WO2009148100A1 (en) * 2008-06-04 2009-12-10 日産化学工業株式会社 Liquid crystal aligning agent and liquid crystal display element using same
RU2011126148A (en) * 2008-11-27 2013-01-10 Шарп Кабусики Кайся LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR ITS MANUFACTURE
JP5522384B2 (en) * 2010-04-20 2014-06-18 Jsr株式会社 Manufacturing method of liquid crystal display element
WO2012014898A1 (en) * 2010-07-26 2012-02-02 日産化学工業株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200900433A (en) * 2007-03-02 2009-01-01 Cheil Ind Inc Liquid crystal aligning agent and liquid crystal alignment layer formed using the same
WO2011132751A1 (en) * 2010-04-22 2011-10-27 日産化学工業株式会社 Liquid-crystal alignment agent, liquid-crystal alignment film, and liquid-crystal display element

Also Published As

Publication number Publication date
CN104136542B (en) 2016-05-25
CN104136542A (en) 2014-11-05
KR102035366B1 (en) 2019-10-22
TW201343788A (en) 2013-11-01
JP2020056034A (en) 2020-04-09
KR20140129217A (en) 2014-11-06
JPWO2013125595A1 (en) 2015-07-30
JP2018083943A (en) 2018-05-31
WO2013125595A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
TWI568796B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TWI486380B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP5257548B2 (en) Liquid crystal display element and liquid crystal aligning agent
TWI586757B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
TWI637043B (en) Liquid crystal display element, liquid crystal alignment film, and liquid crystal alignment treatment agent
TWI547524B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TWI564283B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TWI513753B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TWI638008B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TW201510078A (en) Liquid crystal display element, liquid crystal alignment film and liquid crystal aligning agent
JP5900337B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI635135B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TW201514248A (en) Liquid-crystal orientation treatment agent, liquid-crystal orientation film, and liquid-crystal display element
TW201504282A (en) Liquid crystal display element, liquid crystal alignment film, and liquid crystal alignment treatment agent
TWI623518B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI627202B (en) Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI545147B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI633128B (en) Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TW201500462A (en) Polymer, liquid crystal orientation treating agent, liquid crystal orientation film and liquid crystal display element
TWI649411B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI575022B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI542633B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TWI542632B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TW201602242A (en) Liquid crystal display element, liquid crystal alignment film, and liquid crystal alignment treatment agent